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Abstract 
The importance of monitoring, and where possible reducing, the level of radiation dose from 
diagnostic X-ray examinations has been recognised for many years and is becoming of increasing 
concern. Dose reduction is of particular concern in paediatric radiology, and there are specific 
problems associated with the monitoring and comparison of radiation doses to children. 
Any optimisation study relies on a framework of good dosimetry. Two techniques have been 
developed to improve the collection of patient dose data: the automation of survey techniques 
to increase the quantity of data collected; and a method of correcting for patient size which 
reduces one source of variability in the data. An optimisation strategy has been developed, 
consisting of theoretical simulations, experimental verification and clinical implementation. 
Monte Carlo techniques were used for the theoretical study, which investigated the effect of 
beam filtration on radiation dose and image quality for a wide range of parameters, specifically 
for a neonatal size phantom. Simulations included both radiography of bone in soft tissue and 
fluoroscopy of iodine and barium based contrast media. The results were assessed in terms of 
the beam spectra and the absorption and transmission characteristics of the phantom and image 
receptor. Experimental measurements of dose and contrast were made for a simple slab phantom 
corresponding to that simulated, and results showed good agreement with those predicted. A 
further set of experimental measurements were carried out using anthropomorphic phantoms in 
a clinical setting, which demonstrated how the theoretical predictions translated to clinical 
practice. A clinical trial of the use of a 0.1mm copper filter for fluoroscopic examinations of 
infants was performed, and the filter shown to give substantial dose reduction with no significant 
loss in image quality. Some general recommendations on dose quantities and the application of 
optimisation strategies to paediatric radiology have been made. 
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Chapter 1 
Introduction 
Diagnostic X-rays have been in use for over a hundred years and whereas their usefulness 
has never been in question, there is a growing awareness of the associated radiation risks 
both in the scientific and lay communities. Diagnostic radiology accounts for ninety-five 
percent of the UK population dose from man-made radiation, a total of approximately twenty 
thousand man sieverts (Hughes and O'Riordan, 1993). The importance of monitoring, and 
where possible reducing, the level of radiation doses from diagnostic X-ray examinations has 
been recognised for many years, and is becoming of increasing concern. Recent years have 
seen initiatives from the Commission of the European Communities (EUR 16260,1996; EUR 
16261,1996), the World Health Organisation (WHO 689,1986; WHO 757,1987) and, in 
the UK, the National Radiation Protection Board (IPSM, 1992) dealing specifically with this 
issue. 
Radiation dose from diagnostic X-ray examinations has been the subject of much 
investigation over the years. Early work often focussed specifically on either gonadal dose 
from a variety of X-ray examinations (Clayton et al, 1957; Johns and Wilson, 1958) or on 
obstetric radiography (Bewley et al, 1957). This reflected the chief concerns at that time, 
which were the genetically significant dose and foetal doses, as such doses affected 
individuals who were not directly benefiting from the radiographic examination. Since then, 
analysis of the available risk data has shown genetic effects to be less significant at low doses 
than first thought (ICRP 60,1990) and advances in ultrasound have rendered obstetric 
radiography less common. The main risk arising from low radiation doses, such as those 
from diagnostic radiology, is now taken to be that of carcinogenesis (ICRP 60,1990) and 
the principle of keeping medical irradiation As Low As Reasonably Achievable applies. As 
a results of this, the clinical benefit to the patient of a diagnostic X-ray examination does not 
diminish the importance of monitoring and where possible reducing their dose. 
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The first large scale dose survey to be carried out in Britain was that of the Adrian 
committee (1959,1960,1966) and this concluded that the benefit to the patient of carrying 
out radiological examination outweighed both the risk of cancer induction and the slight 
genetic risk. It was also shown that if the radiography standards in all hospitals were raised 
to those of the best 25%, the genetically significant dose would be reduced by a factor of 7. 
This raised the significant problem of large fluctuations in radiation dose for what is 
nominally the same examination, which was then highlighted in a number of national surveys 
including Australia (Morris, 1983), the USA (Johnson and Goetz, 1986) and England 
(Shrimpton et al, 1986) besides regional surveys in Britain (Harrison et al, 1983). Differences 
in both radiological practices and patient doses were also identified between countries 
(Contento et al, 1988). 
The legislative framework for radiation protection of the patient was established in the 
Ionising Radiations Regulations (1988) (POPUMET), and guidelines have been drawn up by 
both the National Radiological Protection Board (NRPB, 1990) and the Royal College of 
Radiographers (CoR, 1990). In addition, a combined working party from the NRPB, CoR and 
Institute of Physical Sciences in Medicine (IPSM) has drawn up a National Protocol for 
patient dose measurement in diagnostic radiology (IPSM, 1992), to encourage both the 
continued collection of patient dosimetry data and a uniform manner of collection. 
Over recent years, the advent of new technology, such as carbon fibre tabletops, rare-earth 
screens and sophisticated digital equipment has helped to decrease doses from individual 
examinations, as has increasing awareness of the radiation detriment to the patient (Rainbow 
and Cockshott, 1989). This is well illustrated by comparison of the results from the most 
recent British surveys (Shrimpton et al, 1986; Hart et al, 1996) in which patient doses per 
examination were shown to have fallen by around 30% for most examinations. This 
reduction, however, is offset by the increasing numbers of radiological examinations and 
particularly the more widespread use of X-ray computed tomography, so that the population 
dose from diagnostic radiology has not fallen in the same way, and is expected to increase 
over the next decades. The most recent national survey also demonstrates that variation in 
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performance between hospitals is still substantial, indicating continuing scope for patient dose 
reduction. 
1.1 Paediatric radiology 
Dose reduction is of particular concern in paediatric radiology for a number of reasons. 
Firstly, and most importantly, there is a greater chance for expression of radiation induced 
effects for children than for the adult population. Children are usually considered to be at 
greater risk for certain types of cancer (Stather et al, 1988), although there is not general 
agreement (Muirhead et al, 1993), mainly due to the uncertainty in the risk data which arises 
from the fact that for the main data source - that from the Japanese atomic bomb survivors - 
people irradiated as children have not yet lived long enough for all possible radiation effects 
to be observed. There is even greater uncertainty over genetic risk factors, as it will take 
considerable time before any radiation induced effects can be traced through the genetic pool. 
This represents an additional potential hazard from irradiation of a paediatric population. For 
neonates, especially those born prematurely, the most appropriate risk factors are almost 
certainly those used for foetal irradiation, which are higher than those for the general 
population, although uncertainties are again large. Another factor to consider is that some 
examinations are carried out with greater frequency for children. In particular, premature or 
sick neonates may receive a large number of X-ray examinations during the first few months 
of life, as their condition is monitored, and this can sometimes continue throughout early 
childhood. Finally, children will often be uncooperative during X-ray examination, thus 
requiring repeat or longer exposures. 
There are particular problems associated with monitoring radiation doses to children. As 
doses are generally significantly lower than for adults, sometimes comparable with 
background fluctuations, greater sensitivity is required in equipment used to record accurately 
dose parameters such as entrance skin dose or dose-area product. This may require purchase 
of specialised equipment, or development of specific techniques for making measurements 
(Broadhead et al, 1997). There are also sparse data available for converting such parameters 
to quantities more directly related to risk, such as energy imparted or effective dose. Factors 
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for deriving energy imparted are limited to the work of Persliden and Sandborg (1993) and 
a general method for estimation of dose distributions using depth dose curves (Almen and 
Nilsson, 1996). Conversion factors for some organ doses have been published (Rosenstein 
et al, 1979; Zankl et al, 1989) and also coefficients for estimating effective dose (Hart et al, 
1996). Such factors exist only for specifically defined patient sizes and examination types, 
and extrapolation to different situations needs to be carried out with care. While this is true 
of all such data, it is particularly important for children whose small size means that critical 
organs will often be close to the edge of the radiation field, which increases the difficulty in 
applying normalised organ dose data when the examination geometry differs from that 
modelled. 
Comparisons of paediatric dose data are also problematic, due to the wide range of patient 
sizes involved. The term `paediatric' applies to a wide range of patients, from a premature 
neonate, who may weigh as little as a few kg, to a young adult of 16 who may be fully 
grown, with a continuous spectrum of sizes in between. This size variability creates problems 
in both the actual dosimetry such as the application of organ dose data, as described above, 
and in the analysis of data, as a simple dose quantity measured for different sized patients 
cannot meaningfully be compared. Although many authors have highlighted the problems 
arising from paediatric size variations (Maillie et al, 1981; Lindskoug, 1997; Almen et al, 
1995), and several have studied the effect (Martin et al, 1995; Wraith et al, 1996), there is 
still no consensus on the best method for addressing the problem, or even the most suitable 
age or size banding to use. The most commonly adopted approach at present is to group 
paediatric dose data in bands according to patient age, with suitable bands defined by the 
CEC (1992). However, there are two problems with this approach. Firstly, the size of a 
patient cannot be reliably linked to his age as, although mean or typical size parameters are 
well publicised, there is considerable variation around these figures. Secondly, even if a 
given age band represented a given band of patient sizes the variation within the band would 
still be large. The use of smaller age or size bands, with correspondingly less variability, 
automatically decreases the amount of data in each group, thus increasing other statistical 
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uncertainties. This issue of size is one of the most fundamental problems in paediatric 
dosimetry, and is addressed in this work. 
Although many surveys have been performed of radiation dose to patients undergoing 
diagnostic radiology, very little of this data relates to paediatric radiology. For instance, the 
1985 National Survey of doses to patients in Britain reports a total of around four thousand 
dose measurements, of which just over one hundred are for children (Shrimpton et al, 1986). 
In the more recent survey, only around 500 of the 52 thousand measurements received by 
the national collation centre were for children (Hart et al, 1996). This lack of data results 
chiefly from the problems described above, and the development of techniques for collecting 
paediatric dose data and the establishment of a paediatric dose database are essential 
components of the work presented here. A review of published paediatric dose data, and the 
methodologies used is given in Chapter 3. 
1.2 Optimisation 
The recommended system for dose limitation for persons undergoing medical exposure is 
based on the principles of justification and optimisation (ICRP 60,1990) ie an exposure must 
be clinically necessary and the radiation dose should be as low as reasonably achievable 
(ALARA). It is important, however, that any radiation risk is balanced against the clinical 
benefit to the patient of performing the examination. Variations in patient dose resulting from 
changes in technique cannot be viewed in isolation, as the associated change in image quality 
must also be considered. An examination performed with minimal radiation dose is of no 
value if it is diagnostically unacceptable and a repeat exposure is required. The indexes used 
to assess image quality must be selected with care, and the required information content for 
the procedure taken into consideration. Not all examinations require the same level of image 
quality eg the detection of an intussusception (a fairly gross intestinal malformation) in a 
small child can be performed with much lower image quality than that required for a skeletal 
survey performed to exclude the possibility of non-accidental injury. The dose quantity used 
for comparison must also be chosen carefully. In addition to being easily and reproducibly 
measurable, the doses described should be related to the radiation risk to the patient. It is 
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essential that the development and implementation of an optimisation strategy must be based 
on a framework of good dosimetry (in both quality and quantity), in order to establish the 
need for such optimisation and to demonstrate its benefits. 
Suggested optimal techniques for paediatric patients have been documented by the CEC 
(1996) but are fairly general in nature, being designed to apply to ".. normal basic 
radiographs which could address any clinical indication" with little scientific work 
referenced to justify the recommendations. The recommendations are made for a limited 
number of patient ages and the examination categories include only plain film radiography 
with the exception of micturating cysturethrography which is carried out under fluoroscopic 
control. As the practice of paediatric radiology encompasses a wide range of variable 
parameters: patient age and size; examination type; clinical indications; available equipment; 
individual radiologist preferences etc, the concept of patient and examination specific 
optimisation is an important consideration. While general recommendations may be a useful 
starting point for a departmental optimisation strategy, an understanding of the underlying 
science and the effect of variations in the recommended technique parameters is required to 
be able to apply them successfully to a particular situation. 
1.2.1 Filtration 
Many potential methods of dose reduction have been investigated over the years, including 
the use of new technology such as carbon fibre tables and rare earth screens (Herman et al, 
1987; Burton et al, 1988; Faulkner et al, 1989), careful use of protective devices (Faulkner 
et al, 1989; Kenny and Hill, 1992) and the selection of technique factors. All these are 
important aspects of the optimisation process, as are the technical practices of both 
radiographers and radiologists. One specific method of reducing dose is the shaping of the 
X-ray beam spectrum through the use of additional or replacement filter material (Jennings, 
1988; Carrier and Beique, 1992; Sandborg et al, 1994). The use of so called 'k-edge' filters 
has been of particular debate, as these have been thought to shape the beam spectrum in an 
optimal manner. Investigations into the effectiveness of such filters have been carried out in 
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a number of ways, as described fully in Chapter 4, and opinion is divided on the efficacy of 
the technique. 
This study involved the assessment of beam filtration as an optimisation tool for several 
reasons: 
0 Unlike some other parameters, such as the use of rare-earth screens, which are 
proven and generally accepted as dose reducing, there is no consensus on what 
constitutes `optimal' filtration. 
0 Changes in filtration can generally be implemented relatively easily on a clinical 
basis, compared to the purchase of new 'dose saving' equipment. 
0 Filtration may also, in principle, be changed on an examination by examination basis, 
and so constitutes a potential method of patient and examination specific 
optimisation. 
1.2.2 Optimisation methodologies 
A variety of techniques has been used to perform optimisation studies. Generally, they may 
be classed as theoretical, experimental or clinical techniques, and each has advantages and 
disadvantages. Theoretical studies may be analytical in nature, with a situation modelled 
mathematically from the underlying physics of the problem, usually employing simplifying 
assumptions (Koedooder and Venema, 1986; Jennings, 1988). Such an approach may be 
straightforward to carry out, but the necessary simplification of the theory eg neglect of 
scatter, may bias the results or lead to the neglect of interesting effects. The other common 
theoretical technique employed is that of Monte Carlo simulation, where the random 
trajectories and interactions of particles ('histories') are monitored individually, by sampling 
the probability distributions of possible events. The cumulation of a large number of such 
histories is used to determine quantities of interest (Shrimpton et al, 1988; Sandborg, 1994). 
Such simulations can be used to characterise radiation behaviour on an interaction by 
interaction basis, thus generating a more realistic representation and therefore more accurate 
results than a simple mathematical model. However, such code is complex to use, and may 
take considerable time to `run' simulations to the required degree of accuracy. 
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Experimental measurements may be carried out using simplified phantoms, such as slab or 
water phantoms to represent the patient (Regano and Sutton, 1992), or by using 
anthropomorphic phantoms. The latter should give a good anatomical representation of the 
human body, but may not always show the correct attenuation properties for the desired 
beam spectra, as they are often designed for a use in a wide range of radiation work. Clinical 
studies use measurements made on actual patients to assess an optimisation technique, and 
so should always be the end point of an optimisation study, but for ethical reasons such 
measurements can only be used to confirm predictions of improved performance. 
Theoretical studies usually have the advantage of allowing variation of a wide range of 
parameters and may be very accurate, within the limitations of any assumptions that are 
made. Experimental work will involve measurement uncertainties, will often be more 
restrictive in scope, but should yield a more realistic picture of what is actually happening, 
and take account of local factors such as limitations in equipment. Clinical studies will be 
even more representative of actual practice, but often involve only subjective assessment of 
image quality, and are likely to be affected by statistical uncertainties. Ideally, assessment 
of an optimisation strategy should include each type of methodology. 
1.3 Summary of background 
In summary, although the collection and study of patient dosimetry data has become an 
active field, there is still a paucity of high quality paediatric dose data, and no suitable 
method for taking individual patient size into account when monitoring doses. General 
methods of optimisation and dose reduction have often been developed with the adult 
population in mind, and are not always directly transferable to a paediatric population. The 
concept of patient and examination specific optimisation needs to be more fully explored, 
particularly in relation to paediatric radiology. Consideration of the dose and image quality 
indexes used in optimisation studies has not always been sufficient and, finally, no such study 
should be considered complete until it has reached the stage of successful clinical 
implementation. 
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1.4 Purpose of work 
The aims of this work were as follows: - 
(1) to devise a method of collecting and utilising paediatric dose data, to perform a large 
scale survey of doses in a number of hospitals. 
(2) to address the question of accounting for patient size. 
(3) to collect data for fluoroscopic examinations on children, from departments across 
the north of England, to study the dose levels and factors affecting them. 
(4) to consider the principles of optimisation as applied to paediatric radiology, and look 
at the use of different dose and image quality indices. 
(5) to look specifically at optimisation of beam spectra, using different filter materials; 
firstly employing Monte Carlo techniques in order to allow variation of a wide range 
of parameters, followed by a more selective study using phantoms to verify the 
theoretical results and form a link to clinical practice. 
(6) to implement results using a clinical trial to assess the practicalities of any suggested 
modification to current X-ray technique. 
Although the development of the data collection and optimisation strategy was designed to 
apply to all paediatric age-ranges, the main focus for the simulations was neonatal radiology. 
This age-group is the extreme example for most of the considerations that have been outlined 
in the first section, with respect to both risk and dosimetric problems. It also represents the 
subset of the population furthest from the `reference man' for which the majority of radiation 
protection work has been carried out. The application of the methods to older age groups was 
considered, and tested by a set of preliminary Monte Carlo simulations. 
1.5 Outline of thesis 
Chapter 2 contains a discussion of the different methods used to describe patient dose, 
including their advantages and disadvantages and their applicability to this work. Chapter 3 
discusses the problems associated with the large scale collection of paediatric dose data, 
along with a brief review of work published to date. A method of automating dose data 
collection is described and a technique for correcting collected data to a number of standard 
patient sizes is developed, in order to facilitate comparisons of the data. The results of a 
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survey of paediatric doses from fluoroscopic examinations around the north of England are 
also presented. Chapter 4 contains a consideration of the different factors that must be 
considered in the optimisation of dose and image quality, and the choice of quantities to be 
used in studying these parameters. A discussion of radiation filters and their effects is also 
given here, along with a review of published work in this area. Chapter 5 describes the 
principles of Monte Carlo simulation and the development of the code used in this work, and 
the results of the Monte Carlo simulations are described in chapter 6. Chapter 7 describes the 
phantoms and methodology used for the experimental study, and chapter 8 the results of the 
experimental optimisation study. The clinical implementation of the ensuing results is 
described in chapter 9. The application of the work to other age groups, and examination 
categories is considered in chapter 10, along with suggestions for further work, and the 
conclusions from the work are given in chapter 11. The full set of results from the dose 
survey is presented in Appendix A, and Appendix B contains a full listing of the user code 
written for the Monte Carlo simulations. A description of the Mortran programming language 
used in the Monte Carlo code is given in Appendix C and Appendix D contains the forms 
used in the clinical trial. 
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Chapter 2 
Radiation Dose Assessment 
2.1 Introduction 
The development and application of any optimisation strategy relies on a framework of good 
dosimetry. The reasons for this are, firstly, to establish where potential for optimisation lies 
and, secondly, to be able to assess the effect of any changes made. Radiation dose to a 
patient may be described in several different ways, including both measurable and calculated 
quantities. The most common dose descriptors are entrance skin dose, effective dose, dose 
area product and energy imparted. In this chapter each of these will be discussed, along with 
their associated measurement and calculation methods. The usefulness of each of these 
quantities has been assessed in terms of their ease of measurement; their comparability when 
used in differing circumstances; and their relationship to the radiation risk to the patient. 
Their specific application to paediatric dosimetry has also been addressed. A section is also 
included to discuss the concept of radiation risk and data pertaining to it. 
2.2 Radiation risk 
Radiation dose to an individual is only important in so much as it carries with it an associated 
risk. Radiation risks may be divided into those that are stochastic in nature ie the probability 
of occurrence increases with the dose received, and those that are non-stochastic or 
deterministic, where a minimum dose must be received before the effect is exhibited. In 
diagnostic radiology it is rare for patient doses to exceed those for which deterministic effects 
may be shown, except for some high dose interventional procedures, so it is the stochastic 
risks that are generally of concern. The chief of these is the risk of cancer induction. Possible 
genetic effects may also have to be considered. 
There are several sources of data from which radiation risk estimates have been assessed. The 
most important of these is the follow up of the Japanese atomic bomb survivors. There is a 
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large amount of uncertainty in the extrapolation of the risk data, particularly down to low 
doses, but it is generally accepted that there is no threshold dose for the risk of cancer 
induction (ICRP, 1991). Risk data for paediatrics is even less well established, as sufficient 
time has not yet elapsed for all possible late effects to be observed. It is suggested though 
that the relative probability of cancer induction in the various organs is different for the 
paediatric population than for the adult population (ICRP, 1991). Changes in the way existing 
data is analysed, and acquisition of further data may both alter current perceptions of risk in 
the future. All risk data must therefore be used with caution, and uncertainties assumed to 
be a factor of at least 2. 
2.3 Entrance skin dose 
Entrance skin dose (ESD), usually expressed in mGy, is the maximum dose at a point on the 
surface of the patient, where the X-ray beam enters the body. It is a very simple quantity to 
both measure and calculate. Measurement can be carried out using a thermoluminescent 
dosimeter (TLD), or by derivation from a dose area product measurement (see Section 2.5 
below) when the entrance field size is known or measured. It can be calculated from the 
technique factors used for the examination and knowledge or assumption of the tube output, 
using the following equation. 
W 
ESD = OUTPUT x 
kV 
x mAs x1x BSF 
802 FSD 2 
where OUTPUT is defined in terms of absorbed dose per unit mAs, at 80kV, lm from the 
tube focus. FSD is the focus-skin distance, kV the generating tube potential, and mAs the 
product of tube current and exposure time. BSF is the back scatter factor, values of which 
are tabulated for different beam qualities, field sizes, and patient thicknesses. The formula 
uses the assumption that output is proprtional to the square of the generating tube potential, 
as is commonly held, but this is not always valid so for greater accuracy the output should 
be measured at each kV of interest. ESD has the advantage of being commonly used in a 
wide range of circumstances, and is the recommended quantity for patient dose assessment 
for simple examinations in adults, for the establishment of reference doses (IPSM, 1992). 
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There are, however, disadvantages to using entrance skin dose as a measure of patient dose. 
Firstly, for complex fluoroscopic examinations there will not be a single entrance point for 
the X-ray beam, so that the measurement will be highly dependent on the exact location 
chosen, and will not adequately represent the entire examination. In addition to this, the 
quantity is not directly related to radiation risk, unless being used to assess the probability 
of skin erythema occurring in high dose interventional procedures. Although useful for 
comparing doses from similar procedures, if very different energy spectra are used in two 
irradiations, measurement of surface dose alone may be a very poor indicator of the change 
in overall patient dose. 
2.4 Effective dose 
Effective dose cannot be measured directly, but is a derived quantity that can be related to 
radiation risk. It is calculated from a weighted sum of organ doses, and was introduced by 
the International Commission on Radiological Protection (ICRP, 1991) as a means of 
assessing the risk to occupationally exposed persons, receiving non-uniform exposure. The 
tissue weighting factors are derived from radiation risk data as applicable to adult workers, 
and are given in table 2.1. The unit used for effective dose is mSv. 
Tissue 7 Weighting Factor 
gonads 0.20 
red bone marrow 0.12 
colon 0.12 
lung 0.12 
stomach 0.12 
bladder 0.05 
breasts 0.05 
liver 0.05 
oesophagus 0.05 
thyroid 0.05 
skin 0.01 
bone surface 0.01 
remainder 0.05 
Table 2.1 : Tissue weighting factors (the remainder comprises 
adrenals, brain, upper large inestine, small intestine, 
kidney, muscle, pancreas, spleen, thymus & uterus) 
Although this quantity is commonly used for assessing the risk from diagnostic X-ray 
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exposure, there are recognised problems in its application as the patient population is 
considerably different from the adult worker population, and the paediatric patient population 
is different again. There is very little justification for assuming that relative tissue sensitivities 
are the same in children as for adults. The calculation of effective dose requires the use of 
published organ dose data. Such data are normally quoted in relation to entrance surface dose, 
or occasionally relative dose area product, and may be derived from Monte Carlo calculations 
(Hart et al, 1996) or from TLD measurements in an anthropomorphic phantom (Broadhead, 
1998). Normalised organ dose factors are highly dependent on beam quality used and on the 
size and shape of the patient. They also apply only for the specific beam size and position 
for which they were derived. Appropriate data may not be available for the particular 
conditions of interest, especially for paediatric patients. Uncertainties in calculations of 
effective dose are considerable, due to the combination of uncertainties in assessment of the 
different organ doses, the radiation risk data used, and the extrapolation to different 
populations of people. These uncertainties make comparisons of effective dose between 
centres difficult. 
2.5 Dose area product 
Dose area product (DAP) is defined as the dose integrated over the beam area 
DAP = 
fD (xy) dx dy 
It is measurable directly, using a dedicated ionisation chamber attached to the X-ray tube. 
DAP is independent of distance from the tube, and may be taken to be equivalent to the 
product of the entrance surface dose (without backscatter) and the entrance field size. It is 
normally measured in terms of mGy cm2. Occasionally air kerma area product may be 
specified instead, when the DAP meter has been calibrated in terms of dose in air rather than 
dose in soft tissue. DAP is the recommended quantity for assessment of dose from complex 
X-ray examinations (IPSM, 1992). It is easy to compare results from such measurements, 
provided that the instruments used have been calibrated in a similar manner, and it is the only 
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reliable way of making dose assessments when the field of view is constantly changing 
throughout an examination. 
The drawbacks of the method are the initial cost of the DAP meter used to make the 
measurements and, for paediatrics in particular, the possibility that the beam area might 
extend outside the patient thus giving an inaccurate reflection of dose. Occasional practical 
difficulties may arise if, for instance, a department uses wedges for beam shaping that cannot 
be fitted easily in conjunction with the ionisation chamber. Factors are available to convert 
DAP measurements to risk estimates, under specific conditions (Le Heron, 1992), and also 
to values of effective dose (Hart et al, 1996). These are subject to the same problems and 
uncertainties as those described above for conversion from ESD to effective dose. 
2.6 Energy imparted 
The term `energy imparted' refers to the total amount of energy absorbed by the patient's 
body during the X-ray examination, measured in mJ. It may be derived from measurements 
of DAP by using published conversion factors (Carlsson et al, 1984; Persliden & Sandborg, 
1993). Data has also been published relating energy imparted to entrance dose for neonates 
(Chapple et al, 1994) When investigating the use of different beam spectra, comparison of 
energy imparted will give a better assessment of changes in patient dose than will a 
comparison of entrance surface dose alone, as it includes information about dose absorption 
throughout the body instead of just at the surface. It does not, however, make any allowance 
for individual organ radiosensitivities. 
An assessment of radiation risk may be made from energy imparted by calculating an 
equivalent effective dose, assuming the energy to have been absorbed uniformly by all 
radiosensitive organs in the body. For many anatomically specific examinations this 
approximation results in large uncertainties in the ensuing risk estimate, but its usefulness 
increases as the proportion of irradiated tissue to unirradiated tissue increases, as the 
approximation to whole body exposure improves. For fluoroscopic examinations of small 
children this condition is often well satisfied, as organs are all close together (for an infant, 
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the total length of the trunk may only be 30-40 cm long) and energy imparted may be the 
most appropriate way of assessing such doses. Energy imparted is not, however, in 
widespread current use - probably because of the almost universal acceptance of effective 
dose as a reliable risk estimator for patient dosimetry, in spite of the limitations discussed 
earlier. 
2.7 Summary 
The most easily measured dose quantities for assessment of patient dose are entrance surface 
dose and dose area product. From these, factors are available for calculating the risk related 
quantities effective dose and energy imparted. Although the former of these gives a well 
defined risk estimate, with consideration of the dose to and radiosensitivity of different 
organs, there are significant uncertainties in its general application. The most appropriate 
quantity to use in a given situation will depend on the reasons for carrying out the 
measurement (eg for specific comparative purposes; to determine the radiation risk for a 
specific patient; or as part of a routine dose survey) and the conditions under which it is 
made, including factors such as patient age and examination type. The correct choice of dose 
quantity may have a significant effect on the quality of the dosimetry data obtained. 
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Chapter 3 
Paediatric Dose Data 
3.1 Introduction 
The collection and analysis of patient dose data is a prerequisite for any optimisation study. 
The dosimetry techniques used must allow comparisons with other data, and the inherent 
variability in patient dose requires that large amounts of data need to be collected. This is 
necessary in order to draw significant conclusions about differences between groups and the 
effect on dose of the various parameters involved. Whereas this is true of all patient 
dosimetry, it is of particular importance in paediatric dosimetry (patients aged 0-16 years) as 
patient size variability is so much greater than for the adult population. This issue of size is 
crucial to the assessment of paediatric dose data. 
A number of authors have contributed to the existing information on paediatric X-ray doses 
over recent years, and their work is reviewed in this chapter in conjunction with some of the 
problems arising in paediatric dosimetry and recommended dosimetry methods. As part of 
this work, two techniques have been developed in order to improve both the quality and 
quantity of paediatric dose data, namely patient size correction and the automation of data 
collection to make large data sets available, and each is described in detail. The results of a 
survey of doses to paediatric patients, carried out using these techniques, are then described. 
3.2 Published data 
3.2.1 Dosimetric techniques 
The National Protocol for patient dose measurements makes recommendations on the type 
and frequency of dose assessments that should be performed in X-ray departments (IPSM, 
1992). Recommendations on sample size and criteria are also made, although there are no 
specific recommendations for paediatric dosimetry. The document states that the currently 
preferred dose measurement techniques are direct measurement using TLD for single 
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radiographs, and dose area product measurement using a calibrated dose area product (DAP) 
meter for complete examinations. A summary of the most recently published paediatric dose 
data, excluding that presented exclusively for neonates, is given in Table 3.1. 
TLDs have been used by a number of groups for the measurement of entrance surface dose 
on paediatric patrients (Smith et al, 1979; Almen and Mattsson, 1995; Martin et al, 1994; 
Persliden et al, 1996). For simple X-ray examinations, the low doses involved for young 
children give these measurements a high level of uncertainty. Entrance surface doses (ESD) 
may be as low as around 0.05 mGy for a neonatal chest X-ray (Smith et al, 1979), and may 
only be around 2 mGy for a pelvic radiograph on an older child in the 6-15 age group 
(Almen et al, 1995). The most usual form of TLD used for such measurements, chips or 
pellets of lithium fluoride or lithium borate, have a minimum detection limit of around 0.1 
mGy (Broadhead, 1997) and the uncertainty due to background fluctuations may be as much 
as 20% at low doses. There are also practical problems with using TLD for neonatal 
examinations, as described by Martin et al (1994) who found TLD unsatisfactory in the 
neonatal nursery because their placement interfered with infection control procedures, and 
also because they produced artifacts on the image. 
ESD values have also been calculated for dose assessment purposes, either from technique 
factors (McDonald et al, 1996; Kyriou et al, 1996) or from DAP measurements (Ruiz et al, 
1991). The latter requires assessment of field size, which is not always straightforward. 
Calculation of ESD for paediatrics has been reported to agree with TLD measurement 
(Kyriou et al, 1996), although the spread in the ratios of measured and calculated results was 
large with standard errors of up to 65%. Insufficient details were given to be able to fully 
assess the data in this paper. Care has to be taken that appropriate back scatter factors are 
used in calculations, and these will vary according to patient thickness, field size and tube 
voltage. Values suitable for paediatric radiography have been tabulated, but they are fewer 
data available than for adults and not all radiographic situations are covered. 
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Author Examinations Age Dosimetry Total no No / 
banding methods patients group 
Gustafsson chest 1-6 mths meas. DAP 38 5-20 
& 4mth-6.5yrs & ESD, 
Mortensson 2.5-11 yrs calc. energy 
(1983) imparted 
Cleveland voiding 0-1 yrs phantom 47 9-20 
et al (1991) cystourethrogram 1-5 yrs mess, calc 
5-7 yrs ESD & mid 
plane dose 
Ruiz et al abdomen, hip & 1 mth-1 yr ESD calc. 492 not 
(1991) pelvis, skull, 1-5 yrs from meas. reported 
spine, chest 5-10 yrs DAP 
10-14 yrs 
Karlsson et diagnosis & none meas. DAP 45 - 
al (1994) hydrostatic 
reduction of 
interssusception 
Martin et al chest, pelvis, infant calc & 522 4-99 
(1994) abdomen, skull, 1-5 yrs meal ESD 
MCU, ba meal 6-10 yrs meas DAP 
11-15 yrs 
6-15 yrs 
Gonzalez et micturating 1 mth -1 yr meas. DAP 48 1- 13 
al (1994) cystourethrogram 1-5 yrs 
5-10 yrs 
10-14 yrs 
Almen et al pelvis, IVU, 0-1 yr meas. DAP 95 2- 18 
(1995) MCU 2-5 yrs & ESD, 
6-15 yrs calc. organ 
doses & 
energy 
imparted 
Kyriou et al chest, skull, I mth-1 yr meas. DAP, 1342 ESD 1- 151 
(1996) abdomen, hip, 1-5 yrs calc ESD 1123 DAP 
spine, sinus, 5-10 yrs 
knee, ankle, 10-14 yrs 
wrist, ba meal 
ba enema, ivu 
McDonald pelvis, chest, 1 mth-1 yr meas. DAP, 392 5-25 
et al (1996) abdomen, spine, 1-5 yrs calc. ESD 
skull 5-10 yrs 
10-14 yrs 
Persliden et small intestinal none meas. ESD 257 - 
al (1996) biopsy 
Table 3.1 : Summary of published paediatric dose surveys 
DAP measurements have been used in a number of surveys, both for fluoroscopy (Karlsson 
et al, 1994; Martin et al, 1994; Gonzalez et al, 1994; Almen et al, 1995; Kyriou et al, 1996) 
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and radiogaphy (Gustaffsson and Mortensson, 1983; Ruiz et al, 1991; Martin et al, 1994; 
Kyriou et al, 1994; McDonald et al, 1996). DAP values from paediatric examinations may 
be as low as 50 mGy cm-' for a simple cystogram, or down to around 5 mGy cm-' for a 
radiographic exposure. Many DAP meters have low dose sensitivity of around 10 mGy cm 2, 
which would obviously be insufficient for the above cases, although some have special 
paediatric settings which can give a sensitivity of 0.1 mGy cm-', as was used by Martin et 
al(1994). One method of improving the accuracy of both DAP and ESD measurements is to 
integrate the dose over a number of exposures on different patients, but this also has the 
effect of reducing the sample number, and losing information on individual patients. 
Values of ESD and DAP have been used to derive values of energy imparted (Gustaffsson 
and Mortensson, 1983; Almen et al, 1995; Chapple et al, 1994) and effective dose (Almen 
et al, 1995). The latter needs to be applied with great caution to paediatric patients, as was 
pointed out by Almen et al in their conclusions. They, however, based this advice solely on 
the unreliability for paediatrics of the risk data used for the determination of organ weighting 
factors. No mention was made of the uncertainties in effective dose values arising from 
varying beam size and position, which make comparisons difficult. 
3.2.2 Grouping of data 
As there are many factors influencing individual patient dose, a reasonable sample size is 
required to make the data meaningful. In addition to variations in dose due to different X-ray 
equipment, factors such as patient size, compliance, clinical indications and complications 
will all influence the resultant dose. Technique factors, such as tube kilovoltage, and 
individual radiologist/radiographer technique, such as the degree of coning and different 
projections used will also have an effect. In the light of this, although the National Protocol 
for Patient Dose Measurements recommends a minimum sample size of 10 per category of 
patient (IPSM, 1992), the uncertainty in mean dose from a sample of this size may still make 
comparison with other data difficult. The survey carried out as part of this work, in 
comparison, used sample numbers of up to 200 for each combination of age group, 
examination type and X-ray room. 
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One of the chief problems in paediatric dosimetry is the wide range of size from neonates 
up to young adults of sixteen years of age. The CEC have defined a number of standard age 
bands into which categories dose estimates should be split. These are 0-1 month (neonates), 
1 month -1 year (infants), 1-5 years, 5-10 years and 10-16 years (CEC, 1993). While some 
authors have used these divisions for collating their data (Ruiz et al, 1991; Martin et al, 
1994; Gonzalez et al, 1994; Kyriou et al, 1996; McDonald et al, 1996) others have chosen 
different age ranges (Gustafsson and Mortensson, 1983; Cleveland et al, 1991; Chapple et 
al, 1992 & 1993; Almen et al, 1995) and others have not grouped data at all (Karlsson et al, 
1994; Persliden et al, 1996). Some confusion is still apparent as to the boundary between the 
different age groups recommended by the CEC eg whether a child between his 5th and 6th 
birthdays belongs in the 1-5 group or the group above etc. This makes comparisons between 
centres rather confusing although, in fact, the high variability in size for children of any 
particular age makes such slight differences in age grouping immaterial. This illustrates how 
the basic premise of grouping dose data according to age rather than a body size parameter 
is fundamentally flawed. This point has been recognised by others (Almen et al, 1995). 
While the use of a grouping system for presenting paediatric dosimetry results is desirable, 
it inevitably decreases the patient numbers in each category. Unless the number of patients 
in a single group is sufficient for their size to be approximately normally distributed ie so that 
their mean size is representative of the whole group, the data may still give distorted 
comparisons with those of other centres. Sample numbers in the published data vary 
enormously. The studies presenting data for all patient ages together (Karlsson et al, 1994; 
Persliden et al, 1996) report the results of several hundred measurements, which would be 
a good sample size were it not for the wide age and size ranges involved. The 1985 national 
dose survey presented data for 9 paediatric examinations, with between 1 and 20 patients in 
each sample (Shrimpton et al, 1986), but no grouping of the data according to either size or 
age was used. The data presented by Ruiz et al (1991) includes only the total number of 
measurements made (492) and sample numbers in the 20 individual data groups are not 
reported, which makes assessment of or comparisons with their data difficult. Most of the 
other age banded data is presented in variable group sizes, with the most extreme example 
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being the work of Kyriou et al where patient numbers range from 1 to 151. Several other 
authors have presented data for sample sizes of less than 5 (Martin et al, 1994; Gonzalez et 
al, 1994; Almen et al, 1995), which can have very limited use, due to the high statistical 
uncertainties. Very little data exists for age grouped data with sample sizes greater than 20, 
excepting some of the initial results from the survey reported here (Chapple et al, 1992, 
1993). It is noteworthy that in the 1995 national survey of patient doses (Hart et al, 1996) 
it is mentioned that for paediatrics 402 ESD measurements and 135 DAP measurements were 
received, but the results are not reported as the amount of data was considered insufficient. 
3.2.3 Examination categories 
The majority of recently reported work has centred on radiographic examinations (Ruiz et 
al, 1991; Martin et al, 1994; Kyriou et al, 1996; McDonald et al, 1996), including skull, 
chest, abdomen, hip, pelvis and spine radiographs. Several studies have also been reported 
of doses from cystourethrograms - probably the most frequent fluoroscopic examination in 
early childhood (Cleveland et al, 1991; Martin et al, 1994; Gonzalez et al, 1994; Almen et 
al, 1995). Other data from fluoroscopic procedures is limited to a small amount of barium 
study data (Martin et al, 1994; Kyriou et al, 1996) and results from two specific 
interventional procedures, namely the diagnosis and hydrostatic reduction of interssusception 
(Karlsson et al, 1994) and small intestinal biopsies (Persliden et al, 1996). Some work has 
also been carried out for paediatric patients undergoing cardiac catheterization (Wu et al, 
1991; Schueler et al, 1994) and initial results from the survey carried out as part of this work 
have been published, for a range of examinations (Chapple et al, 1993). As fluoroscopic 
procedures generally result in considerably larger patient doses than simple radiographic 
procedures, this paucity of data represents a significant gap in the literature. 
3.2.4 Analysis of data 
Many of the paediatric dose surveys that have been performed had a further objective apart 
from contributing to the accumulation of dose data. The most common of these were to 
compare techniques at two or more centres (Gonzalez et al, 1995; Kyriou et al, 1996) or to 
investigate how patient dose is affected by changes in technique such as removal of the grid 
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(McDonald et al, 1996) and the use of digital instead of fluoroscopic spot films (Cleveland 
et al, 1991). Potential dose savings from optimisation of techniques were assessed by 
Gonzalez et al (1995) but the projected 85% reduction in DAP was not verified clinically. 
The potential risk from paediatric chest radiography was assessed by Gustafsson and 
Mortensson (1983), who concluded that the greatest risk was that for possible future breast 
cancer, for girls past infancy. Other studies have investigated relationships between patient 
size and dose (Martin et al, 1994; Karlsson et al, 1994; McDonald et al, 1996) and this issue 
is explored in a later section. 
3.2.5 Neonatal data 
The measurement of radiation dose to neonates is an even more specialised subject than 
paediatric dosimetry in general. This is partly due to the fact that neonatal radiography is 
normally carried out in a special care baby unit or nursery, using mobile equipment, so 
necessitates separate dose survey arrangements. As neonates represent the extreme end of the 
size range for paediatrics ie that furthest from adults, many of the dosimetry problems that 
have been referred to above are exaggerated for examinations of this age group, particularly 
those concerning sensitivity of the dose measurement device. 
A relatively large body of data exists for neonatal radiation doses, compared to paediatrics 
in general. Much of this data consists of TLD measurements of entrance skin dose on patients 
(Smith et al, 1979; Smathers et al, 1984; Werner et al, 1986; Herman et al, 1987; ) in spite 
of the practical problems and high uncertainties associated with such measurements on 
neonates. Others have calculated values of entrance dose (Robinson and Dellagrammaticas, 
1982; Fletcher et al, 1986; Faulkner et al, 1989; Wraith et al, 1995; Chapple et al, 1994), 
or used phantom measurements to assess the dose (Wesenberg, 1977; Burton et al, 1987). 
Other dose quantities such as DAP, selected organ doses or energy imparted have also been 
calculated in some cases (Robinson and Dellagrammaticas, 1982; Faulkner et al, 1989; 
Wraith et al, 1995; Chapple et al, 1994). Dose reduction methods have been usefully outlined 
by Faulkner et al (1989). There is virtually no data in the public domain concerning dose to 
neonates from fluoroscopy. Although such procedures are far more rare than plain 
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radiography, the higher dose associated with them means that assessment of such doses is an 
important area of study. 
3.2.6 Conclusions from literature review 
Altogether, the amount of paediatric dose data collected is small compared to that existing 
for the adult population, and there are difficulties in comparing data from different centres. 
Even when centres have used the same age divisions, the range of patient sizes within the 
band, and the relatively small numbers of dose assessments made usually preclude meaningful 
comparison. For the same reason, development of reference doses for paediatrics has also 
been slow and difficult to apply. 
3.3 Automation of dose survey 
As shown above, many of the problems encountered in paediatric dosimetry may be eased 
by increasing the number of dose assessments made, as this improves the statistical analysis 
of the data. However, the practical problems associated with this have to be addressed. Even 
if only twenty dose measurements are to be made for each age group and examination type, 
and the survey is limited to five common procedures, this will still necessitate five hundred 
measurements in one room. If data is to be recorded on paper, this will result in time 
consuming work for the radiographic staff and the ensuing analysis will require laborious 
entry of data into a suitable software package. This is likely to produce a number of data 
transfer errors, and makes routine surveys unfeasible. The collection of a large quantity of 
paediatric dose information, on a routine basis, is thus facilitated by the automation of dose 
survey techniques. One important advantage of this approach is that data is collected in a 
uniform manner. 
3.3.1 Design of survey 
The priority in designing the dosimetry data collection system was its acceptibility to 
radiographic staff. This was important in order to be able to implement the initiative on a 
routine basis. For this reason, development was carried out with the close cooperation of a 
number of radiographers. This allowed practical problems to be addressed at an early stage. 
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It also enabled the system to meet the needs of the individual X-ray departments, for instance 
providing an instant dose indicator for each patient, in addition to the requirements of the 
physicists wishing to analyze the data. The other requirements of the system were that it 
record all information pertaining to full analysis of the data, and that the data be easily 
exported for analysis. 
The data collection system was designed for use in a regional survey of doses from 
fluoroscopic procedures, monitored with DAP meters. The automation was carried out by 
using computers to collect, store and analyse the dosimetric data. DAP meters were installed 
in X-ray rooms at hospitals throughout the north of England. Each DAP meter was connected 
to a laptop computer, on which data could be collected and stored. Data was then transferred 
at regular intervals to a central computer database for analysis. The data collected consisted 
of dose area product for the examination, read directly from the DAP meter, and data input 
by the radiographer, consisting of the following: 
patient name 
sex 
age 
height 
weight 
examination type 
radiologist 
screening time 
kVp 
number of radiographs 
number of 100mm/DSI films 
The only hardware requirements for running the software were 
" any PC or laptop, 386 or above 
" serial communication link to DAP meter 
" floppy disk drive 
" minimum disk space 1 MByte 
The connections between DAP meter control box, ionisation chamber and the computer were 
wired by technologists from the electronics department and, in most cases, this was a 
straightforward operation using existing cable trunking. 
25 
3.3.2 Data collection software 
The data collection software was written in BORLAND PASCAL and the impact on the 
radiographer minimised by using a series of prompts and menus, via a simple in-house 
graphical user interface. Height and weight information could be entered in either metric or 
imperial units, and age either directly or indirectly as a date of birth from which age was 
calculated. The software was configurable for each department, in that the most frequently 
used radiologist names and examination types were stored in a customised menu. An option 
was developed whereby most of the patient information could be entered prior to the session. 
On arrival of each patient this previously entered data could be retrieved, leaving only height 
and weight to be entered. This minimised the time spent at the computer between patients, 
and ensured that the performance of the examination was not compromised by the data 
collection. The software was designed to reset the DAP meter automatically and take a 
reading from it when the end of the examination had been signalled by a keystroke. The 
examination details and any comments pertaining to it were then entered. Screening time, as 
recorded on the X-ray console, was entered manually via a user prompt, as screening times 
read from the DAP meter were found to be inaccurate for intermittent fluoroscopy. 
Calibration factors for the DAP meter were stored in a department specific data file and 
applied to the DAP readings. The total calibrated DAP value for each examination was 
displayed at the end of the procedure. All data recorded during an examination was appended 
in an ASCII format file, stored on the hard drive. 
The data collection system has been in use for over three years in over twenty X-ray 
departments. Removable disks are sent to each department at three monthly intervals in order 
to transfer data to the central computer in the Medical Physics department. This procedure 
is normally carried out by a designated radiographer at each site. This central computer is 
used to store and analyse the data. Reports are produced for each department detailing the 
DAP values for the quarter according to examination type and radiologist, as agreed between 
Medical Physics and the local department. 
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3.3.3 Impact of automated system 
The system was designed for routine use in a busy X-ray department by staff who were not 
necessarily familiar with the use of computers. After initial training and familiarisation, it was 
generally found to be straight-forward and easy to use. A designated member of staff at each 
site was given additional training to deal with any minor problems, update the list of 
radiologists as required, and download and return the data on receipt of the disk. The 
automated approach has financial implications in that a PC or laptop computer is required in 
addition to the DAP meter used for the dose measurements. The sum involved, however is 
small compared to the costs of installing a new X-ray facility. The automated system enables 
continuous collection of dosimetry data for all patients undergoing fluoroscopic examination 
in a room where it is installed. 
3.4 Size correction 
The importance of accounting for variations in patient size when analysing paediatric dose 
data has already been stressed in the earlier sections of this chapter. The objectives of any 
approach dealing with this issue are: 
" to enable comparisons of data between centres 
" to enable the determination and application of reference dose levels for paediatrics 
" to enable an assessment of radiation risk to be made for any specific patient. 
The first two of these points essentially relate to removing the size component from actual 
dose measurements to obtain `typical' values, and the last point relates to including a size 
component in the extrapolation of `typical' dose/risk factors to a particular patient, who may 
be of a different size. The ways in which size affects dose, and some of the work previously 
carried out in this area are discussed below. The derivation of a technique for routinely 
correcting data for patient size is then described, and an analysis carried out of its effect on 
sample dose data. 
3.4.1 Affect of patient size on dose 
The size of a patient affects the radiation dose received in a number of ways. The chief of 
these is the increase in technique factors required for a larger patient. In addition to this, a 
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greater proportion of beam energy will be absorbed than for a smaller patient and a larger 
field size may be required. Several authors have addressed the question of patient size 
(Maillie et al, 1981; Lindskoug, 1992; Martin et al, 1995; Wraith et al, 1996; Almen et al, 
1995), including the problems in determining an individual patient's dose (Maillie et al, 
1981) and the assessment of `typical' data for a given set of patients (Lindskoug, 1992). 
Recommendations have been made that exposure-area product measurements be interpreted 
in terms of the beam quality used for the examination (Maillie et al, 1981). The issue of 
organ dose data for a continuous range of phantom sizes has also tackled in a number of 
ways. These include an algorithm for determining organ position according to age and sex 
for paediatrics, using growth curves (Francois et al, 1988), and the use of voxel phantoms 
for studying the variation of paediatric organ doses with patient diameter (Veit and Zankl, 
1993). The latter work showed that organ doses increased with patient diameter, especially 
for organs on the beam entrance side of the patient, as might be expected. Organ dose data 
has recently become available for a defined range of paediatric sizes, examinations and beam 
qualities (Hart et al, 1996). This covers a much wider range of applications than previously 
available (Rosenstein et al, 1979), but no guidance is given on extrapolating between sizes. 
Dose data in the form of DAP or ESD measurements have been plotted as functions of 
quantities such as age (Kyriou et al, 1996) and weight (Karlsson et al, 1994; Wraith et al, 
1995) but the reported correlation is variable, with the correlation between DAP and age 
reported as mainly affected by use of a grid for the older patients (Kyriou et al, 1996). DAP 
is reported as being proportional to neonatal weight in one study (Wraith et al, 1995), but 
no correlation was observed in another study involving a wider range of ages (Karlsson et 
al, 1994). 
To facilitate the comparison and checking of radiation dose estimates, the ICRP (1975) 
defined the concept of `Reference Man' as a well defined reference individual for estimation 
of radiation dose in health physics. This concept was then adapted by Lindskoug (1992) in 
his work on dose data reduction. He introduced the parameter equivalent cylindrical diameter, 
which is derived from a person's height and weight, by assuming them to be a cylinder with 
the density of water (1 g cm Z), as illustrated in Figure 3.1, and equating density to mass 
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divided by volume. Height and weight are measured in cm and g respectively to give the 
correct form of the equation. 
XAI -4 
De. 
,I 
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Figure 3.1 : Body Equivalent Cylinder 
Equivalent diameter de = 2Aý (3.1) 
V7rH 
This parameter equivalent diameter was used in preference to quantities such as weight or 
body thickness as the outer dimension of the trunk does not include any information about 
density and the weight takes no account of body shape. The formula described above takes 
some account of both body shape and composition. Additionally, for fluoroscopic 
examinations, multiple projections are normally used so that a single body thickness 
measurement would not be appropriate. The total energy imparted during an examination was 
shown to correlate well with equivalent cylindrical diameter of the patient (Lindskoug, 1991), 
and the equivalent diameter of Reference Man was used to standardize the data using a 
simple coordinate transform. Lindskoug also showed that the energy imparted to children 
during trunk examinations increased logarithmically with equivalent diameter, in a similar 
manner to that for adults. He used this to derive appropriate exposure parameters for 
paediatric examinations, according to the height and weight of the patients. Martin et al 
(1994) have also investigated the relationship between dosimetric quantities and equivalent 
cylindrical diameter for children, and showed good correlation of entrance dose with this 
parameter for simple radiographic examinations. For complex examinations, energy imparted 
showed some correlation with equivalent cylindrical diameter for barium meal examinations, 
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but not for cystogram examinations. This was explained by the large amount of scatter in 
dose-area product due to differences in individual examinations, and also a general decrease 
in screening time with age for the latter examination which compensated for increasing size. 
For the radiographic exposures, simple exponential correction factors were derived from 
retrospective analysis of the data to enable comparisons to be made between children of 
different ages. 
3.4.2 Isolation of size dependence 
The work described above illustrates the usefulness of the concept of equivalent cylindrical 
diameter, and its potential for enabling comparison between dose data for individual patients, 
including children. The methods previously used, however, require retrospective analysis of 
an existing data set, and isolation of the size dependence is difficult due to the many other 
criteria affecting variation in dose, such as complexity of the examination and the technique 
used. An independent method of determining dose variation due to patient size would be 
more generally applicable. 
Separation of the size dependent component of dose variability may be made by considering 
how dose at the exit side of a phantom may be expressed as a function of the dose at the 
entrance side. Both point dose and DAP will be considered as the dose quantity of interest. 
A pictorial representation is given in Figure 3.2, where d is the soft tissue thickness and FSD 
the focus skin distance. D and D' represent the dose quantity of interest. 
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Figure 3.2 : Parameters used in derivation of equations 
The attenuation through the phantom may most simply be expressed by 
(3.2) 
where tL ff is the effective attenuation coefficient for the phantom. This would then give 
In D= µe1d + In D' (3.3) 
ie a simple exponential relationship between dose and size, which is an intuitive 
approximation, and has been validated and used in previous work (Martin et al, 1994). 
However, equation 3.2 neglects several effects, which should be mentioned. These may be 
summarized as follows: 
" When applying equation 3.2 to point doses, a term should be included to allow for 
the reduction in D' due to the inverse square law effect. This would give 
D' =D e'ß 
FSD2 (3.4) 
(FSD + dj2 
and 
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lnD=laetr'd+2ln(FF. 
SDd) +1n 
D' (3.5) 
This additional factor is automatically included when using DAP as the dose quantity 
of interest, as the change in area includes the inverse square effect. 
0 Equation 3.2 only strictly applies to narrow beam conditions ie when the effect of 
scatter is neglected. An additional factor B is required in the expression to account 
for the increase in D' arising from photons scattered inside the phantom. B is a 
complex variable and will depend on the beam energy, beam area, phantom thickness 
d and the distance between phantom and image receptor. Inclusion of this factor in 
the expression for variation of DAP would give 
InDAP=µ1, d+InD' - InB (3.6) 
0 The above analysis assumes that examinations are carried out under conditions of 
equal dose at the exit of the phantom whereas, in fact, the correct criteria would be 
equal film density or intensifier light output. Each of these will depend on the energy 
absorption in the image receptor which will vary to some extent with the energy of 
the beam entering it. This in turn will depend on the original beam quality and the 
phantom thickness. 
An exact evaluation of the interdependence of these parameters is beyond the scope of this 
work, but it should be noted that as the phantom thickness increases the generating potential 
will also be increased, leading to a decrease in µ, . ff, and an 
increase in B. 
As a first approximation, the simple exponential form of the equation can be applied to DAP 
measurements on patients to give 
In DAP=kd0+c (3.7) 
where de is the effective equivalent diameter, ka scaling factor and c is a size independant 
term. From this one may derive that the dose-area product equivalent to a standard sized 
patient is given by 
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DAP. f= DAPS x 
ekdd (3.8) 
where meas refers to measured values and ref those for a standard sized patient. From this, 
one may define a size correction factor 
F= e'ýdaý ' dam (3.9) 
dc(rc, ) is the equivalent diameter of the reference size patient to which data is being corrected, 
and d«mein is the equivalent diameter of the patient. 
3.4.3 Experimental determination of equation parameters 
The factor k, which is equivalent to the effective attenuation coefficient through the phantom, 
can be determined experimentally. This was done by carrying out fluoroscopic exposures of 
different thicknesses of tissue equivalent phantom material (RMI, Wisconsin, USA) under 
automatic exposure control. Dose-area product values, normalised to 1 minute screening time, 
were recorded for each thickness. The field size was kept constant so that the observed 
changes in DAP were due solely to the changes in exposure factors, as determined by the 
automatic exposure control (AEC) device required for imaging different phantom thicknesses. 
A plot of In DAP against phantom thickness yielded a straight line graph, the gradient of 
which was the factor k. Figure 3.3 shows such plots for a number of X-ray sets around the 
region. Values of k ranged from 0.13 to 0.18 cm'' (median 0.14 cm"') for the different rooms 
in which measurements were made, all with correlation coefficients greater than 0.997. For 
the purposes of the regionwide survey, a single value of 0.14 was selected for ease of 
calculations. Individually determined values of k could be used for each X-ray set for greater 
accuracy. 
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Figure 3.3 : Determination of k for five different x-ray sets 
Several points should be made about the form of this graph. Firstly, the curves all exhibit 
excellent linear regression fits to the data. Although this conforms well to the simplified 
theory, it is not the behaviour expected as the AEC devices increase tube voltage with 
increasing phantom thickness, and this should reduce the effective attenuation coefficient and 
hence the slope of the graph. This would result in a flattening of the curves as phantom 
thickness increases. Although the magnitude of the effect may be small, and partially 
compensated for by the other effects described, it is suprising that such linearity is obtained. 
The similarity of the slopes of the curves indicates that the effective attenuation coefficient 
over the range of thicknesses used is fairly invariant between the sets investigated. This might 
be expected if similar kV values are selected by the AEC devices, as tube filtration does not 
vary much between the rooms. The shift between the curves relative to the y-axis of the 
graphs is related to the different AEC settings for the brightness required (different values 
of D' in equation 3.2). 
It can be seen from this analysis that the scaling factor is essentially a property of the AEC 
device on the set, which determines the kV and mA combination used, along with the tube 
filtration. When exposures are being performed under manual control the analysis will still 
be valid, if it is assumed that the radiographer selects technique factors in a similar manner 
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to the AEC. If the factors selected are very different (for instance the same factors for both 
a6 year old and a twelve year old) the effect of the patient size will deviate from that 
deduced above. 
3.4.4 Application to paediatric dosimetry data 
This method of size correction may easily be applied to paediatric dose data, by using age 
bands for grouping the data. A standard height and weight is defined for each age band, as 
given in Table 3.2. These data are taken from that used for the CRISTY anthropomorphic 
paediatric phantoms (Cristy, 1980). The resultant equivalent diameter, in each case, is used 
in equation 3.9 for correcting the dose-area products of all children in that age band. The 
Cristy model is widely accepted and has been used in many applications (Hart et al, 1996). 
The heights and weights given in Table 3.2 agree closely with those found from child growth 
charts based on United Kingdom cross-sectional reference data (Cole, 1994, Freeman et al, 
1995, Chinn et al, 1996). This latter data is given in Table 3.3 in the form of centiles. The 
centile values also give an idea of the spread in height/weight data for the different age- 
groups, and are further evidence for the inappropriateness of using age bands for grouping 
data. Any change to the reference size being used may be made by a simple substitution of 
d« 0 in equation 3.9. 
Age Band Reference Age Reference 
Height (cm) 
Reference 
Weight (kg) 
Equivalent 
Diameter (cm) 
neonate 0 51.5 3.51 9.32 
infant 1 75.0 9.36 12.61 
1-5 yrs 5 109.0 19.1 14.94 
6-10 yrs 10 138.6 32.1 17.17 
11-16 yrs 16 164.0 54.5 20.57 
Table 3.2 Reference Paediatric Sizes 
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height (cm) weight (kg) 
Age 
2nd 
centile 
50th 
centile 
98th 
centile 
2nd 
centile 
50th 
centile 
98th 
centile 
birth 46.5 50.5 54.5 2.6 3.3 4.3 
1 yr 69.2 75.0 80.5 7.9 9.9 12.1 
5 yrs 101.0 109.3 118.0 14.7 18.5 24.1 
10 yrs 126.0 138.5 151.5 23.3 33.0 48.0 
16 yrs 154.0 168.8 181.8 43.3 60.0 82.8 
Table 3.3 : Height/weight data from local child growth charts 
The correction factors derived in this way account for the effect of patient size on the 
exposure factors required for the examination, but make no allowance for changes in field- 
size, which will also affect DAP. However the size of internal organs, which govern the 
required field size, are not as variable as the outer dimensions and composition of the trunk. 
The relationship between organ size and de will be complex and depend on age, the organ 
concerned and, in some circumstances, any existing pathology. Although there will be 
significant differences in field size between examinations of an infant and an adolescent, 
within an age band field-size variations will be a relatively minor effect. 
3.4.5 Analysis of the effect of size correction on data 
To assess the use of the size correction factors that have been developed, the technique was 
applied to DAP data from paediatric cystograms that were monitored as part of the dose 
survey described earlier, to study its effect on the dispersion of the data. The unavoidable 
problem in this approach is that for real data the variation arising from different patient sizes 
may be masked by the other sources of variation in the data. One of these other sources of 
variation was removed to some extent by dividing the DAP values by screening time. The 
effect of the manipulation of the data is shown in Figures 3.4 and 3.5. These show the spread 
of dose-area product data, normalised to unit screening time, for cystogram examinations for 
two age bands both with and without size correction. Data for which height and weight 
information is unavailable, or obviously entered incorrectly, has been omitted from the 
analysis. 
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Figure 3.4 : DAP data, normalised to unit screening time, for cystograms (neonates) 
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Figure 3.5 : DAP data, normalised to unit screening time, for cystograms (11-16 yrs) 
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The dispersion of the data is characterised in Tables 3.4 and 3.5. The former gives standard 
deviation as a percentage of the mean DAP value and the latter gives the interquartile range, 
defined as the difference between the upper and lower quartile values of the data. 
Age Band Stand. Dev. of DAP normalized to Unit Screening Time No in 
Uncorrected Data Size Corrected Data 
sample 
neonates 184% 167% 66 
infants 173% 155% 252 
1-5 years 89% 89% 266 
6-10 years 66% 63% 173 
11-16 years 81% 57% 47 
Table 3.4 Effect of size correction on DAP distribution (standard deviation) 
Age Band Interquartile range of DAP normalized to Unit Screening Time No in 
Uncorrected Data Size Corrected Data sample 
neonates 665 mGy cm' 506 mGy cm' 66 
infants 513 " 492 " 252 
1-5 years 755 " 734 " 266 
6-10 years 835 " 893 " 173 
11-16 years 1816 " 2296 " 47 
Table 3.5: Effect of size correction on DAP distribution (interquartile range) 
Standard deviation is a quantity that is most usefully used to describe a normal data 
distribution, whereas patient dose data typically forms a positively skewed distribution with 
a long, high dose, tail. It may, however, be defined numerically for any distribution and gives 
an efficient measure of dispersion of the data, as all data points are used. It is particularly 
useful in this context as the comparison is between the same data set before and after a 
numerical transformation, rather than between two different data sets. The interquartile range 
is not affected by outliers to the distribution, but gives the range of variability which is 
sufficient to contain fifty percent of the population. 
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Tables 3.4 and 3.5 show that for the 11-16 year age group the standard deviation of the data 
is considerably reduced by application of size correction factors, though the interquartile 
range increases. This is a relatively small data set compared to the other groups (47 patients) 
with probably the greatest range of patient sizes. The extreme normalised DAP values are 
mostly due to patients at each end of the size range, and these are taken closer to the centre 
of the distribution during the size correction analysis. Variations throughout the mid-range 
of DAP values will be influenced by technique differences as well as size. For the neonate 
age group the reduction in interquartile range is more marked, with a smaller decrease in 
standard deviation. Size variations within this group are smaller and less likely to be the 
cause of extremes of DAP value. The middle age-groups demonstrate small reductions in 
standard deviation after size correction and, apart from the 6-10 year group decrease in 
interquartile range also. The older age group may have greater variability in clinical 
indication. Overall, the technique can be seen to reduce variability in paediatric DAP data, 
even for these samples which contain data from a number of different hospitals with 
modification made only for screening time. 
For interest, it is possible to correct data for the different reference ages to that for a 
reference adult size (equivalent diameter 22.8 cm). The results of this are shown in Table 3.6 
for barium meal and enema studies where for each age group the mean size corrected DAP, 
as found in the study, is listed along with the same value corrected to reference adult size. 
The mean adult doses for these examinations, for the same region are 9 and 21 Gy cm2 
respectively. It can be seen that even with corrections made for patient size there are still 
differences in DAP between the different age groups. The effect of variations in field-size 
with age should produce a small increase of DAP with age, but other factors such as patient 
compliance will also affect the results, and may be related to patient age. Compliance, for 
example, is generally at its worse for the 1-5 year group, as the children are not small enough 
to be easily held and not old enough to cooperate. The clinical reasons for performing an 
examination and the type of diagnosis required may also vary for different age-groups, and 
influence the dose given. All this is evidence that size correction should not be applied over 
broader age groupings than those used currently. It also supports the view that children are 
not just `small adults' and cannot be treated as such for dosimetry purposes. 
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Age Band DAP for Barium Meal (Gycm2) DAP for Barium Enema (Gycm2) 
ref. child size ref. adult size ref. child size ref. adult size 
neonates 1.2 8.7 1.2 8.9 
infants 1.0 4.4 4.6 20.1 
1-5 years 1.4 4.7 4.5 14.6 
6-10 years 2.5 5.9 8.3 19.5 
11-16 years 4.9 6.8 10.8 15.0 
Table 3.6 : Paediatric DAP data with conversion to reference adult size 
3.5 Survey results 
The automated dose survey has been carried out for 3 years in hospitals around the north of 
England. The data collected has been subdivided into agebands and the size correction factors 
described above applied. A total of 3859 paediatric measurements had been collected at the 
time of analysis. Large variations were observed between hospitals, as shown by Figure 3.6. 
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Figure 3.6 : Dose variation between hospitals for infant cystograms 
Mean size-corrected doses across the region for the different examinations are given in Tables 
3.7 - 3.11. Each hospital is represented by a letter, with different numbers for each room in 
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that hospital. One of the main factors influencing dose is the type of equipment in each room. 
The majority of rooms have digital X-ray sets but rooms A2, E, G, J2, K2 and M1 have 
older non-digital equipment and it is apparent that these give consistently higher doses, 
throughout the range of ages and examination types. The other factors having a major impact 
on dose are the screening time and the number of radiographs taken. Common practice at 
most hospitals is to take a minimal number of radiographs, if any. Room 01 has fairly 
consistently low doses. This room uses dedicated paediatric techniques, with low radiation 
dosage an active priority. Full details of the technique factors and other data collected during 
the survey are given in Appendix A. 
For the neonatal examinations (Table 3.7), many of the higher doses are mirrored by higher 
screening times, in particular for the cystograms in M1 and A2, barium swallows in M1, F1 
and K2 and the barium enema in F I. The high dose for barium meals in room G is probably 
related to the 13 radiographs taken. The majority of rooms use only a single radiograph or 
none at all. 
For infants (Table 3.8), the extremely low barium swallow dose at QI corresponds to a 
minimal screening time (6 s). This may, in fact have been an incomplete examination. The 
high dose at KI for the same examination is also markedly due to the screening time. 
In the 1-5 year old data (Table 3.9), the highest screening times for cystograms are found at 
A2, Fl, H, K2 and M1. These are also the rooms with the highest doses. A long screening 
time is also found for barium swallows at Kl. The extremely high barium meal dose at room 
G is due to a combination of 8 radiographs, 10 spot films and a long screening time. 
Similarly, the high enema doses at A2 and Ql involved 4 and 2 radiographs respectively. The 
low dose at N2 for barium meal and swallow corresponds to a short screening time. 
For the 6-10 year old children (Table 3.10), room A2 gives by far the highest cystogram 
dose, with a long screening time. The high dose enema examinations are all from rooms 
utilising multiple radiographs. Screening time appears to be the main contributor to the 
barium meal and swallow dose in A2. 
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For the highest age group (Table 3.11), high doses are again linked to either screening time 
(cystograms in A2 and M1, barium swallows in H and KI, barium follow through in K2) or 
number of radiographs (10 for A2 enemas, 8 for G enemas, and 5 for L2 enemas). 
It should be noted that much of the data presented, in all age groups consists of only a single 
examination for a given room. Such data cannot be assumed to be representative of routine 
practice. However, some trends may be indicated, as illustrated above and results from 
different rooms combined to give local reference dose levels for the different examinations. 
Third quartile values of dose area product have been produced in this way and are given in 
Table 3.12 for the three most common examinations. Routine dosimetry results are reported 
back to both radiologists and radiographic staff at each department to enable further 
investigation of doses or potential changes in technique where appropriate. Potential for dose 
reduction is indicated where results are consistently high. This may be achieved in some 
cases by purchase of new equipment but also by review of technique, in particular in relation 
to the use of radiographic films for diagnosis. 
3.5 Summary of chapter 
A review has been given of data published in the field of paediatric dosimetry, with particular 
respect to the dosimetric techniques employed, the grouping of the data and the sample sizes. 
The amount of data available is small compared to that for the adult population, particularly 
for fluoroscopic examinations, and there are problems in comparing data and deriving 
reference dose levels due to the large variability in patient size. Two techniques for 
improving the collection of paediatric dose data have been presented: the automation of 
survey techniques and a method of correcting for patient size. These techniques have been 
applied to a region wide survey of paediatric doses, and the results of the survey have been 
described. 
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Hospital ID Mean Size Corrected Dose Area Product (mGy cm2) and (Number in Sample) 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
A2 1164 (9) 1995 (1) 
B1 530 (2) 478 (5) 4474 (5) 1469 (1) 
C1 928 (3) 437 (5) 800 (1) 526 (3) 
C2 341 (2) 1070 (5) 1198 (3) 
D 144 (1) 188 (2) 491 (3) 
E 1042(2) 702(l) 850(l) 
F1 723(l) 927(5) 8116(l) 1015 (3) 292(l) 
G 10011(1) 
H 649 (4) 189 (1) 667 (2) 
I 251 (23) 1251 (1) 655 (9) 
11 118(2) 3149 (1) 
K1 583 (1) 
K2 1272 (2) 1226(13) 3490 (1) 1225 (1) 761 (4) 
L2 430 (86) 589 (11) 1095(29) 1787 (1) 491 (23) 
M1 1573 (17) 2094 (5) 2136(16) 893 (1) 1551 (1) 
NI 205 (2) 123 (2) 
N2 40 (1) 317 (3) 253 (7) 
01 72 (14) 133 (1) 234(16) 96 (2) 
02 60 (18) 76 (1) 125(10) 
P1 485 (9) 432 (2) 798 (1) 636 (1) 
R 334 (3) 219 (2) 297 (3) 
Table 3.7 : Dose area product data for neonates 
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Hospital ID Mean Size Corrected Dose Area Product (mGy cm2) and (No in sample) 
Cystogram Ba Swat. Ba Meal Ba Enema Ba 
Meal&Swal 
Al 254 (6) 464 (1) 
A2 815 (11) 223 (1) 2699 (1) 
B1 746 (12) 1113(16) 1360 (11) 750(2) 
Cl 661 (8) 763 (6) 1740 (5) 613 (2) 
C2 785 (9) 1705(11) 819 (2) 1027(5) 
D 388 (3) 957(11) 466 (4) 874 (1) 427 (1) 
E 2416 (1) 2088 (1) 4342 (1) 
F1 852 (15) 496 (3) 708 (9) 2275 (2) 719 (3) 
H 622 (4) 2296(15) 1184 (3) 4793 (1) 
I 583 (67) 1284 (6) 1438 (26) 14937 (7) 1494 (4) 
it 787 (9) 798 (2) 955 (1) 661 (1) 
J2 2041 (4) 296 (1) 
K1 59245(2) 1488 (3) 1495 (8) 
K2 1841 (3) 1792 (14) 
L2 526 (203) 918 (20) 878 (81) 1156 (14) 682 (43) 
M1 1260(5) 3479 (11) 2142 (12) 3197(3) 1710(4) 
Ni 165 (4) 561 (1) 
N2 472 (12) 500 (12) 845 (3) 
01 133 (57) 168 (7) 371 (16) 171 (2) 268 (3) 
02 92 (58) 193 (1) 184 (12) 
P1 667 (52) 856(30) 1297 (1) 
Q1 18 (1) 1415 (1) 
Q2 240 (1) 
R 356 (12) 511 (4) 196 (1) 
S 5029 (1) 
Table 3.8 : Dose area product data for infants 
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Hospital ID Mean Size Corrected Dose Area Product (mGy em2) and (No in Sample) 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
Al 142 (1) 
A2 3452 (2) 1867 (1) 1678 (4) 24456 (1) 
B1 943 (20) 1357 (3) 1116 (7) 2749 (1) 
B2 6877 (1) 
C1 1543 (4) 118 (1) 1256 (3) 3235 (1) 2565 (1) 
C2 962 (7) 2107 (5) 3500 (3) 2133 (1) 2896 (3) 
D 1013 (8) 500 (1) 760 (2) 
E 1632 (2) 5880 (2) 
F1 1770 (18) 570 (4) 1040 (5) 1611 (3) 1440 (1) 
F2 371 (1) 
G 36867(1) 
H 1521 (5) 4838 (4) 1863 (3) 1427 (1) 804 (1) 3267 (4) 
I 1177 (50) 3175 (3) 2132(17) 4178 (6) 1310(22) 2401 (3) 
11 1718 (6) 698 (1) 6409 (1) 1056 (1) 
J2 1145 (1) 1158 (1) 
K1 4893 (1) 
K2 1671 (19) 1367 (7) 4112 (1) 2024 (2) 
L2 1138(204) 1733(32) 1560(64) 2707 (12) 510 (2) 1351 (49) 
M1 3723 (10) 4814 (4) 2447 (5) 3151 (3) 
Ni 536 (7) 217 (1) 
N2 411 (21) 283 (7) 537 (8) 8013 (3) 3261 (1) 215 (1) 
01 310 (34) 359 (1) 607 (25) 203 (1) 215 (3) 2146 (3) 
02 216 (27) 458 (5) 310 (26) 
P1 1148 (38) 1162(11) 2047(6) 3056(l) 2449(13) 1382(4) 
Q1 21233 (1) 
R 555 (11) 1015(5) 
S 294 (1) 
Table 3.9 : Dose Area Product data for 1-5 yr olds 
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Hospital Mean Size Corrected Dose Area Product and (No in Sample) 
ID 
Cystogram Ba Swal. Ba Meal Ba 
Enema 
Ba 
Fo1. Thr. 
Ba 
Meal&Swal 
A2 14492 (1) 5465 (1) 9266 (1) 
B1 1653 (3) 2519 (2) 2105 (4) 
Cl 3304 (1) 1706 (2) 5617 (1) 5767 (2) 1199 (1) 
C2 3172 (3) 4434 (5) 3193 (2) 3318 (4) 3242 (9) 
D 1469 (3) 1377 (2) 
E 7604 (2) 
F1 3122 (13) 789 (1) 1402 (1) 12397(2) 1271 (1) 
G 25531(4) 
H 998 (4) 2310 (2) 2961 (3) 2734 (1) 2974 (3) 
I 1859 (32) 2016 (2) 3059(16) 3779 (1) 3168(13) 4164 (4) 
11 1483 (1) 1472 (1) 1358 (1) 
J2 986 (1) 
K2 1844 (9) 2501 (3) 9236 (1) 3388 (1) 3231 (3) 
L2 1758(103) 1389(14) 2413(31) 6088 (7) 667 (2) 2180 (14) 
M1 2885 (6) 10773(3) 5760 (1) 14734(2) 5152 (1) 
NI 5368 (6) 1625 (1) 
N2 1026 (13) 4240 (7) 1423(13) 434 (1) 
01 516 (15) 1439(13) 1559 (5) 1168 (4) 
02 378 (16) 592 (6) 
P1 2351 (15) 1601 (8) 4953 (7) 5031 (3) 1528(11) 4633 (1) 
Q1 733 (1) 3130 (1) 
R 604 (7) 722 (7) 1393 (1) 
S 3157 (1) 
U 5220 (1) 
Table 3.10: Dose area product data for 6-10 yr olds 
46 
Hospital 
ID 
Examination Type 
Cystogram Ba Swal. Ba Meal Ba 
Enema 
Ba 
Fol. Thr. 
Ba 
Meal&Swal 
Al 149 (1) 2146 (1) 
A2 20487 (2) 2419 (1) 16070(1) 1145 (1) 
B1 841 (1) 2883 (2) 2215 (1) 
B2 
Cl 599 (1) 2395 (1) 3786 (2) 2045 (1) 
C2 4234 (1) 6381 (2) 8542 (3) 3273(11) 
D 4725 (1) 5204 (3) 2294 (1) 
E 12584(1) 
F1 3272 (3) 1937 (2) 7560(5) 2163 (2) 
G 1568 (1) 12956(2) 
H 6406 (6) 4554 (2) 8917 (2) 
I 3476 (12) 2772 (4) 7137(14) 8446(4) 3625(21) 5871 (2) 
JI 8286 (1) 
K1 6212 (3) 5078 (1) 
K2 8619 (1) 6506(3) 12314(1) 20043(1) 24126(2) 
L1 1655 (1) 
L2 4253 (46) 3548(12) 5167(36) 15828(7) 6979 (3) 3980 (16) 
M1 10332 (1) 3977 (2) 10644(1) 22289(1) 3230 (1) 6626 (3) 
Ni 3911 (2) 
N2 243 (1) 759 (5) 2930(11) 6252(2) 3778 (2) 1806 (2) 
01 1640 (1) 1031 (2) 1508 (4) 1574(3) 5053 (4) 359 (3) 
02 5071 (7) 1088 (7) 1467 (4) 1235(1) 1457 (4) 
P1 5071 (7) 5418 (7) 4750 (5) 16174(3) 4455 (4) 6198 (1) 
Q1 4943 (3) 6823 (4) 
R 2246 (4) 1716 (1) 1701 (7) 2081 (1) 
S 3480 (1) 4623 (3) 
Table 3.11 : Dose area product data for 11-16 yr olds 
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Dose Area Product (mGy cm2) 
Age Band 
Cystogram Barium Meal Barium Swallow 
neonates 431.2 1082.1 1190.6 
infants 672.6 1561.3 1713.7 
1-5 years 1373.2 2073.5 2448.6 
6-10 years 2043.8 3290.0 - 
11-16 years 4826.7 5819.9 - 
Table 3.12 : Third quartile dose area product values for frequent examinations 
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Chapter 4 
Optimisation of Dose and Image Quality 
4.1 Introduction 
One of the fundamental problems in diagnostic radiology is the conflicting requirements for 
good image quality and low patient dose. Optimisation, in this respect, is the process of 
balancing the different technique factors for a given examination in order to achieve 
maximum patient benefit ie a successful diagnosis with minimal radiation dose. The 
principles governing this process and the techniques used are reviewed here. The specific use 
of beam filtration as an optimisation technique is discussed in depth, followed by a 
description of the optimisation strategy to be used in this work. 
4.2 Principles and techniques of optimisation 
To achieve good image quality, the photon energies in the X-ray beam must be such as to 
maximise the differential absorption between the various body tissues that are being 
examined - usually bone and soft tissue, or soft tissue and an artificially introduced contrast 
medium such as barium or iodine. This differential absorption generally decreases with 
increasing photon energy and thus a lower generating tube voltage (kV) is beneficial to 
contrast, and hence image quality. However, to minimise the radiation dose to the patient 
requires a reduction in the number of photons absorbed. As low energy photons are 
preferentially absorbed, this is achieved by increasing the mean photon energy of the X-ray 
spectrum by increasing the tube potential. This results in a favouring of high tube potential 
on the grounds of dose. The product of tube current and exposure time (mAs) must be 
selected in order to achieve an acceptable film density and dose increases with mAs. 
An X-ray beam contains a spectrum of energies from zero up to the generating tube 
potential. The relative proportions of photons of different energies is often referred to as the 
`shape' of the X-ray beam, and this will depend on the tube potential used and the X-ray 
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absorption characteristics of any media through which the beam has passed. The use of a 
beam filter, usually aluminium (Al), removes the lowest energy photons from the beam, 
which are absorbed in the patient and contribute to dose but little to image formation. The 
current regulatory requirement for diagnostic X-ray sets is for a minimum total filtration 
equivalent to 2.5 mm Al - including both the inherent filtration of the tube housing and light 
beam diaphragm and any additional filtration. The European guidelines on quality criteria 
for diagnostic radiographic images in paediatrics (Kohn et al, 1996) recommend additional 
filtration of up to lmm Al plus 0.1-0.2 mm Cu, in addition to inherent filtration of 2.0 mm 
Al, although no scientific evidence is referenced to support this recommendation. 
In practice, the selection of all the relevant technique parameters is usually carried out 
according to individual department protocol, with reference to prescribed guidelines such as 
those documented by the European Commission for both adults and children (EUR 16260 
and EUR 16261,1996). The problems in selecting technique factors are compounded when 
radiographing children, due to the wide variations in size, and also the need to minimise 
exposure time to limit the, often inevitable, patient movement. For paediatrics, the type of 
radiographic equipment used plays a crucial role in the optimisation process. Some 
generators are not capable of producing the short exposure times needed, and an undesirable 
drop in generating tube potential may be required to prevent overexposure of the film. 
Ideally all paediatric radiography would be carried out on powerful machines producing a 
radiation waveform that is almost rectangular, with minimal ripple. This is because, for short 
paediatric exposures, any pre and post peak voltage times are likely to be a significant 
proportion of the total exposure time, and thus have a noticeable effect on the mean beam 
energy for the exposure. Automatic exposure control devices, unless specifically designed 
for paediatric use, are often inappropriate for X-raying children due to their inability to 
compensate for varying body sizes and proportions. This is due to the large size and fixed 
position of the ionisation chambers used in the devices. Ideally, a small mobile detector is 
required, that can be positioned with regard to the area of interest. Unfortunately, financial 
constraints result in many X-ray departments being unable to use dedicated paediatric 
equipment, or upgrade equipment to the recommended specification. 
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A full discussion of the different principles associated with good imaging performance is 
given in the European guidelines on quality criteria for diagnostic radiographic images in 
paediatrics (EUR 16261). This document aims to produce a list of quality criteria that 
characterise the level of acceptability of normal basic radiographs which could address any 
clinical indication. The influence of patient age, and functional differences between adults 
and children - such as heart rate, ability to control inspiration etc - are recognised. The 
general principles, such as use of low attenuation materials in table-tops and cassettes and 
the importance of accurate positioning, beam limitation and shielding, are outlined clearly 
and apply to all paediatric radiography. Examples of good radiographic technique are then 
given for different radiographic examinations, along with diagnostic requirements for image 
criteria and patient dose criteria. Although comprehensive, the recommended techniques are 
stated to have `evolved from the results of European trials' rather than having any firm 
scientific basis. The image criteria specify important anatomical structures that should be 
visible on a radiograph to aid accurate diagnosis and three degrees of visibility are defined 
and used. Although some of the criteria specified reflect the performance of the imaging 
system and the technique factors employed, others reflect the positioning and compliance of 
the patient. The latter group are not descriptive of image quality in the usual sense of the 
word, and would be better considered separately. The selection of image criteria for a given 
examination are those deemed necessary to produce an image of standard quality, and are 
intended to ensure that pathological details are not missed. Although it is stated that lower 
levels of image quality may be acceptible for certain clinical indications, this is not discussed 
at length and this is a definite weakness in the document. Discussion with a small number 
of paediatric radiographers revealed that the quality criteria were felt to be rather too general 
for their use to be readily applicable. The criteria used for radiation dose to the patient is the 
reference entrance surface dose for the examination. These values are derived from results 
of a European trial, but values given are for a five year old patient only, which limits their 
usefulness. It should also be noted that the dosimetric results are based on only a single 
measurement for each examination category at each hospital involved in the trial, and for 
several examination types no data is presented at all. The dose criteria are thus virtually 
unusable for most applications. 
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The optimisation of image quality and patient exposure in paediatric diagnostic imaging has 
also been discussed by Fendel et al (1989). This paper defines radiological effective quality 
as a function of the product of effective (ie that needed and not more than that needed) 
information and the reciprocal of patient dose. This parameter thus increases with increasing 
information content and with decreasing dose, both of which are desirable features. The 
results of a survey at 35 institutions are presented, comparing dose and image quality 
coefficient - defined in terms of optical density, resolution and low image contrast - for 
different paediatric examinations. Results are analysed in terms of technique factors and 
equipment used. Although use of such a coefficient simplifies comparisons between centres 
and procedures, the image quality parameters used take no consideration of the level of 
image quality required for an examination and thus do not represent the `effective 
information' described earlier. There is no justification for combining the different 
parameters in any specific format to give an `optimised' result, and presentation of data in 
such a way may not accurately reflect the true situation. 
A number of optimised techniques have been proposed for specific examinations, where the 
degree of image quality required can be specified more exactly. Joseph et al (1976) 
described a technique utilising selective filtration, high kilovoltage and fine focal spot 
magnification for the study of upper airway obstruction in infants and small children. The 
filter used comprised tin, copper and aluminium and effectively increased the air contrast 
with respect to the bone contrast. A high kilovoltage filtered beam technique has also been 
proposed for demonstrating bronchial situs in children (Furlonger, 1982). This also utilises 
a copper/tin filter, inserted into the collimator, and is reported to reduce patient exposure in 
addition to providing satisfactory images without repeat exposures. 
Further advances in optimisation of patient dose and image quality are unlikely unless 
consideration is taken of the particular requirements of different X-ray examinations, in 
terms of diagnostic endpoint, image quality and any specific dose concerns, eg if one 
particular radiosensitive organ is being irradiated. The required end point of any examination 
needs to be well defined, especially when image quality need not be improved beyond a 
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certain level. Once the required information content is reached, improving the quality of the 
image will only increase the detriment to the patient in terms of radiation dose. A second 
important consideration is that variations in technique and their influence on both patient 
dose and image quality need to be assessed on a scientific basis, rather than from an ad hoc 
or historically based approach. Assumptions made in the past, particularly concerning the 
capabilities of equipment, should always be justified in the light of current knowledge and 
technology. Finally, any recommendations or suggestions for optimisation must always take 
into consideration the practicalities of their application. Even a well designed, scientifically 
based optimisation strategy with proven benefits will fail if implementation is not feasible 
in the majority of departments. 
4.3 Choice of quantities to be optimised 
4.3.1 Dose descriptors 
A full discussion of the different quantities used to describe patient dose has already been 
given in Chapter 2. The computer simulations presented in this work use values of both 
entrance surface dose and total energy imparted to compare the dose effectiveness of 
different techniques. These quantities are straightforward to model, allow comparison with 
the work of others and, together, give a reliable indication of the dosimetric effects of 
irradiations performed using different techniques. The dose quantities measured during 
experimental work were chosen to mirror these as far as possible, and consisted of entrance 
surface dose, mid-body dose and individual organ doses. 
4.3.2 Image quality descriptors 
The quality of an image may be assessed in many different ways, and is a complex subject 
as it is affected not only by characteristics of the image but also the viewer's visual response 
system. Image quality indexes describing physical performance of a system include contrast, 
unsharpness and noise, and each of these may be specified and measured by a number of 
means. The effect of the observer may be included by physical and physiological assessment 
of images. Subjective quality criteria, such as those recommended by the CEC (1996) may 
also be used. The choice of image quality parameter to be used in a comparative study is 
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influenced chiefly by the techniques under investigation and their effect, but also by the ease 
of measurement or calculation of the parameter in a reproducible fashion. 
In film-screen radiography, radiographic contrast is defined as the difference in optical 
density between two adjacent areas of film 
C, d* = D1 - D2 
This is dependant on both the inherent contrast of the film as described by -y, the gradient 
of the characteristic curve, and the radiation or primary contrast. Radiation contrast has been 
defined in a number of ways, most commonly in terms of photon contrast or kerma contrast 
C= 
N1 - N2 C= 
Ki -K2 
photon N kerma 
2 
where Ni and N2 are the photon fluences through the contrast area and the background 
respectively and K, and K2 are the air kerma values due to the photon fluences N, and N2. 
Other variables that give a measure of the signal may also be used in this definition and the 
appropriate choice will depend on the situation to which it is being applied. As an image 
receptor responds proportionally to the energy imparted to it, one variable which is 
particularly useful is the energy absorbed in the receptor, per unit area, behind (E, ) and 
outside (E2) the region of interest. 
Cabs 
en 
E1 -E2 
-E 
2 
This parameter has been used by others as a measure of contrast (Koedooder, 1985; 
Sandborg, 1989) and also in derivation of signal to noise ratios (Sandborg et al, 1989). The 
energy absorption contrast thus includes detector response and is related to air kerma contrast 
through the absorption coefficients of the screen phosphor, which will depend on the energy 
spectra of the beam. 
Radiation contrast may be related to radiographic contrast through the phosphor and film 
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responses. The relationship between the speed of a screen/film system and the energy 
absorption in the screen has been investigated by a number of authors. Venema (1976) 
showed that the speed of seven rare earth screens, relative to that of calcium tungstate 
screens, has the same energy dependence as did their relative X-ray absorption. Vyborny et 
al (1977) demonstrated that the effects of the screen phosphor absorption edge on system 
speed are of great importance in determining the overall response, while the effect of the 
film is negligible by comparison. The same authors later investigated six typical systems and 
concluded that their speeds act in a manner similar to that which would be predicted if only 
the energy absorption properties of their screens were considered, except for energies below 
30 keV where the screen conversion efficiency drops and, to a small extent, around the K 
absorption edge of non calcium tungstate screens (Vyborny et al, 1980; Vyborny, 1977) also 
showed that radiographic contrasts in film-screen systems can be predicted using a single 
characteristic curve for a particular system, with photographic density expressed as a function 
of X-ray energy absorbed in the screens rather than of relative exposure. This sensitometric 
relationship between absorbed X-ray energy and film density was verified by Chan and Doi 
(1983). 
Radiation contrast is very much affected by the energy of the X-ray beam, as it 
fundamentally relies on the difference in attenuation coefficients between the tissue or 
medium of interest and the surrounding area. It also depends on the thickness of the contrast 
region. Photon, kerma or absorbed energy contrasts may all be fairly easily determined from 
a Monte Carlo simulation, and radiographic contrast may be derived from measurements of 
film density. Different definitions of contrast would be expected to give different numerical 
results for the same irradiation conditions, but comparative measurements to illustrate the 
effect of a change in parameter should give broadly similar results. Radiation contrast 
defined in terms of energy absorption in the phosphor will give the closest approximation 
to radiographic contrast. 
Unsharpness of a radiological image may be geometric unsharpness, arising from the focal 
spot of the X-ray tube, movement unsharpness, or unsharpness arising from the image 
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receptor. None of these are directly affected by the technique factor selected or energy of 
the beam, although a longer exposure time may increase the likelihood of patient movement, 
especially for paediatrics. Image unsharpness is often described in terms of the modulation 
transfer function (MTF), a concept based on Fourier analysis. This may be explained simply 
by considering that at any stage in the imaging process all information may be expressed in 
terms of a spectrum of spatial frequencies. For an exact image, all frequencies would have 
to be reproduced with one hundred percent efficiency. However, each separate component 
of the imaging chain will modify this spatial frequency spectrum by the component's MTF. 
An MTF of 1 results in precise transmission of that frequency and, in general, the MTF 
decreases with increasing spatial frequency as the high frequency information in an image 
(fine detail) is more likely to be degraded. The MTF of the entire system is given by the 
product of the individual component MTFs. MTF is generally used to describe the imaging 
characteristics of a chain of system components itself, and is dependant on the equipment 
used and not by changes in beam spectrum. Image unsharpness may be assessed in practice 
by measuring the resolution obtainable from a system, using a suitable test object. 
Noise can degrade an image irrespective of its contrast and resolution. Noise may arise from 
statistical fluctuations in the number of X-ray photons detected per unit area - known as 
quantum noise - or from the receptor itself - radiographic noise. Noise can be expressed in 
terms of its Wiener spectrum or as a signal to noise ratio. The Wiener spectrum is obtained 
by taking the Fourier transform of the noise and plotting its square against frequency, to give 
the power spectrum. It will contain information on all components of noise and its 
measurement is complex. The signal to noise ratio (SNR) may be defined according to the 
theory of Rose (1948), in which an observer is thought to compare a signal with a region 
of background equivalent in area to the object. From this, the SNR may be given by 
(N2 - Nl)at SNR = 
(Nlat)12 
where a is the area of the object, t the integration time of the image receptor and N. and Ni 
the photon fluences through and beside the object. It may be seen from this that SNR is 
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closely related to photon contrast. If two images of an object have the same contrast, they 
will only differ in SNR if the number of photons reaching the detector per unit area is 
significantly different. In practice, noise is usually only a limiting factor for image detection 
when very fast intensifying screens are used, radiographs are enlarged, or in digital radiology 
over a small area. For the same image receptor and display system, noise will only be 
affected by the number of photons reaching the receptor. Under conditions of equal 
background film density, in a comparative study such as this, the noise variation should be 
small; and ratios of SNR are unlikely to yield any more information than ratios of contrast, 
as defined earlier. Calculations of SNR will only be of use in an optimisation study if the 
parameters being varied have an effect on the image noise eg when comparing different 
types of equipment. 
For the simulations presented here, energy absorption contrast was selected as the image 
quality parameter to be optimised against dose since, of all the parameters, contrast will be 
affected most by changes in the input energy spectrum, which is the major variable in the 
study. Energy absorption contrast in the detector was used in preference to other contrast 
definitions as it takes account of phosphor response, is easily calculated using Monte Carlo 
techniques and, for film-screen radiography, can be related to the radiographic contrast 
observed on the film. For the experimental work, radiographic contrasts were derived from 
measurements of film density behind and beside the area of reduced transmission. 
4.4 Beam filters 
X-ray beam filters are used to change the shape of the energy spectrum emitted from the 
tube in order to improve performance. This occurs as all materials will selectively attenuate 
different photon energies. The way in which they do this will depend on the atomic number 
of the filter material. Low atomic materials, such as carbon, may be classed as general 
attenuators, with the most uniform attenuation across a beam spectrum. This occurs as their 
chief mode of attenuation is by Compton scattering which is independant of photon energy. 
As atomic number increases, photo-electric absorption becomes the dominant feature over 
the diagnostic energy range. When this occurs, the absorption coefficient will decrease with 
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increasing photon energy, except when an absorption edge occurs in the energy range of 
interest, when the absorption coefficient increases sharply. When such a K-edge is not 
present, and photo-electric absorption is dominant the material acts as a high-energy pass 
filter, removing chiefly low energy photons from the beam. Materials with atomic number 
ranging from 25 to 35 fulfil these criteria most effectively. For materials with slightly lower 
atomic number, such as aluminium both photo-electric absorption and Compton scattering 
are present, making them less efficient high energy pass filters. When a K-edge occurs 
within the emitted spectrum the material acts as a bandpass filter, selectively removing both 
low energy photons and those with energies above the K-edge of the filter material. It has 
been proposed that such filters can both reduce patient dose and maintain or improve image 
contrast. To illustrate the characteristics of the different filter types, Figure 4.1 shows how 
the reciprocal of the mass attenuation coefficient varies with energy for carbon (Z = 6), 
aluminium (Z = 13), copper (Z = 29) and erbium (Z = 68). Plotting the reciprocal of µ 
means the graphs give an illustration of the transmission of the filters. 
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Figure 4.1 : Reciprocal of mass attenuation coefficient plotted as a function of 
energy for (i) carbon; (ii) aluminium; (iii) copper; (iv) erbium 
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4.4.1 Previous work 
Many authors have addressed the issue of filtration in diagnostic radiology, but there is still 
no consensus of opinion on the suitability of K-edge filters for dose reduction. This is 
mainly due to the wide range of both methodology and endpoint employed in the various 
studies. The methodologies used may generally be classified as theoretical, often utilising 
computer programming to `rank' filters according to defined performance criteria; 
experimental where laboratory measurements are carried out with phantoms to determine 
how parameters change according to beam filtration; or clinical where a filter is installed in 
an X-ray room and its effect on patient dose and image quality assessed. Each of these three 
techniques has its merits and drawbacks, and these are discussed below. 
Early work on the use of K-edge filtration was based on the intuitive premise that the beam 
shaping properties of such band pass filters would be beneficial to X-ray imaging (Atkins 
et al, 1970; Villigran et al, 1978; Fleay et al, 1980). The filters studied were selected on the 
basis of a subjective consideration of the spectra obtainable and the absorption 
characterisitics of the contrast media. While this is a reasonable starting point, it results in 
a fairly arbitrary choice as the K-edge energy does not vary rapidly for elements of similar 
atomic number, and the reason for selecting one over its neighbours is unclear. The 
experimental measurements made were limited in nature as only a small range of parameters 
was investigated in each case. The quantity used to assess dose reduction, in all the above 
work, was entrance exposure which gives a poor indication of risk to the patient. In addition, 
the parameter used to assess image contrast has not always been clearly defined (Atkins et 
al, 1970; Fleay et al, 1980). The recommended filters were gadolinium (Atkins et al, 1970) 
and holmium (Villigran et al, 1978) for iodine studies and erbium or samarium for paediatric 
examinations (Fleay et al, 1980). 
A number of clinical trials of specific filters have been carried out including the use of 
gadolinium in paediatric radiology (Johnson and Burgess, 1981), the use of yttrium (Wang 
et al, 1984) and several evaluations of erbium filters (Wesenberg et al, 1987; Levett, 1990; 
Cranage et al, 1992). Each of these demonstrated dose reduction with acceptable contrast. 
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The results of such trials are important as they involve results from actual patients who 
should always be the end point of any optimisation study. The subjective assessment of 
image quality also takes account of the fact that the most significant criteria in such a 
comparison is whether or not the resultant images are of acceptable diagnostic quality. 
However, a number of points must be made about the limitations of such purely clinical 
trials: 
0 All the above papers refer only to reduction in entrance skin exposure and include 
no assessment of any absorbed dose quantity, which would almost certainly be 
affected far less by the introduction of extra filtration. 
0 As only one filter is assessed in each case, there is no reason to suppose that use of 
a different filter might not achieve equally good, or improved, results. 
0 The results obtained strictly only apply to the conditions involved in the trial. Use 
of the filter under other conditions (patient thicknesses, tube potentials, examination 
types etc) may not give comparable results. 
Two main types of theoretical assessment of filtration have been carried out. The first of 
these is a consideration of the spectra themselves, and methods for comparing or matching 
spectra passing through different filter materials (Shrimpton et al, 1988; Jennings, 1988; 
Carrier and Befque, 1992; Nickloff et al, 1993). A theoretical study of the influence of 
filtration and tube potential on dose (Shrimpton et al, 1988) concluded that the best dose 
reduction could be achieved using a high kV technique and that effective dose was affected 
much less than entrance dose by additional filtration. The concept of precise spectral 
matching for different filter materials has been explored theoretically (Jennings, 1988; 
Nickloff, 1993) with similar spectra obtained for different filter materials, depending on their 
thicknesses. Relative efficiencies (ie transmissions) of the different filters were then used to 
compare their performance and that for aluminium (the most usual filter material) was shown 
to be low. An alternative comparison of filters, matching those that gave the same ratio of 
entrance exposure to energy absorbed in the detector, demonstrated similar results (Carrier 
and Beique, 1992). However, it was not possible to achieve spectral matching for K edge 
filter materials, and unpredictable behaviour was observed regarding efficiency, contrast and 
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dose for such filters (Carrier and Betque, 1992), illustrating that the presence of a K-edge 
discontinuity cannot be easily fitted into a simple theoretical model. 
The second type of theoretical study appearing in the literature is the comprehensive 
computer based investigation, which aims to cover a wide range of filter materials and 
irradiation conditions, in order to determine the advantages, if any, of one type of material 
over another (Koedooder and Venema, 1985; Gagne et al, 1992; Sandborg, 1994). These 
were carried out using computer models incorporating attenuation through a phantom, 
absorption in an image receptor and calculation of dose and image quality parameters. The 
conclusions of the studies are similar in that beam hardening filters, such as copper, are 
reported to be at least as good as, if not better, than K-edge filters in most circumstances. 
The advantage of these studies lies mainly in the large number of parameter variations that 
are covered, but a number of flaws may be identified: 
0 In order to make absolute comparisons of different filter materials, the studies have 
all incorporated constraints to the system under investigation. Equal energy 
absorption in the energy receptor (or background density on a film) was a universal 
requirement, and most have enforced equal contrast (Koedooder and Venema, 1986; 
Gagne et al, 1993) and some equal tube load (Sandborg et al, 1994). Although such 
methodology does allow an absolute ranking of filters it is not necessarily a 
reflection of clinical practice. Clinical use of a filter would certainly require that the 
images obtained were still approximately the same background density, and that 
images were still of diagnostic quality, but equal is not always the most relevant 
term for an X-ray reporting room. The complexity of spectral behaviour - influenced 
by filter, kV, patient tissues and thicknesses etc - means that slight fluctuations in 
one parameter, eg contrast, might be accompanied by relatively large changes in 
another parameter eg dose. Constraining system parameters may thus result in some 
interesting effects being missed, or poor understanding of the underlying behaviour. 
0 Although many filter types have been studied, and a number of image receptors and 
contrast media, fewer data are available for paediatric than for adult thicknesses even 
although that which has been presented shows more potential for the use of K-edge 
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filtration (Gagne et al, 1993). 
0 Experimental verification of the theoretically determined results is, in general, sparse 
and insufficiently detailed (Koedooder et al, 1985), and for some studies no such 
verification has been carried out at all (Gagne, 1993). There has also generally been 
no extrapolation to the clinical environment. 
A smaller number of purely experimental studies have been carried out (Regano and Sutton, 
1992; Heggie, 1992; Hansson et al, 1997). The first of these used heavy metal salt solutions 
as filters with bone/soft tissue contrast, and took the approach of matching a range of 
phantom thicknesses and tube potentials to a given filter, from a consideration of the K-edge. 
The results give some insight into the effect of the K-edge and tube potential on the different 
parameters, but the method of calculating absorbed energy contains large uncertainties. 
Heggie (1992) studied the use of a number of filters in Automatic Brightness Controlled 
(ABC) Fluoroscopy and Digital Subtraction Angiography (DSA), using phantoms and test 
objects. The results are highly dependent on the operation of the ABC algorithm. The study 
reported by Hansson et al (1997) contains high quality data but again is for one highly 
specific examination, with only one filter tested. It is also worth noting that the examination 
in question (double contrast enemas) is not one that is performed on paediatrics in this 
region. 
To summarise, those authors who advocate the use of K-edge filtration have in general 
focussed on the dose reductions achievable, and assessed the associated effect on contrast 
subjectively, often looking only for `acceptable' contrast. In many cases only the impact on 
entrance dose has been assessed. This is a serious flaw as it has been shown to be very 
different to the impact on integral dose, which is the more important quantity. Direct 
comparison with beam hardening filters, such as copper, have not usually been made. Those 
who reject the superiority of K-edge filters over more conventional materials have usually 
done so on the basis of a more theoretical study in which various constraints are put on the 
system, such as equal contrast or tube loading. Although this may seem to be a logical way 
forward, in practice the concept of 'acceptable' contrast may be more in keeping with the 
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principles of dose limitation than that of `equal' contrast. More importantly, tube loading 
will now often not be a major factor to be taken into consideration, particularly for paediatric 
examinations where exposures are small. A filter that may be appropriate for a particular 
examination, and perhaps a particular range of patient sizes, may not necessarily be 
appropriate for general use. Optimisation of beam spectra should ideally be applied on an 
examination and patient specific basis. This then raises the important consideration of the 
practicality of using a given filter, if it is not suitable for permanent installation on a piece 
of equipment. 
4.5 Methodology for optimisation study 
4.5.1 Aims 
Three stages were identified in the development of an optimisation strategy: 
(1) A theoretical analysis of the behaviour of a wide range of filters with variation of 
different parameters, and interpretation of the results. 
(2) Experimental verification of the theoretical results, and assessment of the influence 
of practical and clinical constraints. 
(3) Clinical implementation of results 
The theoretical analysis was necessary in order to carry out as complete a study as possible, 
and to avoid prejudicing results by artificially constraining the system eg by forcing equality 
of tube load or contrast. Experimental validation was essential not only to ensure that the 
results were correct, but also so that practical considerations could be accounted for. The 
clinical implementation, and assessment, of an optimised technique had to be the final 
objective of any such study, as the increased benefit to the patient is the motivation for 
performing it. 
The specific aims of the theoretical study, which was carried out using Monte Carlo 
techniques as described in the next chapter, may be listed as follows: - 
0 For each simulation, to calculate both the entrance surface dose and the total energy 
imparted to the patient, plus the absorbed energy contrast and total absorbed energy 
in the screen. 
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0 To study a wide range of filter materials and thicknesses, in order to explore the 
characteristics of different filter materials without imposing numerous constraints. 
0 To consider a number of different contrast scenarios, eg bone in soft tissue; 
barium/iodine in soft tissue; lung in soft tissue. 
0 To use a simulation geometry that could be reproduced experimentally, in order to 
verify the results. 
0 To carry out simulations for a range of paediatric patient sizes. 
The reasoning behind the choice of dose and image descriptors has been discussed above. 
It could be expected that optimal beam spectra might depend crucially on the patient 
thickness and also on the tissues and contrast media being imaged, so the effect of these 
factors needed to be studied as far as possible. As neonates comprise the extreme of the size 
range - differing the most from adults, for whom the majority of filtration work has been 
carried out - this age group was the focus of the initial set of simulations. The criteria of 
experimental reproducibility was essential in order to validate the Monte Carlo results 
obtained. 
4.5.2 Geometry 
The geometry used for the simulation is shown in Figure 4.2. 
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Figure 4.2 : Geometry for Simulation 
An X-ray beam is incident normally on a thin filter, with the patient phantom a fixed 
distance beyond. The phantom is represented by a defined thickness of uniform tissue, 
containing a small disc of contrasting material at its centre. Below the patient is an optional 
thickness of table top (which is not required when simulating irradiation of an infant lying 
directly on a film cassette) followed by the image receptor, which may be an intensifying 
screen, as used with film, or a phosphor used directly in fluoroscopy. The incident spectrum 
is prefiltered with aluminium, and produces a circular field of variable size. 
4.5.3 Range of variables to be tested 
The filter materials included in the computer study are listed in Table 4.1 together with the 
range of thicknesses used. The choice of filter thickness was made initially from study of 
previous work, using a range of thicknesses similar to those recommended by others. For 
most materials, this meant multiples of 0.05 mm thicknesses, although filters of samarium 
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and tin have commonly been used in smaller thicknesses (Jangland and Axelsson, 1990; 
Gagne et al, 1994) Early results were then used to assess where extension of the range of 
simulations would be useful, leading to simulations incorporating slightly greater thicknesses 
of tin and samarium and intermediate thicknesses of both copper and dysprosium, to give 
more closely spaced data points for these graphs on subsequent analysis. 
Filter Material Thicknesses (mm) 
Aluminium 0.5,1.0,1.5,2.0,2.5,3.0,3.5,4.0 
Dysprosium 0.050,0.075,0.100,0.125,0.150,0.175,0.200,0.225, 
Erbium 0.250 
Copper 0.05,0.10,0.15,0.20 
Gadolinium 0.050,0.075,0.100,0.125,0.150,0.175,0.200 
Holmium 0.05,0.10,0.15,0.20 
Samarium 0.05,0.10,0.15 
Tin 0.04,0.05,0.08,0.10,0.15,0.20 
Terbium 0.04,0.05,0.10,0.15 
Ytterbium 0.05,0.10,0.15,0.20,0.25 
0.05,0.10,0.15,0.20 
Table 4.1 : Filters used in simulation 
The thickness of tissue being irradiated could be varied to represent patients of different 
ages. Initially all simulations were carried out for 5 cm tissue, to represent a neonate. This 
thickness is less than that of a `standard' newborn, as the babies receiving most radiographic 
examination are those born prematurely, as they tend to have a range of clinical problems. 
The chosen thickness thus corresponds to a typical patient size in a special care baby unit. 
Consideration was later given to how the techniques might be applied to other age groups. 
Appropriate tube voltages were selected for the study. For the neonates, the reference voltage 
was 60 kV and simulations were carried out at 55,60 and 70 kV to investigate the effect 
of varying tube voltage. When considering thicker phantoms, the reference voltage was 
70 kV. The reference voltages were determined from routine practices in the department 
where the clinical trial was carried out. 
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The composition of the irradiated tissue was either soft tissue or lung, with contrasting inset 
of bone, lung, iodine or barium, enabling a range of radiographic conditions to be simulated. 
The tissue compositions were taken from White et al (1977) who describes a number of 
epoxy resin systems for use in constructing simple phantoms. He showed that the 
composition of a child may be simulated by the same resin as for an adult. The materials 
used chosen for use here were MS20 was for soft tissue, LN10 for lung, and SB5 for bone. 
The relative compositions and densities of these materials are given in Table 4.2. The 
method by which these materials were incorporated into the Monte Carlo simulation are 
described in Chapter 5, and blocks of the material were obtained for the experimental 
measurements. 
Material Name Composition (% by weight of each element) Density 
H C N 0 Mg Cl Ca Si (g cm') 
MS20 (muscle) 8.1 58.4 1.8 18.6 13.0 0.1 1.00 
LN10 (lung) 8.4 60.5 1.7 17.3 11.2 0.1 0.8 0.288 
SB5 (bone) 2.6 30.6 1.0 38.9 0.1 26.8 1.87 
Table 4.2 : Tissue equivalent materials used in simulation 
Compositions were obtained of a number of commercially available intensifying screens, but 
the majority of work was carried out for two screens - Agfa Gevaert Curix Ortho Regular 
screens (Gd2O2S, phosphor thickness 60 mg cm 2) and Agfa Gevaert MR200 screens (LaOBr, 
phosphor thickness 43 mg cm-') - and for a CsI fluoroscopic phosphor. The majority of rare 
earth screens contain either gadolinium or lanthanum, and the screens simulated correspond 
to those available for experimental work and that used locally. The appropriate thickness of 
phosphor to be used in the simulation was determined from the mass thickness and the 
density of the material. 
4.6 Summary of chapter 
This chapter has presented a discussion on the general principles and techniques of 
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optimisation in diagnostic radiology, with particular reference to paediatrics. A summary of 
different image quality parameters has been given, along with an explanation of the choice 
of both dose and image quality descriptors used for this work. The subject of beam filtration 
in relation to the optimisation of dose with image quality has been explored in depth and the 
published work in this area reviewed. In particular, the merits and drawbacks of the different 
types of optimisation studies performed have been outlined. Finally, the strategy employed 
for the optimisation study carried out in this work has been described. 
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Chapter 5 
Development and testing of Monte Carlo 
Code 
5.1 Introduction 
The theoretical investigation of the effect of beam filtration on paediatric dose optimisation 
was carried out using Monte Carlo techniques. This chapter contains a general description 
of these techniques and details of the specific code, EGS4, used for the simulations. 
Modifications made to the code for the purpose of this work, and the development of the 
user-written interface are also described, along with full details of the input parameters and 
the format of the results obtained. A discussion of the variance reduction techniques 
employed and the accuracy of the code are included at the end of the chapter. A complete 
listing of the usercode that was written to run the simulations is given in Appendix B. 
5.2 Monte Carlo techniques 
Monte Carlo techniques are so named because they use the laws of chance to carry out 
sampling of an event, or sequence of events. Monte Carlo techniques of radiation transport, 
in particular, comprise the simulation of the random trajectories of individual particles. This 
is carried out using machine-generated random numbers to sample from the probability 
distributions governing the physical processes involved. A single particle history thus 
comprises the simulation of the movement and interactions of that particle and all particles 
arising from it until they have all either left the regions of interest or their energy has 
dropped below a cut-off value. The number of histories simulated affects both the statistical 
significance of the results and the execution time of the code. 
Monte Carlo techniques of radiation transport have been in use for over forty years, and 
many codes have been developed, including the EGS4 (Electron Gamma Shower) code 
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(Nelson et al, 1985). The initial use of such code was confined to the realms of high energy 
physics, but applications in the field of medical physics were found and the code has been 
extended and improved to allow simulation of low energy interactions. Another code that 
was available was the ETRAN code, (Berger and Seltzer, 1968). This code treats low energy 
processes in greater detail than the earlier versions of EGS4, as it was originally designed 
for the energy regime below a few MeV whereas EGS was originally a high-energy physics 
code, designed for energies up to the GeV range. Thus, ETRAN includes treatment of 
fluorescence, sampling of the angular distribution of photoelectrons and the use of the Eiwert 
correction factor to modify bremsstrahlung cross-sections. It does not, however, include 
coherent scattering which is an option in the EGS4 code. Other effects accounted for in 
ETRAN are the atomic binding effect on atomic electrons, and energy loss straggling. The 
chief disadvantage of ETRAN is its lack of flexibility. It is designed as complete codes, 
allowing the user to select one of a wide variety of geometries and elect a variety of outputs 
in each region. While this makes the code easy to use, it restricts the user's options and 
ability to extract information. The code has not generally been in widespread use, but was 
used extensively in testing EGS4. The remaining code of note that has been in general use 
is the MCNP code (Thompson, 1979) which consists of continuous-energy coupled neutron- 
photon transport, with an arbitrary configuration of materials using generalised geometry. 
5.2.1 Use of Monte Carlo techniques in medical physics 
Over the last twenty years there has been an increasing use of Monte Carlo techniques in the 
field of medical physics, mainly in the fields of nuclear medicine, radiotherapy, diagnostic 
radiology and radiation protection. A full review of this work has been given by Andreo 
(1991). Microscopic Monte Carlo techniques have also been used in the study of electron 
microscopy, radiation track structure and microdosimetry. 
In the field of diagnostic radiology, the energy response of detectors used in the 
measurement of X-ray spectra has been investigated by Chen et al (1980), and Yamaguchi 
(1983) has investigated the influence of a tungsten absorption edge filter on X-ray spectra. 
Several authors have studied scatter fractions and scatter to primary ratios, using 
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monoenergetic photon pencil beams on a parallelpiped or slab water phantom (Neitzel et al, 
1985), and Chan and Doi (1984) looked at the spatial distribution of energy deposition from 
pencil beams in water slabs. Monte Carlo techniques have been used extensively by 
Sandborg, Persliden and their colleagues for a number of diagnostic radiology problems, 
including studies of grid performance (Sandborg et al, 1994), performance of contrast agents 
(Sandborg et al, 1995), calculation of dose and image quality parameters (Sandborg et al, 
1993) and the derivation of factors for calculating energy imparted to a patient (Persliden 
and Alm-Carlsson, 1984). Work has also been carried out in the area of mammography, such 
as the derivation of conversion factors for mean glandular breast dose from air kerma 
(Dance, 1990). More recent work includes the calculation of dose conversion factors for 
posterior-anterior chest radiography (Schultz et al, 1994), using the MCNP package, and 
simulation of the upper gastrointestinal fluoroscopic examination for the calculation of 
absorbed dose to tissue (Stem et al, 1995). Monte Carlo techniques have also been used to 
determine the upper limiting values of back scatter factors for low energy X-ray beams 
(Patrocinio et al, 1996). Applications in radiation protection include the use of mathematical 
anthropomorphic phantoms for the calculation of internal exposures and organ doses from 
external beams (Drexler et al, 1984). There are also calculations using the ICRU sphere 
(Grosswendt, 1988) and radiation shielding problems such the retrospective analysis of shield 
design in a diagnostic X-ray room (Metzger, 1993) using the MCNP code. 
5.2.2 Choice of Monte Carlo code 
The EGS4 code was chosen for use in this work as it has many advantages to its use, the 
chief of which is its extreme flexibility. The geometries may be defined by the user, using 
any combination of planes, spheres and cylinders and any materials may be specified, in the 
form of elements, compounds and mixtures. The code is also easily modified and extended 
to suit the user's requirements. The use of EGS4 is widespread, and this has enabled the 
code to be tested under a variety of conditions. This code was also already available for use 
within the department. The EGS4 code may be run on a VAX system, PC DOS system or 
a unix operated system. The PC version was used in this instance, and the code run initially 
on a 386 Compaq with 4 Mbytes memory, later on a 486 Opus with 16 Mbytes memory. 
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5.3 EGS4 code 
The EGS (Electron Gamma Shower) code was first introduced in 1978 and is a general 
purpose package for the Monte Carlo simulation of the coupled transport of electrons and 
photons in an arbitrary geometry. The radiation transport of electrons or photons can be 
simulated in any element, compound or mixture and both photons and charged particles are 
transported in random rather than discrete steps. The dynamic range of charged particle 
kinetic energy goes from a few tens of keV up to a few thousand GeV, and for photons the 
dynamic range lies between 1 keV and several thousand GeV. The code has been used in 
many medical applications, including both radiotherapy and diagnostic radiology problems. 
EGS4 has been used to calculate the shielding requirements for constant potential diagnostic 
X-ray beams, by simulating their transmission through lead, concrete, gypsum, wallboard, 
steel and plate glass (Simpkin, 1989). Simpkin and Mackie (1990) have also used the EGS 
system to compute ß dose-kernels for monoenergetic electrons and ß emitters. In 
radiotherapy, McCall et al (1978) calculated spectra from a number of high energy X-ray 
targets and flattening filters, using EGS. 
5.3.1 Structure of code 
The EGS4 package consists of a number of subroutines, which carry out the radiation 
transport, and these are held together by a flexible user interface which sets up parameters 
specific to the problem in hand and calls the transport subroutines. The properties of the 
original particles - type of particle, charge, initial position, direction and energy - are defined 
in this interface, as is the number of particles whose histories are to be tracked. All particles 
are tracked individually, by determining the distance that the particle will travel, the type of 
interaction undergone and the position, energy and direction of the original particle and all 
new particles arising from the interaction. As new particles are created, their properties are 
stored in a `stack' structure fe tracking always continues with the most recently created 
particle, until it is either totally absorbed or leaves the region of interest, when the next 
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particle on the stack is selected. When the entire history is complete, the next incident 
particle history is initiated. 
An accompanying preprocessor package, PEGS, is used to provide interaction data for the 
simulations, and this is described in section 5.3.2 below. The programming language used 
throughout EGS4 and PEGS4, including the usercode, is MORTRAN3; a structured language 
implemented as a set of macros which are used by the macro processor to translate the 
language into FORTRAN. A summary of the main features of the MORTRAN3 language 
is given in Appendix C. The macro facility is an important feature of EGS4 as macros may 
be defined in the usercode, and used to control or overide various functions in the EGS 
transport code. A macro definition takes the form 
REPLACE (pattern) WITH {replacement) 
where pattern is any string of text, including variables if required and replacement is the 
desired new text. This definition has the effect of searching all the ensuing code for the 
pattern and replacing it with the replacement text. This allows the user to make changes to 
the supplied code without having to edit it permanently. 
The geometry of the simulation is defined by a subroutine named HOWFAR, which must 
be written by the user. Standard code is available for defining planes, cylindrical surfaces 
and spheres, from which many different three dimensional geometries may be constructed. 
A further user-written subroutine (named AUSGAB) is called under a set of very well 
defined and selectable conditions (eg at the end of every photon and electron step) and is 
used to keep track of the parameters of interest, and to extract the required information. 
The relationship between the different parts of the EGS and user codes is shown in Figure 
5.1, where the shaded regions indicate the parts of the code written by the user. Arrows 
indicate the direction of data flow: PEGS provides input to EGS4 via a group of data sets 
containing interaction data; all sections of the user-written code provide input to EGS, and 
may also request output eg an absorbed energy value at the end of a simulation or a running 
total of the number of particle histories simulated etc. 
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Figure 5.1 EGS Code Structure 
5.3.2 Preprocessor for EGS4 
The radiation transport simulation requires the appropriate data on the various interaction 
cross-sections employed, specific to the media being traversed, and the energy range of the 
particles tracked. An accompanying preprocessor program (PEGS4) is used to create cross- 
section data files, suitable for use by EGS4, for materials specified by the user, across a 
specified energy range. PEGS4 works by constructing piecewise-linear fits over a large number 
of energy intervals of the cross-section and branching ratio data. This means that a linear fit 
is performed with a given number of subintervals, and the number of subintervals is doubled 
until the fit satisfies all tolerances. Data can be produced for elements, compounds and 
mixtures of elements, as specified in a user-written input file of defined format. In general, 
PEGS4 need only be used once to obtain the media data files required by EGS4 for a given 
simulation. 
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5.3.3 Interaction processes 
The physical interaction processes accounted for in EGS4 include Compton scattering, 
Rayleigh (coherent) scattering, pair production and the photoelectric effect for photons. The 
production and transport of fluorescent photons is not included in the default version but 
may be partially incorporated by use of an additional option (see section 5.3.4 below). 
Electron processes include bremsstrahlung production - excluding the Elwert correction at 
low energies, Moliere multiple scattering where the reduced angle is sampled from a 
continuous distribution for randomly selected arbitrary step sizes, and Moller and Bhaba 
scattering using exact rather than asymptotic formulae. For continuous energy loss applied 
to charged particle tracks between discrete interactions, the total stopping power consists of 
soft bremsstrahlung and collision loss terms. The latter is determined by the Bethe-Bloch 
stopping power (Berger and Seltzer, 1964) with Sternheimer treatment of the density effect. 
Compton scattering cross-sections are generated from Klein-Nishina formulae (Klein and 
Nishina, 1929), and both photoelectric and Rayleigh scattering cross-sections from Storm and 
Israel (1970). The formulae used for bremsstrahlung are those described by Koch and Motz 
(1959), and cross-sections for Moller and Bhabha scattering are given by Messel and 
Crawford (1970). K-edge fluorescent yields are from Lederer et al, with cross-sections and 
energies from Storm and Israel (1970). 
5.3.4 Options and enhancements to EGS4 
In addition to the basic EGS4 code, there are a number of options that may be included. One 
of the more recent enhancements to the code is the PRESTA algorithm (parameter reduced 
electron step transport algorithm) for electron transport. This allows electron step sizes to be 
reduced in the vicinity of an interface, so that the majority of electron paths take place as 
if in an infinite medium. This algorithm was not incorporated into the current code as it was 
not available when the software was first obtained and used and in low energy photon 
beams, such as those simulated, the estimation of quantities such as absorbed dose is 
relatively insensitive to the electron transport part of the calculation (Rogers and Bielajew, 
1990). 
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The EGS4 code includes optional subroutines which may be used to track the production and 
paths of K-edge fluorescence particles in elements with atomic number up to 100. This 
applicability to elements only is restrictive for many purposes and the treatment of K-edge 
fluorescence was extended for the purposes of this work, as described in section 5.6.1. 
The simulation of Rayleigh scattering is also optional, and may be selected or deselected for 
each geometrical region used in the simulation. 
5.4 User input 
A number of parameters must be specified as input to each of EGS4 and PEGS4. For 
PEGS4 these are: 
0 definition of materials 
" energy range over which cross-sectional data is to be generated 
" whether or not Rayleigh scattering cross-sections are required. 
These input parameters are listed in a data file of defined format, and typical PEGS input 
is shown in Figure 5.2 for an element (aluminium) and a mixture (tissue equivalent material 
MS20). Cross-section data was generated from 0 to 100 keV and Rayleigh scattering data 
was generated for all media. 
select material that is an element 
set Rayleigh scattering on 
specify data set identifier as 'AL' 
set atomic symbol to be 'AL' 
set energy ranges for electrons & photons 
do piecewise linear fit to data 
select material that is a mixture 
set no of elements to 6, density to 1 g/cm3 
specify relative atomic amounts by weight 
set Rayleigh scattering on 
specify data set identifier as 'MS20' 
set atomic symbols to be HCN0 MG CL 
set energy ranges for electrons & photons 
do piecewise linear fit to data 
Figure 5.2 : Examples of PEGS input files for (i) Aluminium & (ii) MS20 
The input required for EGS4 includes: 
0 the random generator used (default or user-defined) 
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" cut-off energies for tracking particles 
" selection or deselection for Rayleigh scattering in each region 
" number of particle histories to be simulated 
Additional information is required to detail the geometry, media types and result parameters 
for the problem in hand, and these aspects are dealt with more fully in later sections of this 
chapter. 
The cut-off energy for tracking particles was selected to be 1 keV for photons and 0.7 MeV 
for electrons. Rayleigh scattering was switched on for all regions. The default random 
number generator was used for the simulation. This is a multiplicative congruential random 
number generator (MCRNG), of the form 
In+1 = (aIn + c) modulus 2k 
where a= 663608941 and k= 32. As there is no theoretical method for predicting the 
optimum MCRNG parameters, they must be determined and evaluated experimentally and 
this MCRNG has been shown to be fast with good spectral qualities and a cycle length of 
approximately 109 (Ehrman, 1981). It is coded in-line which considerably improves the speed 
of the simulation as the alternative call to a subroutine takes significantly more time (Rogers 
and Bielajew, 1990). 
The number of histories run for each simulation varied from 1 million to 4 million, 
depending on the stage of development and the precise materials being used. Particle 
splitting was used as a means of variance reduction, and this is described in detail later in 
this chapter. 
5.5 Development of usercode 
The basic EGS4 usercode uses a monoenergetic, uni-directional beam of particles from a 
point source. Code was written to enable simulation of a diverging beam containing a 
spectrum of energies, representative of diagnostic X-ray procedure. 
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5.5.1 Diverging beam 
A macro was written to enable use of a divergent input beam. When used, a beam angle is 
specified, resulting in a circular radiation field of variable radius. The macro determines the 
direction of the incident particle by using random numbers to select the initial directional 
cosines of the particle over the required range. This macro is then called before the initiation 
of each new particle trajectory. The macro was tested by running a simulation which tested 
the positions of particles generated using the macro, on intersection with a plane at a 
distance of 80cm, and checked for uniform distribution. For a run of 100 000 histories, the 
standard deviation of the number of particles within each of one hundred equally sized 
squares was 4 percent of the mean. An outline of the macro is given in Figure 5.3, where 
UIN, VIN and WIN are the initial direction cosines of the incident particle. 
select random numbers RANDIR1 and RANDIR2 
use RANDIR1 to select COSTHE over allowed range 
determine SINTHE from COSTHE 
use RANDIR2 to select PHI (0-2pi) 
find cos(PHI) and sin(PHI) 
set UIN, VIN and WIN 
(UIN = SINTHE x COSPHI, VIN = SINTHE x SINPHI, WIN = COSTHE) 
Figure 5.3 : Form of macro used to produce a diverging beam. 
5.5.2 Energy spectrum 
The project required simulation of diagnostic X-ray spectra, and this necessitated using 
particles of variable initial energy. The spectral data used were generated using a program 
developed from the Birch-Marshall spectra generation program (Birch & Marshall, 1978). 
These spectra were developed according to a semi-empirical model, and were shown by the 
authors to give very good agreement with measured spectra. Their spectra have been widely 
used, and form the basis of the Hospital Physicists' Association handbook of spectral data 
(Birch et al, 1979). Other spectra have been published since the start of this work (Tucker 
et al, 1991) which have been demonstrated to give close agreement with measurement, and 
discrepancies with the Birch and Marshall model. Bissonnette and Scheiner (1991) carried 
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out a comparison of the two models and found that although the Tucker model had some 
advantages, the differences between the spectra were not very significant. 
Code was written to select the initial energy of a particle according to the probability 
distribution of the appropriate beam spectra. The beam spectra data is stored in a separate 
data file and, as part of the initialisation procedure, the data from this file is read into an 
array (IRAWDATA), which then contains the number of photons at each energy, in 1 kV 
steps. A second array (ISUMDATA) is then set up to contain cumulative totals of photons 
at each energy 
ISUMDATA(I) = ISUMDATA(I-1)+IRAWDATA(I). 
and this array is then normalised to give the array SPECTRUM. A macro is then used to 
select the input energy by comparing a random number with this array. An outline of this 
macro is given in Figure 5.4. This macro is then called to determine the initial energy of 
each new particle in the simulation. 
select random number RANDX 
compare RANDX with each element of SPECTRUM 
until RANDX > SPECTRUM(IENERGY) 
set input energy to IENERGY/1 000 
(gives energy in MeV) 
Figure 5.4 : Form of macro used to produce a spectrum of input energies 
This macro was tested by running simulations in which particles were generated using the 
macro, and the initial energies selected were recorded. The distribution of these energies was 
then compared to the original Birch-Marshall spectra, and for 100 000 histories the mean 
difference between photon numbers at each energy was 2.8%. 
5.6 Modifications made to EGS4 
5.6.1 Simulation of K-edge fluorescence in compounds and mixtures 
The optional subroutines included in EGS4 which may be used to track the production and 
paths of K-edge fluorescence particles are only valid for elements. They consist of an 
independent subroutine which sets up the branching ratios and fluorescent photon energies, 
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and a modified version of the subroutine controlling photoelectric interactions. A flag 
(IEDGFL) is used for each medium, which is set to the appropriate atomic number, or to 
zero to disable K-edge fluorescence. When a photoelectric event is selected during tracking 
of a photon history this flag is checked and, if the flag is non-zero and the photon energy 
is above the binding energy of the element, a random number is used to determine whether 
interaction occurs with the K-edge electron and whether fluorescence or the Auger process 
occurs. Any fluorescence photon created is added to the particle stack and treated as a new 
particle. 
The planned simulations, however, involved the use of compound screen phosphor materials 
in which K-edge fluorescence was likely to be an important feature, as contrast and 
background were determined from energy absorption in the phosphor. The code was thus 
extended to account for K-edge fluorescence in mixtures and compounds. The extension to 
the code involved making IEDGFL a two dimensional array, to allow for up to three 
elements in each media. Subroutine PHOTO was further amended to include an initial step 
of determining with which type of atom within the media the photon is to interact, and then 
proceding with that element as in the default K-edge treatment. Determination of the atom 
with which interaction was to occur was according to its proportion by weight. The 
modifications required are outlined in Figure 5.5. 
define EDGFL to be three dimensional array 
set ATPROP to be proportions by weight of each 
type of atom in compund 
set CUMPROP to be cumulative proportions of 
above 
IN PHOTO compare random number RAND to CUMPROP to 
determine which atom has been hit 
check IEDGFL to see whether fluorescence occurs 
Figure 5.5 : Outline of code used to track K-edge fluorescence in compounds 
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5.6.2 Testing of K-edge fluorescence 
The treatment of K-edge fluorescence was tested by carrying out simulations of X-ray 
absorption in phosphor materials and comparing the results with published data. A summary 
of the results obtained is given in table 5.1, and good agreement was observed between the 
Monte Carlo results obtained here and those given elsewhere (Venema, 1979; Marshall et 
al, 1996). 
Percentage energy absorption 
Energy Phosphor 
Monte Carlo Published data 
80 kVp GdAO2S 41.1 37.7* 
80 kVp LaOBr 41.7 41.5* 
100 kVp Gd2OAS 5.5 5.7f 
Table 5.1 : Comparison of energy absorption in phosphors with results of 
Venemä and Marshall? 
5.6.3 Modifications to PEGS code 
As a further test of the K-edge fluorescence code, simulations were also carried out of the 
absorption of monoenergetic X-rays by phosphor materials at a series of energies, in 1 keV 
steps around the K-edge. These results were used to check that the K-edge was being 
determined accurately, as the K-edge is marked by a sharp rise in absorption. The initial 
results revealed an inadequate resolution of photoelectric cross-section at the K-edge. This 
was due to the way in which the PEGS code interpolated between a limited number of points 
when determining cross-section data. The PEGS code was modified so that the energy of the 
highest K-edge in the media was forced to be an interval boundary, and the cross-sections 
immediately each side of this boundary were used for the interpolation of the intervals on 
either side. This effectively split the data fitting procedure into two parts, one above and one 
below the K-edge, and yielded good resolution of the cross-section data, as demonstrated by 
the Figures in Table 5.2 which shows the percentage absorption of monochromatic X-rays 
of different energies in a gadolinium filter (k edge 50.229 keV). 
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Energy (keV) Absorption 
49.0 25.9% 
50.0 24.9% 
50.1 24.8% 
50.2 24.7% 
50.3 80.2% 
51.0 78.9% 
52.0 77.0% 
Table 5.2 : Absorption of monochromatic x- 
rays in gadolinium, using modified 
EGS code 
5.6.4 Changes in Precision 
During initial test simulations it was apparent that calculations of contrast were being 
adversely affected by the precision to which numbers used in the calculation were being 
stored. The precision of variable EDEP, which is used throughout the program to store the 
amount of particle energy that is about to be deposited, was increased to 
DOUBLE PRECISION, by means of a macro called in the user program. This could then 
account for smaller differences in energy deposition in different parts of the screen. 
5.7 Definition of Geometry 
The geometry defined in the usercode is shown in Figure 5.6. This assumes a point radiation 
source at coordinates (0,0), with radiation incident along the z-axis. Six infinite planes, 
perpendicular to the z-axis, are defined (depicted with numbered triangles), and one 
cylindrical surface, to give the ten regions shown (depicted with numbered circles). Region 
2 represents a filter, of variable thickness (TEILT) and composition and regions 1,3 and 7 
are air at standard temperature and pressure. The patient is represented by a slab of tissue, 
comprising regions 4,8 and 9, enclosing region 10, a cylinder of contrast material of 
variable radius (RCONT). The thickness of tissue (TBODY) and depth (DCONT) and 
thickness (TCONT) of contrast are variable, as are the compositions of the two regions. 
Region 5 represents the table on which the patient is lying, and may be set to zero thickness 
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(TGAP) if the patient is in direct contact with a film cassette. Region 6 represents the screen 
phosphor of a film cassette or intensifying screen, of thickness TPHOS. 
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Figure 5.6 : Geometry used in simulation; as defined by subroutine HOWFAR 
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This simple geometry was chosen for ease of development, reproducibility under laboratory 
conditions and for a reasonable speed of simulations. As the study was designed to make 
comparative rather than absolute measurements of dose in the various regions, the possible 
effect on the results of a non-anthropomorphic model was outweighed by the large number 
of simulations that could be carried out. The biggest deviation from a true patient geometry 
was the use of semi-infinite planes throughout, which means that the loss of scattered 
radiation from the sides of the patient is neglected. However, for a small field-size toward 
the centre of the patient, this is a small effect and for the comparative measurements carried 
out in this work, the approximation should not significantly affect results. The single 
geometry illustrated was used throughout the study and, by varying the distances between 
planes and the composition of the different regions, a wide range of simulations could be 
carried out. 
w"v mPaos 
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5.7.1 Simulation input 
For each simulation carried out, the specific values of the geometry parameters were 
specified by means of an input data file. The format of this file is given in Figure 5.7, where 
the distances as defined in Figure 5.6. 
random number seed 
beam angle 
filter, tissue, contrast, phosphor, gap 
Z values for filter fluorescence 
Z values for contrast fluorescence 
Z values for phosphor fluorescence 
particle splitting parameter 
TFILT, FSD, TBODY, TGAP, TPHOS, TCONT, RCONT, DCONT 
number of histories 
Figure 5.7 : Format of input file for Monte Carlo simulation 
the 3rd line of the input file contains the definitions of media type in the different regions, 
and the `fluorescence' lines contain the atomic numbers of up to 3 constituent elements for 
which K-edge fluorescence is to be simulated in the stated media. The `particle splitting 
parameter' is for variance reduction, and will be described later, in section 5.9. 
5.8 Extraction of results 
A number of parameters were required from the simulation, in order to study optimisation 
of patient dose and image contrast. The energy imparted to the patient corresponded to the 
energy absorbed in the whole of regions 4,8 and 9. An assessment of entrance surface dose 
was made from the energy absorbed in region 8, within a depth of 1 cm from the body 
surface, and a radius of 1 cm from the central axis. Calculation of contrast and background 
density was made from the energy absorbed in region 6 at different spatial coordinates. All 
these quantities were easily calculated by summing any particle energies deposited in the 
appropriate region. All of the above parameters were recorded for each simulation, along 
with the input parameters. The code used for keeping track of the required parameters, as 
found in the AUSGAB subroutine, is outlined in Figure 5.8, where variable EDEP contains 
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the value of the current particle energy that is about to be deposited as part of the interactin 
process. 
implement whenever energy EDEP is about to be 
deposited 
if in region defining patient, increment absorbed 
energy by EDEP 
if within 1 cm of patient surface & inside 1 cm 
radius disk, increment entrance dose by EDEP 
if in screen & behind contrast area, increment E, ot 
by EDEP 
if in screen & within background area, increment Ebak 
by EDEP 
Figure 5.8 Code used for defining scoring quantities 
5.9 Variance reduction 
One of the fundamental problems in the use of Monte Carlo techniques is that of balancing 
the need for statistical accuracy (ie using a large number of particles to calculate a result) 
with reasonably short processing times. Variance reduction is the name applied to a variety 
of techniques that are used to improve the statistical accuracy of Monte Carlo simulations 
while minimising the increase in simulation time. Techniques available include, among 
others, exponential transformation of photon path length, which can be used to increase 
information in the build-up region, enhanced cross-sections to make the probability of an 
interaction more favourable, range rejection of electrons, where the tracking of an electron 
stops once its residual range is smaller than the distance to the nearest boundary, and particle 
splitting. These methods are described fully by Rogers and Bielajew (1990) and Nelson et 
al (1985). For this work, the method of particle splitting was employed. 
Particle splitting is useful in regions where only a small number of particles are incident, or 
where important parameters are being scored. The technique involves turning single particles 
into multiple particles with identical properties but reduced weight. For example, a photon 
with weight 1 might be split into ten identical photons each with weight 0.1. The weighting 
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factor of a particle is then taken into account when scoring parameters such as the energy 
absorbed in a region, so that numerical results are not biased. The increased number of 
particles improves the statistical accuracy of quantities to which they contribute, as variance 
of a quantity is inversely proportional to the number of particles used to score the quantity. 
As the particle splitting is only carried out for specific regions, the increase in simulation 
time is far less than it would be if the total number of histories had been increased by the 
same factor. 
For this series of simulations, particle splitting was carried out in region 10 (the small area 
of contrast) and region 6 (the screen). This ensured that the accuracy of parameters scored 
in these areas was comparable to that in other regions. 
5.10 Accuracy of Code 
There are many factors influencing the accuracy of the results obtained from a particular 
Monte Carlo simulation. These are uncertainties arising from the data used, systematic errors 
and statistical uncertainties. 
All results are limited by the quality of cross-sectional data used by the code. For the 
simulations performed during this study, electron cross-sections have far less impact than the 
photon cross-sections, because of the low energy range employed, so their accuracy is not 
discussed here. For photon interactions, the uncertainty in total cross-section ranges from 2- 
3% where Compton interactions are dominant to 3-5% when photoelectric interactions 
dominate (Storm and Israel, 1970, Hubbell, 1982). The latter is for lower photon energies, 
upto around 30 keV for carbon, greater for higher atomic number elements. The way in 
which these uncertainties affect the final results can be complex and cannot be quantified 
exactly. 
Systematic errors may arise from programming errors, that may still occur in spite of the 
extensive checking that codes such as EGS4 have received, modelling inaccuracies such as 
approximations in electron transport algorithms, or truncation errors resulting from the finite 
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precision with which the computer represents real numbers. Systematic errors need to be 
identified and removed or reduced as far as possible. One way in which this has been done 
for this study was the increase in variable precision described earlier (section 5.6.4). The 
possibility (albeit slight) of undiagnosed systematic errors is one reason for carrying out 
experimental verification of any particular usercode, to supplement the range of benchmark 
tests available. 
Statistical uncertainties in Monte Carlo results are commonly obtained by calculating the best 
estimate of the variance of the mean of a quantity, by carrying out a number of independant 
runs, each with the same number of histories. If N runs are performed to estimate quantity 
x, and a normal distribution is assumed, this estimator s2 of the true variance v2 is given by 
N 
SZ=1E (x. - Gx> )2 (5.1) 
N (N -1) 1.1 
If it is also assumed that individual run estimates are drawn from a normal distribution then, 
in the limit of a large number of histories (n), the quantity na' is constant. Thus the 
estimated uncertainty in a calculation is roughly proportional to the inverse of the square root 
of the number of histories used. 
1 
Q« 
VF(n) 
(5.2) 
This can be used to assess the precision of a result from a series of runs taken with fewer 
histories. For the work carried out here, statistical uncertainty was calculated for each 
quantity of interest using 10 independant runs of 50,000 histories each. These were than used 
to assess the statistical uncertainty in the results obtained from the longer simulations used 
for the study. 
5.11 Summary of chapter 
The principles and brief history of Monte Carlo techniques were introduced in this chapter, 
along with a summary of some of the codes available. The reasons for using EGS4 were 
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outlined, and the structure and implementation of this code fully described, including the 
input required. Modifications made to the code for the purpose of this work, namely the 
extension of K-edge fluorescence treatment, increased precision of variables and the 
improved resolution of cross-section data at energies around a K-edge, have also been 
explained. The development of usercode to simulate a divergent beam with a spectrum of 
energies has been described, along with the simulation geometry and the method for 
obtaining the required results. The variance reduction techniques used and factors influencing 
the accuray of the results have been presented at the end of the chapter. 
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Chapter 6 
Results from Monte Carlo Simulation 
The first section in this chapter presents the numerical uncertainties for the calculated 
quantities obtained from the simulations. The results from the simulations carried out are then 
presented in detail, according to the flow diagram in Figure 6.1. 
Slmulatlons for neonates 
(5cm phantom) 
bone in soft tissue Ba/I In soft tissue 
La phosphor Cs I phosphor 
II 
results for simulations results for simulations 
at 
i 
0kV at 
i 
60 IN 
discussion of results discussion of results 
effect of effect of 
change in kV change in scr n phosphor 
comparison with results of others 
effect of 
using replacement filtration 
comparison with results of others 
summary of results 
Figure 6.1 : Outline of chapter 
All the results presented in this chapter are for a5 cm phantom (a neonate) and for 2 
categories of examination; radiography of bone in soft tissue and fluoroscopic examination 
involving iodine or barium based contrast media. The radius of the contrast cylinder was lcm 
and all simulations were carried out with a FSD of 80 cm and no air gap ie direct contact 
between slab phantom and phosphor. The radiography of bone in soft tissue is considered 
first, and results presented for simulations carried out at 60 kV. These results are then 
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discussed in terms of the beam spectra used and the absorption and transmission 
characteristics of the various media simulated. The effect of a number of modifications in the 
simulation model are then presented and discussed; changes in tube voltage, the use of partial 
replacement filters instead of additional filters and changes in the screen phosphor used as 
the image receptor. The results from this category of simulations are then compared to results 
available from published literature. For the fluoroscopy simulations, results are presented for 
a number of mass thicknesses of contrast media, for beams generated at 60 kV and using a 
caesium iodide (CsI) phosphor. These results are also discussed in the light of the beam 
spectra produced by the various filters, and the absorption characteristics of the contrast 
media and image receptor. Results obtained from published literature are again used to 
compare those obtained here, and the chapter concludes with a summary of all the results that 
have been presented. 
6.1 Calculation of uncertainties 
Random uncertainties have been derived as described in Chapter 5, section 5.10 for each type 
of simulation carried out. Values of the uncertainties were calculated for each quantity of 
interest ie entrance dose, absorbed dose and contrast, though values for absorbed dose are 
small compared with the other two, due to the relatively high number of photons contributing 
to its measurement, even with the variation reduction techniques employed. Details of the 
batched runs used to calculate the standard error of the mean are summarised in Table 6.1 
below, where the variance s is determined from equation 5.1. 
l i i 
number 
h b 
number 
i / hi t 
estimator of variance s (for n histories) 
b k 'd s mu at on 
set 
atc es 
(N) 
or es s 
batch (n) abs. en ent. dose contrast backg'd 
ac g 
value 
radiography 10 50 000 0.14% 4.4% 3.3% 0.15% 405 
fluoroscopy 10 10 000 0.22% 8.2% 6.1% 0.66% 43 
Table 6.1 : Derivation of uncertainties in calculations 
For the actual simulations, the standard errors of the mean of each dose quantity were 
calculated from the relative number of particle histories involved in the sample and the actual 
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simulations, according to equation 5.2. The figures in Table 6.1 were calculated for reference 
beam conditions, and so simulations involving additional filtration would be expected to have 
greater uncertainty than that predicted from consideration of the number of histories, as the 
filter reduces the number of photons contributing to the calculated quantities. Similar 
derivation of uncertainties for the most beam hardening filter simulated (0.2 mm erbium) 
gave uncertainties a factor of 2 higher than those given in Table 6.1, but this was 
compensated for by increasing the number of histories for the higher beam filtrations. For 
contrast, the uncertainties could be more accurately expressed by applying equation 5.2 to the 
number of photons reaching the image receptor, which is related to the energy absorption in 
the `background' area of the phosphor. The uncertainties in ratios of dose and contrast were 
determined from summing the individual uncertainties in quadrature. The uncertainties 
derived for the different category of simulations performed are listed in Table 6.2 below, 
within 95% confidence limits (ie two standard errors of the mean). In this table, the contrast 
uncertainties are given in teens of the calculated background, as described above, along with 
values calculated for the minimum and maximum background values obtained in each of the 
two sections of the study. 
uncertainty for 106 histories uncertainty in contrast 
abs. energy ent. dose general minimum maximum 
radiography ± 0.06% f 2.0% f 132% 
Vbkgd 
f 0.9% 
(bkgd 20 000) 
t 2.4% 
(bkgd 3000) 
fluoroscopy ± 0.04% t 1.6% f 80% 
/bkgd 
± 0.9% 
(bkgd 8000) 
± 2.5% 
(bkgd 2000) 
Table 6.2 : Values of uncertainties used in calculations 
6.2 Radiographs of bone in soft tissue 
The first series of simulations was carried out for a lcm thick bone detail in 5cm soft tissue, 
to simulate plain film radiography of a premature neonate, using a lanthanum based screen 
similar to those commonly in use on the local special care baby unit. Figure 6.2 shows the 
variation of contrast, entrance surface dose and total energy absorbed in the patient with 
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increasing tube load (corresponding to different filter thicknesses) for aluminium filtration. 
Graphs are shown for generating tube potentials of both 60 and 70 kV. For these plots, the 
total filtration ranged from 1.5 mm to 6 mm aluminium. Tube load can be defined as the 
product of tube current, exposure time, and generating potential. In this figure, however, all 
data has been normalised to that for a total filtration of 3 mm aluminium at the tube potential 
used ie in Figure 6.2(1) a tube load of 1.0 corresponds to 3 mm Al at 60 kV and in Figure 
6.2(ii) a tube load of 1.0 corresponds to 3 mm Al at 70 W. The tube load is then effectively 
proportional to mAs, which is related to the number of input photons used in the simulation. 
Measurements of entrance surface dose have been left in terms of energy absorbed in the 
appropriate region, rather than converting to conventional units as the values are for 
comparative purposes only. The error bars shown in the graphs represent ± two standard 
errors, calculated as described above. Those for values of absorbed energy are of the same 
magnitude as the data points themselves. The lines drawn on this and all subsequent graphs 
should be viewed as trend indicators, enabling multiple graphs to be viewed. They are not 
accurate curve fits to the data and, in some cases, it would be possible to draw slightly 
different shaped curves with equal validity. 
92 
T". 
40 
i 
u° 30 
20 
10 
03 
22 
s 
,. 
P 
W 
O 1. 
d 
O 
14 
iz 
YÄ 
0.50 
0.45 
0.40 
0.35 
0.30 
025 
os 
so 
I 
ý 40 
?I 
0 70 
.I 
s 
W ZO 
1o 
0.6 1.0 1A 2.0 2A 
Relative Tube Load 
22 
_ 
20 
Is 
W 
fe 
11 
12 
0.! 
030- 
0.45- 
0.40- 
035. 
0. ]0 
0.25 
0.5 1.0 13 2.0 i. 0 
Relative Tube Load 
Figure 6.2 : Trends in dose and contrast for different thicknesses of aluminium filtration (i) at 60 
kVp and (ii) at 70 kVp 
It can be seen from the graphs that, as expected, each dose quantity decreases with increasing 
tube load, for both generating potentials. However, while entrance surface dose drops fairly 
steadily as the amount of filtration is increased, the corresponding plots for absorbed energy 
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show an initial sharp decrease followed by a flattening of the curves, above a tube load of 
around 1.0. This effect is more marked at the higher tube potential, and suggests that 
increasing the amount of aluminium filtration beyond 3 mm is an inefficient method of 
patient dose reduction. Numerically, at 70 kV the absorbed energy for a tube load of 1.5 is 
95% of that at tube load of 1.0, whereas the entrance surface dose is 84% of that at tube load 
1.0. At 60 kV, the figures are 94% and 70% respectively. From this it can be seen that 
filtration affects entrance dose more dramatically than absorbed energy, and that the reduction 
in absorbed energy is similar for the two tube voltages. The dose values illustrated for 
different values of tube voltage have been normalised to different background densities, each 
corresponding to that obtained for 3mm aluminium at the relevant tube voltage, so should not 
be directly compared. The plots of contrast against tube load show a gradual decrease with 
increasing amounts of filtration, and at 70 kV the contrast values are all significantly lower 
than at 60 kV as the beam energy is higher. 
Similar curves were plotted for the other filters under investigation, in order to compare their 
behaviour. For ease of comparison, data for the different filters is displayed on the same 
graph, omitting the individual data points and error bars for clarity. Initially, three different 
filter thicknesses were simulated for each material, but additional simulations of intermediate 
thickneses were then performed for a selection of filter materials for which initial results were 
of particular interest, so that the number of data points used to generate each curve ranged 
from four to ten depending on the filter material. The data points correspond to the filter 
thicknesses listed in Table 4.1. 
6.2.1 Dose variation for different filter materials 
Figure 6.3 shows entrance surface dose and absorbed energy data for ten filters, including 
aluminium, using a generating potential of 60 kV. Reference conditions were taken to be 
3 mm aluminium at 60 kV, and all other filters were used in conjunction with 3mm 
aluminium. This baseline filtration was chosen as it is representative of the total filtration 
found on X-ray sets around the local region. 
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Figure 6.3 : Trends in (i) entrance surface dose and (ii) absorbed energy with increasing tube load 
for different filter materials at 60 kV 
Several features are apparent from the above graphs. The first of these is the behaviour of 
the absorbed energy curve for the tin filter. Unlike the other curves displayed, this shows an 
increase in dose with filtration, up to 124% at a tube load of 3. The corresponding curve for 
samarium is almost flat, and all other filter materials show a gradual decrease in absorbed 
energy with tube load. The rate of dose reduction (described by the gradient of the curves) 
is dependant on the atomic number (Z) of the filter. Copper gives the greatest rate of dose 
reduction (absorbed dose is 83% of the reference level at a tube load of 1.5 and 76% at tube 
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load of 2), and aluminum one of the poorest (around 94% reference level at a tube load of 
1.5) - an interesting result considering that it is the most widely used filter material for 
diagnostic X-ray sets. The curves for entrance dose reduction show less variation with atomic 
number, and a decrease is seen with increasing tube load for all filter materials, albeit a slight 
one for tin and samarium. The apparent crossing of some of the curves shown in Figure 6.3 
is likely to arise from the magnitude of the uncertainties in the points plotted. Entrance dose 
reduction is of the order of 35% at a tube load of 2 for the majority of filter materials (ie 
entrance dose with additional filtration is 65% reference level). The Z-dependance of the dose 
reduction is depicted in Figure 6.4 where absorbed energy has been plotted as a function of 
Z for tube loadings of 1.5 and 2. The dashed lines in these plots join data points for which 
intermediate values cannot be deduced from the graph. A useful extension to this work would 
be obtain similar results for filter materials such as yttrium (Z=39) and niobium (Z=41) to 
characterise this part of the graph. The form of this graph will be considered in section 6.2.3. 
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Figure 6.4 : Z-dependance of the calculated absorbed energy at fixed tube load 
(60 kV) 
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Figure 6.5 : Trends in calculated contrast with increasing tube load for different 
filter materials (60 kV) 
6.2.2 Contrast variation for different filter materials 
Curves were also plotted showing the variation of contrast with tube load, as shown in 
Figure 6.5. 
In most respects these curves show similar trends to those for the dose variation illustrated 
in Figure 6.3; filters exhibiting a rapid rate of dose reduction with tube load also show a 
rapid reduction in contrast, as might be expected as the beam energy affects both dose and 
contrast in the same way with higher photon energies giving lower doses and lower contrast. 
The contrast reduction is of the order of 15% for copper, and 6% for terbium, at a tube load 
of 2.0. However, tin shows a reduction in contrast in addition to its poor dose performance, 
confirming it as a bad choice of filter material, and the curve for aluminium drops off steeply 
after a tube load of around 1.5. A full discussion of these effects is given in the next section. 
For small tube loads, most of the curves lie close together, within ±9% of the mean value at 
a tube load of 2 with most curves flattening off after this point. The crossing of some of the 
curves is again due to the magnitude of the uncertainties in the values. It should be noted that 
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the similarity of the contrast curves suggests that a choice of filter may be based primarily 
on its dose reduction properties. The Z dependance of the calculated contrasts is illustrated 
in Figure 6.6 for tube loads of 1.5 and 2. 
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Figure 6.6 : Z-dependance of contrast at fixed tube load (60 kV) 
A slight rise in contrast is apparent from the graph for Z= 68 (erbium) but this is only of 
the order of 2% and, as can be seen from Figure 6.5, the curves all lie close together at this 
point. 
6.2.3 Discussion of results 
Much of the performance predicted by the simulations can be explained by considering the 
spectra of the beams incident on the patient phantom for the different filtration conditions, 
and the absorption and transmission characteristics of the materials in the beam. All 
absorption and transmission spectra illustrated in this section have been produced using 
software based on Birch Marshall data, as described previously in Chapter 5, section 5.5.2. 
The absorbed spectra for a 60 kVp beam, filtered by 3 mm aluminium (ie the reference 
spectrum), passing through a5 cm patient phantom is given in Figure 6.7. This is 
representative of energy absorption in the patient and shows a peak at around 28 kV. Beam 
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spectra produced by various additional filters are shown in Figure 6.8. The poor performance 
of tin as a filter material is readily explained by its transmission spectrum (Figure 6.8vi), 
which is dominated by its K absorption edge at 29.2 keV. This coincides with the absorption 
peak in the phantom and so a large proportion of the tin filtered beam will contribute to the 
absorbed energy in the patient. Increasing thicknesses of tin give an increasingly large K-edge 
peak and thus, for the same background energy absorption, the absorbed dose to the patient 
increases with increasing tin filtration. 
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Figure 6.7 : Energy absorption in 5cm patient phantom for 60 kV beam filtered by 3 mm Al 
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For the materials with Z from 62 to 70 the transmitted spectra peak at progressively 
increasing energy, as the K-edge energy increases, which results in a higher mean photon 
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energy as given in Table 6.3. The effect of photon energy on dose has already been discussed 
in general terms (section 4.2) and the theory of lower dose with higher energy is followed 
for the mean beam energies observed here. This results in progressively greater dose 
reduction, for equal tube load, as the mean photon energy increases and this has the effect 
of reducing dose under conditions of equal background density. Table 6.3 lists mean spectral 
energies for all the filters illustrated in Figure 6.8, together with tube loads. The transmission 
curves for copper (Figure 6.8ii) show a broader spectrum, as the K-edge energy is not high 
enough to influence the shape of the beam, and as the highest energy photons are attenuated 
less, the mean energy of the spectrum is higher than that for the K-edge filters, at the same 
tube load, making it a particularly good filter for dose reduction. 
Filter (all + 3mm Al) Mean Photon energy(keV) Relative Tube Load 
no added filtration 37.06 1.0 
0.5mm Al 37.76 1.1 
1.0mm Al 38.39 1.2 
0.1mm Cu 40.84 1.5 
0.15mm Cu 42.09 1.9 
0.2mm Cu 43.11 2.3 
0.05mm Sn 37.80 1.8 
0.1mm Sn 38.35 3.1 
0.15mm Sn 38.74 4.9 
0.05mm Sm 38.08 1.5 
0.1mm Sm 38.71 2.1 
0.2mm Sm 39.55 4.0 
0.1 mm Dy 40.97 2.0 
0.15mm Dy 42.11 2.8 
0.2mm Dy 43.01 3.7 
0.1mm Er 42.08 2.1 
0.15mm Er 43.52 2.9 
0.2mm Er 44.65 3.8 
Table 6.3 : Mean photon energy and tube load for 60 kV beam, with 
various filtration 
101 
The graph of contrast variation for the different beam spectra (Figure 6.5) may be understood 
from a consideration of the transmission spectra through the different parts of the phantom 
as these determine the calculated contrast values. The terms that will be used in this method 
of analysis are explained in Figure 6.9, which shows an `input' spectrum incident on a 
phantom containing a contrast detail. The photon spectrum transmitted through the uniform 
phantom only is termed the `background spectrum', and produces the background energy 
absorption in the image receptor. The signal transmitted through the contrast detail and 
phantom is termed the `contrast spectrum', and contributes to the absorption in the phosphor 
behind the area of contrast. The difference between these two spectra (ie for each photon 
energy the number of photons in the background spectrum minus the number of photons in 
the contrast spectrum) is termed the `signal spectrum'. This signal spectrum gives an 
indication of which photon energies in the input beam contribute most to the signal in the 
detector ie the difference in energy absorption behind and beside the area of contrast. This 
concept has been used previously to describe the imaging performance of various beam filters 
(Gagne et al, 1994) and these terms will be used to analyse results throughout this chapter. 
Input Specturm 
Q phantom 
IA Contrast Background 
I/ 1 Pee ee Spectrum 
inm9e remtor 
Figure 6.9 : Explanation of terms used for spectral 
analysis of results 
Figure 6.10 illustrates this concept with the formation of the signal spectrum corresponding 
to 1 cm bone in 5 cm soft tissue. The spectra shown have been calculated for 
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" 60 kV, 3 mm Al beam filtered by 5 cm perspex (background spectrum) 
" 60 kV, 3 mm Al beam filtered by 5 cm perspex + 0.27 cm calcium (contrast 
spectrum) 
" The difference between the above two (signal spectrum) 
The perspex was used to represent the soft tissue, and the calcium to represent the bone, with 
he thickness derived from the bone composition given by White (1991). 
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Figure 6.10: Formation of contrast signal spectra for bone in soft tissue 
The graph illustrates how the low energy part of the incident spectrum contributes to the 
resulting image contrast, with the signal peaking at around 33 keV. At higher photon 
energies, the difference in attenuation behind and beside the bone gets progressively less. At 
energies below the signal peak the number of photons transmitted through the phantom 
decreases rapidly so, although there is a large difference in attenuation coefficients for bone 
and soft tissue at these energies, they do not contribute much to the calculation of contrast. 
Figures 6.8 and 6.10 can be used to explain the observed contrast variation for the different 
filters. In general, increasing filtration shifts the beam spectra to higher energies, away from 
the signal spectum peak exhibited in Figure 6.10, and results in a loss of contrast. Although 
the tin filtered spectra peak just below 30 keV (Figure 6.8vi), they drop sharply just above 
30 keV and the combined effect is to reduce contrast for increasing tin filtration. The spectra 
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produced by filtration with samarium show a broad peak around 40 keV, with a reduction 
in the number of high energy photons (Figure 6.8v), which enables contrast to be maintained 
with increasing filter thicknesses. For the other K-edge filters, contrast is reduced with 
increasing filter thickness, as the attenuation of the highest energy photons is outweighed by 
the concurrent attenuations at the lower photon energies which contribute most to contrast. 
The often proposed beneficial effect of the higher K-edge filters on contrast is thus negligible 
for the phantom thickness and tube potential used here. 
6.2.4 Variation in generating tube potential 
The trends in dose and contrast for different filters (Figures 6.3 and 6.5) show that filter 
materials may be broadly classified into 2 groups, according to their dose/contrast 
characteristics. 
(1) Those which displayed good dose reduction but a degradation of contrast (this 
includes the majority of filters) 
(2) Filters showing little contrast degradation but also little dose reduction 
For the filter materials in the first of these groups, simulations were carried out at 55 kV, as 
the lower energy could be expected to enhance contrast. The purpose of the simulations was 
to investigate whether an improved balance between dose reduction and contrast could be 
achieved. The results of simulations at 55 kV for these filter materials are shown in figure 
6.11 for both absorbed energy and contrast. All results have been normalised to reference 
conditions of 3mm aluminium at 60 kV, and the absorbed dose and contrast for the reference 
conditions have been indicated on the graphs for comparison. The scales on the y-axis match 
those used earlier. 
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Figure 6.11 Trends in (i) absorbed energy and (ii) contrast at 55 kV for various filter materials. 
The dose and contrast values for reference conditions of 3mm Al at 60 kV are 
indicated. 
As anticipated, all the curves in Figure 6.11 are shifted up, toward higher dose and higher 
contrast. However, whereas the dose curves cross the reference line at a tube load of around 
1.3, the corresponding contrast curves cross at a tube load of around 1.65. Between these 
values of tube load, contrast values are above reference levels and dose values below 
reference levels, which suggests that for these modest tube loads, at the reduced tube 
potential, dose reduction may be achieved with no loss in contrast. Although the dose 
reductions attainable for numerically equal contrasts are small (around 10% for copper), the 
dose curves exhibit a steeper gradient than those for contrast, so acceptance of a slight loss 
in contrast could result in much greater dose reduction (for copper a 18% dose reduction with 
6% contrast reduction). The full implications of this point are discussed in detail in relation 
to the clinical implementation of results (Chapter 9). It can be concluded, however, that 
careful choice of tube voltage can be used in conjunction with thin additional filtration for 
dose reduction in neonatal radiography, provided that the required increase in tube load 
(effectively mAs) can be accommodated. 
A further feature of Figure 6.11 is that the curves for the K-edge filters lie close together, 
with copper showing slightly better dose reduction than the K-edge filters and aluminium 
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very poor dose reduction. As 55 kV is below the K-edge energy of the filter materials shown 
on the graph, none of the materials are able to act as a band pass filter and they produce very 
similar spectra, as shown in Figure 6.12. 
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Figure 6.12 : Calculated spectra generated at 55 kV for different filter materials, at 
a tube load of 1.5 
It is interesting to note that aluminium appears to give a much higher absorbed dose than the 
other materials, in spite of having a very similar beam spectra. This is due to the 
predominance of Compton scattering over photoelectric absorption in the aluminium filter. 
The spectra illustrated in Figure 6.12 represent narrow beam attenuation, and includes only 
photons that have passed straight through the filter. The Monte Carlo code, however, also 
accounts for absorption in the phantom of photons that were scattered in the filter. This has 
the effect of increasing the calculated absorbed energy values for the aluminium filter, 
relative to calculations made using a simple attenuation model which neglects scatter, as 
shown in Figure 6.13. 
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Figure 6.13 : Effect of Compton scatter in aluminium 
filter 
This effect increases with filter thickness, as the amount of scatter produced increases with 
the thickness of the scattering material, as the number of Compton interactions increases. If 
the additional aluminium filtration is built into the X-ray tube, then this scattered dose to the 
patient would be reduced in clinical practice, due to the collimators which would remove any 
components of scatter not travelling within the beam direction. However, if an aluminium 
filter is added by the radiographic staff for selected examinations the dose increase due to the 
scatter, indicated by the results presented in Figure 6.11, will be genuine. Its magnitude will 
be slightly overestimated by the Monte Carlo simulation as this used a semi-infinite slab to 
simulate the patient, rather than one of finite dimensions. Further simulations to check the 
magnitude of this effect showed that, for 5 mm aluminium filtration, absorbed energy was 
reduced by 9% when all photons leaving the filter at a divergence greater than that of the 
beam were rejected. For the other filter materials under investigation, the chief mode of 
interaction is photoelectric absorption, so the effect of scatter in the filter is not apparent. 
For filters in the second group (those giving good contrast but poor dose performance) 
simulations were carried out at 70 kV, as the higher tube voltage could be expected to reduce 
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doses. Figure 6.14 shows these results for samarium, gadolinium and tin. The results have 
again been normalised to those at 60 kV, 3 mm Al filtration, and the contrast and absorbed 
dose for these reference conditions are again indicated on the graphs for comparison. 
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Figure 6.14: Trends in (i) absorbed dose and (ii) contrast at 70 kV 
It is apparent from Figure 6.14 that although doses have been reduced, the trends for both 
samarium and tin are for increasing dose with increasing filter thickness, and almost constant 
dose for gadolinium. Contrast has also been considerably reduced (around 15%). There is 
thus no benefit to using any additional filtration under these conditions. Although raising the 
tube voltage by a smaller amount, eg to 65 kV, may improve the results, the magnitude of 
the dose reduction is not as great as for the previous set of results at 55 kV. 
6.2.5 Results for replacement filtration 
Simulations were also carried out for the different filters in conjunction with 1.5 mm rather 
than 3 mm aluminium ie partially replacing the existing filtration on a set rather than adding 
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to it. These results are sumarised below in Figure 6.15, where results have been normalised 
to 3 mm Al for comparison. 
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Figure 6.15: Trends in (i) absorbed energy and (ii) contrast for filtration added to 
1.5 mm Al (60 kV) 
These curves are mostly similar in shape to those presented previously in Figures 6.3 and 6.5, 
although the following points can be noted: 
" The increase in absorbed dose with increasing thickness of tin filtration is much 
greater than that observed previously. 
" The absorbed dose curve for samarium initially shows a slight increase. 
" For the other filters there is similar dose reduction at the same tube load, compared 
to adding the filter to 3 mm Al. 
" For the contrast curves, tin shows better contrast performance than when used in 
conjunction with 3 mm Al, as do aluminium and copper to a lesser extent. 
To understand these effects, Figure 6.16 shows the beam spectra produced by a number of 
filters in conjunction with 1.5 mm Al (ie replacement filters). Additional spectra are plotted 
for comparison, including that for the same filter thickness with 3 mm Al and that for the 
additional filter with the most similar tube load. 
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Figure 6.16: Spectra for 60 kV beam filtered by 1.5 mm Al and (i) copper (ii) tin (iii) erbium and 
(iv) samarium 
Figure 6.16 shows that for copper, which does not have a K-edge within the useful part of 
the spectrum, the replacement and additional filters resulting in the same tube load give 
almost identical beam spectra. Those for erbium, with its K-edge just below the maximum 
tube potential, are also very similar. For tin, however, the low energy peak is both broader 
and taller for the replacement filter than for the additional filters shown, as these low energies 
are well attenuated by the `extra' 1.5 mm aluminium in the additional filter compared to the 
replacement one. This difference in spectral shape accounts for both the increased doses and 
reduced contrast loss observed for the replacement tin filtration in Figure 6.15 above. For 
samarium, the shift in spectra toward higher energies corresponds to the increase in tube load, 
although the spectral changes are relatively large for a small difference in tube load, 
compared to those for copper and erbium. 
The results indicate that there is no advantage to the optimisation process in this approach 
and in clinical application there would be practical difficulties for existing X-ray units, as the 
required changes to existing filtration would probably need to be carried out by 
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manufacturers. Greater thicknesses of the chosen filter material would be required to give the 
same tube load and dose reduction properties as the equivalent additional filter, and this 
would have financial implications for the department. For these reasons, the use of 
replacement filtration was not investigated further in this work. 
6.2.6 Results for a different intensifying screen 
To investigate the effect of the image receptor on the results obtained, simulations were 
carried out with the lanthanum screen replaced with a gadolinium one. These results are 
displayed in Figure 6.17. The results may be assessed in terms of the absorption 
characteristics of the two screens, as shown in Figure 6.18. 
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Figure 6.17: Variation of (i) absorbed energy @ 60 kV (ii) contrast @ 60 kV (iii) absorbed 
energy @ 55 kV and (iv) contrast @ 55 kV for gadolinium screens 
III 
aa4 
Relative Tube Le. dn1 
a"4$ 
Relative Tube Loading 
:14 
Rd. Öw. Tubs Lesdmg 
f"4f" 
Rd. tlvw Tab. Lo. ng 
°c 30 
0 25 
c 0 20 
ö 
a 
.. 15 0 
0 
z 10 
10 5 
0 
Energy (k. V) 
Figure 6.18: Absorption characteristics of LaOBr and GdO2S 
intensifying screens 
The curves given in Figure 6.17 show very little difference from those for the lanthanum 
screens (Figures 6.3,6.5 and 6.11). The variation in absorbed energy for samarium shows 
a slight increase with tube load whereas the corresponding curve for the lanthanum screen 
was almost flat. This could be due to the absence of the second absorption peak in the 
lanthanum screen (40-50 kV) which overlaps the peak in the samarium filtered beam spectra. 
The increase in detector absorption with increased tube load compensates for the increased 
absorption in the patient, so that absorbed dose at constant background absorption remains 
constant. Contrast variation is similar for both screens as their absorption in the `signal' 
region of the spectrum (20-40 kV) is alike. The implication is that the results obtained for 
lanthanum based screens can be broadly applied to other rare-earth screens. 
6.2.7 Comparison with previous work 
Some of the results reported here may be compared with those presented by Koedooder 
(1986) from a wide-ranging theoretical study. Koedooder found an increase in absorbed dose 
with tube load for added tin filtration, as has been observed in this work, but also indicated 
that aluminium, copper and the higher K-edge filters all have a very similar effect on dose 
with increasing tube load, contrary to the results observed here. However the different 
methodologies used are largely responsible for this, in particular the calculation of results for 
112 
0 10 20 30 40 50 60 
equal contrast, and thus at varying tube potentials. Koedooder's work was also carried out 
for greater phantom thicknesses, and correspondingly higher tube voltages than the 
simulations performed here. Scattered radiation was also neglected, which would result in 
overestimates of values of absorbed energy. The results that may be most easily compared 
(due to the small change in tube voltage) are those for 0.12 mm erbium at 69 kV, with 
reference conditions of 3 mm aluminium at 70 kV, for which the entrance dose ratio was 
0.59 and the integral dose ratio 0.83, with a tube load of 2.0. The results presented here for 
0.1 mm erbium relative to 3 mm aluminium (both at 60 kV) were a tube load of 2.1, 
entrance dose ratio of 0.73 and absorbed energy ratio of 0.82. These values are in good 
agreement with those of Koedooder considering the differences in methodologies. The greater 
similarity between ratios of entrance and absorbed dose found here are due to the smaller 
phantom size as, for constant entrance dose, the dose at a point inside the phantom for a 
heavily filtered beam relative to a less filtered beam increases with depth. 
The results of Sandborg (1994) are more similar to those reported here in that copper was 
shown to exhibit the greatest dose reduction effects and a contrast increase with tube load 
was observed with the samarium filter, in addition to the absorbed dose increase with 
additional tin filtration. Table 6.4 gives some of Sandborg's results, obtained at constant tube 
potential (70 kV), compared to some of those presented here. Filter thicknesses were not 
identical and, for the copper filter, measurements were made at a different tube voltage, 
besides applying to a different phantom size. The results for copper are in excellent 
agreement, indicating that the use of a lower tube voltage combined with a thinner filter gives 
similar dose reduction in a small phantom to that obtained for a larger one at higher tube 
voltage and greater filter thickness. Results for the tin and samarium filters are also in 
reasonably good agreement, considering the different calculation parameters. 
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Results of Sandborg (1994), 20cm phantom Results from this work, 5cm phantom 
Filter Abs. Ent. Contrast Filter Abs. Ent. Contrast 
dose dose ratio dose dose ratio 
ratio ratio ratio ratio 
0.27mm Cu 0.76 0.57 0.93 0.20mm Cu 0.73 0.58 0.83 
(60 kV) 
0.08mm Sn 1.66 1.09 0.93 0.05mm Sn 1.21 1.00 0.89 
(70kV) 
0.08mm 1.50 1.29 1.11 0.10mm Sm 1.10 1.00 1.01 
Sm (70kV) 
Table 6.4 : Comparison of results with those of Sandborg (1994) 
The results may also be compared to those reported for specific filters in clinical use. 
Cranage (1992) reports an entrance surface dose reduction of 50% with use of a 0.1mm 
erbium filter replacing 1 mm aluminium on the X-ray set. Effective dose reduction ranged 
from 17 - 64% depending on the examination. Technique 
factors used with the erbium in 
place were unchanged tube voltage and doubled mAs (ie a relative tube load of 2). 
Measurements were carried out for adult patient examinations, and the reported dose 
reductions are greater than the most similar results obtained in this work which were an 
entrance surface dose reduction of 27% and absorbed energy reduction of 18%. Several 
factors will contribute to this difference in dose, including the smaller size of patient being 
simulated in this study, compared to the adult data used by Cranage, and the corresponding 
lower tube voltage. In addition to this, the clinical measurements were made using subjective 
assessment of the mAs value required for radiographs comparable with those obtained 
without the erbium, and the tube load of 2.0 is slightly less than that calculated here for the 
same erbium thickness. 
Levett (1990) reported entrance dose reduction of 34% after a clinical trial of use of a 
0.1 mm erbium filter for paediatric examinations at 66 kVp, again with unchange tube 
voltage and a tube load of 2.0. This is in excellent agreement with the corresponding value 
of 27% demonstrated here. If results are extrapolated to a tube load of 2.1, as was found in 
this work, the dose reduction would be 31% which is in even closer agreement. Although 
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Levett's results were obtained for paediatrics, the average size was greater than the 5 cm 
phantom used here, and the tube voltage was slightly higher. 
The above comparisons show that the results from the Monte Carlo simulations carried out 
as a part of this work are in broad agreement with the published literature. This is in spite 
of the difficulties in making direct comparisons of the data, due to the many variations in 
simulation and experimental set-up, and also in presentation of the data. 
6.3 Fluoroscopy using iodine or barium contrast agent 
The preceeding sections have dealt with the simulation of bone in soft tissue, corresponding 
to simple radiographs. Another important category of patient examination is that of 
fluoroscopic studies involving an artificially based contrast media, based on either barium or 
iodine. A second set of simulations was thus carried out for a contrasting disk of either 
barium or iodine in 5 cm soft tissue. The image receptor was 0.014 cm thick caesium iodide, 
corresponding to a typical image intensifier phosphor, and 2 cm perspex was used between 
the patient and the phosphor to represent the couch. Four different specifications of contrast 
media were used: 4930 mg cm-' and 100 mg cm'2 iodine, 3500 mg CM -2 and 70 mg cm 2 
barium. The simulation procedure followed was similar to that for the radiographic 
simulations with all calculations carried out at 60 kV. The results have been normalised to 
reference conditions of 60 kV and 3 mm Al filtration. 
6.3.1 Dosimetry results 
Figures 6.19 and 6.20 show the variation in dose parameters for both iodine and barium 
contrast media, for the different filter materials. The results presented here are for 4.9 g cm-' 
iodine and 3.5 g cm Z barium, but the dosimetry results are not discernably affected by the 
mass thickness of contrast used, as the composition of the small volume of contrast makes 
negligible difference to the amount of energy absorbed in the surrounding tissue, or at the 
phantom surface. The dosimetry results can also be seen to be similar for iodine and barium 
(Figures 6.19 and 6.20), for the same reason. 
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Figure 6.19 : Variation of absorbed energy with tube load for (i) iodine and (ii) barium contrast 
in soft tissue (60 kV, CsI detector) 
150 
125 
0 
0 
loo 
c W 
150 
125 
S 
0 100 
ü 
W 75 
Figure 6.20: Variation of entrance dose with tube load for (i) iodine and (ii) barium contrast in 
soft tissue (60 kV, CsI detector). 
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The curves are very similar in shape to those previously presented for bone in soft tissue 
(Figures 6.3,6.5). Copper filtration exhibits the best rate of dose reduction, and tin is again 
a particularly poor choice of filter. Most of the comments previously made (section 6.2.3), 
pertaining to the effect of the different filtered spectra on patient dose apply also to the 
results observed here. The only altered parameter that will affect the dose is the image 
receptor. The absorption of the CsI phosphor, compared to the gadolinium and lanthanum 
screens is illustrated in Figure 6.21. 
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Figure 6.21 Calculated absorption of caesium iodide phosphor 
compared with film screen materials 
Although the absorption spectra for the caesium iodide detector peaks at a different energy 
from the two screens simulated previously, this does not greatly affect the trends in absorbed 
dose and entrance dose, except for filters with a K-edge close to one of those found in the 
screens. 
6.3.2 Contrast results 
Figure 6.22 shows the variation in image contrast for the different mass thicknesses of iodine 
and barium simulated. 
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Figure 6.22 : Variation in contrast with tube load for (i) 4.9 g cm Z iodine (ii) 100 mg cm 2 iodine 
(iii) 3.5 g cm -2 barium and (iv) 70 mg cm -2 barium in soft tissue (60 kV, CsI detector) 
The first point to note from this set of graphs is the relatively small amount of contrast 
variation compared to that apparent in the bone/soft tissue graphs, given in Figure 6.5 (a 
spread of around 0.05 on the y-axis, compared to 0.1 for the radiography simulations). For 
the larger mass thicknesses of contrast (i and iii) the curves are almost flat, with contrast 
effectively independent of the filtration employed. This occurs due to the high X-ray 
absorption in the contrast media, which results in virtually no radiation passing directly 
through the area of contrast detail. Conversely this means that almost all the radiation passing 
through the phantom will contribute to the contrast, which then becomes independent of the 
shape of the beam spectrum and hence the filtration used. This will be the case for any study 
involving high levels of contrast. 
For the lower contrast graphs, a more complex pattern emerges. Contrast is seen to improve 
with increasing tube load for aluminium and samarium and, to some extent, for gadolinium, 
terbium and dysprosium. The curve for copper is almost flat initially followed by a drop in 
contrast, and for the remaining filters a gradual decrease is seen with tube load. The shape 
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of the curves may be interpreted by looking at the absorption characteristics of iodine and 
barium, as illustrated in Figure 6.23 which shows the transmission of a 60 kVp beam through 
iodine and barium in conjunction with the 5cm phantom. 
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Figure 6.23: Transmission of reference beam (60 kV, 3 mm Al filtration) through phantom and 
contrast media 
From the above curves, the effective signal spectrum may be deduced for each contrast detail, 
as described in section 6.2.3, by subtracting its transmission curve (ie the contrast spectrum) 
from the backgound spectrum. Figure 6.24 shows the signal spectra derived in this way for 
70 mg cm-' barium and 100 mg cm Z iodine. 
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Figure 6.24 : Effective `signal' spectra for iodine and barium in a 5cm phantom 
These spectra show that for iodine and barium contrast media, the most useful part of the 
input beam spectrum is toward the middle of the range of beam energies, above the K-edge 
of the media, rather than at the low energy end of the spectrum. This means that the image 
contrast obtained from different filtered spectra will depend on the proportion of the resultant 
beam with energies within this range eg an incident spectrum which peaks at around 40 keV 
would give much better barium contrast than one that peaks below 30 keV and drops off 
rapidly at high energies. The use of this concept is illustrated for iodine in Figure 6.25 which 
shows the signal spectrum for 100 mg cm 2 iodine superimposed on some of the filtered beam 
spectra displayed earlier in Figure 6.8. The reference beam (60 kV, 3 mm Al) is also 
displayed on each graph. Contrast can be expected to depend on the amount of overlap 
between the input and signal spectra. 
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Figure 6.25: Signal spectra for iodine (shown in dotted line) with filtered beam spectra for (i) 
aluminium (ii) copper (iii) dysprosium (iv) erbium (v) samarium (vi) tin. The reference 
beam (60 kV, no added filtration) is also given in each case. 
The first graph in Figure 6.25 shows how increasing amounts of aluminium filtration cause the 
beam spectrum to shift towards that of the iodine signal spectrum, to give the increasing 
contrast observed in Figure 6.22. This is also the case for small amounts of copper filtration 
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(Figure 6.25ii), but as the amount of copper increases the peak shifts beyond that of the 
iodine signal, so that contrast starts to fall again. This effect can also be seen in the 
dysprosium graph. For erbium, the beam hardening effect is greater and even the thinnest 
filter simulated shifts the beam spectrum beyond that which is optimal for contrast. 
Additional samarium filtration gives a good contrast response as the beam spectra peak 
sharply in the same region as the iodine peak (Figure 6.25v), and this is more pronouned for 
increasing filter thicknesses. The low energy peak in the tin filtered spectra, however, gives 
rise to poor contrast performance, as there is little overlap between the input and signal 
spectra (Figure 6.25vi). 
Similar arguments apply to the barium contrast studies but, as the barium signal peaks at a 
higher energy, the K-edge filters give improved contrast over a greater range of thicknesses, 
and samarium is no longer the optimal filter with respect to contrast. 
6.3.3 Implication of results for optimisation 
The above analysis shows how the potential for optimisation of dose and image quality with 
beam filtration is greater for contrast media studies than with simple radiography. For the 
phantom thickness and tube voltage studied here, small amounts of added filtration can be 
used to give reduced skin and whole body doses while maintaining image contrast. The 
presence of the K-edge in both iodine and barium means that it is not necessary to reduce 
the tube generating potential in order to prevent contrast degradation, which in turn increases 
the dose reduction achievable. 
The results show that copper filtration exhibits the greatest dose reduction for equal tube load 
and, although it does not give the best contrast performance, for small amounts of copper 
contrast is maintained or slightly improved. This would make it the filter of choice when 
aiming to reduce the radiation dose to infants from fluoroscopy with iodine or barium 
contrast media. If, however, it is necessary to improve contrast for a particular examination 
eg when looking for a small fistula, then the use of a samarium or gadolinium filter may be 
preferable, as this would improve contrast without increasing the dose to the patient. 
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As the results, particularly those relating to contrast, are highly dependant on the tube 
potential and on the phantom thickness, care must be exercised in extrapolating to larger 
sizes. However, these results and the spectral analysis can be used to assess the most 
promising areas for further simulation. This application to other age-groups is discussed more 
fully in Chapter 10. 
6.3.4 Comparison with the work of others 
Several authors have presented work concerning the use of additional filtration in paediatric 
fluoroscopy. Nagel (1989) recommended gadolinium for iodine examinations in small 
patients, reporting a 7% increase in contrast and 5% reduction in integral dose compared to 
copper, for 0.3mm copper equivalent filtration at 70 kV. This result was based on a 
theoretical analysis and the contrast change compares very well with the result obtained here; 
a contrast increase of 9% for a 0.2mm gadolinium filter compared to a 0.2mm copper filter. 
The energy imparted, however, increased by 17% for gadolinium compared to copper in this 
work, but the discrepancy is not surprising considering the differences in tube potential and 
filter thicknesses. 
Heggie (1992) also compared different filter materials for fluoroscopy, over a range of patient 
thicknesses, and demonstrated aluminum and copper to give the best dose reduction. For a 
5cm phantom he reported relative dose rates of 0.58 for 0.2mm added copper at 68 kV and 
0.74 for 0.1mm gadolinium at 70 kV, with contrasts of 0.81 and 0.86 respectively. These 
figures are compared to the situation with no added filtration at 63 kV. These values may be 
compared to those obtained here at 60 kV, namely relative entrance doses of 0.60 for copper 
and 0.80 for gadolinium, and relative contrasts of 0.96 and 1.05 respectively. These results 
are in good agreement as the increased tube voltage used by Reggie would be expected to 
improve dose reduction and reduce contrast. 
The work reported by Gagne (1994) focusses on the variation of imaging performance per 
dose (SNR2ID), and this also recommends copper as the best general purpose filter, with 
gadolinium giving improved performance for small patient thicknesses. The image quality 
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performances are partially analysed in terms of effective signal spectra, as has been done 
here, and this highlights the importance of patient thickness in optimisation of iodine contrast. 
For a 30 cm phantom the effective signal spectra for 100 mg cm-' iodine has been calculated 
according to the method used throughout this work, and is as illustrated in Figure 6.26. 
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Figure 6.30: Signal spectra for 100 mg cm-' iodine in 30 cm tissue 
This spectra appears the same as that given by Gagne (1994), and differs from that given 
earlier for 5cm tissue (Figure 6.24) as the lower energy peak has disappeared. In effect, the 
greater absorption in the thicker patient masks the K-edge of the iodine contrast media. This 
explains why the enhanced performance exhibited by filters such as gadolinium or samarium 
for small patient thicknesses disappears for larger patients. It is difficult to compare results 
directly to thos of Gagne, as the latter are mostly presented in terms of SNRZ/D rather than 
in separate dose and image quality parameters. However for a 10cm phantom, with barium 
contrast, the values of integral dose and contrast, relative to the reference system are 0.64 and 
0.97 respectively. The most closely corresponding conditions found here gave corresponding 
results of 0.88 and 0.77, but these were for a thinner phantom, a thinner contrast detail, 
varying tube potentials and a slightly different reference spectrum. 
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6.4 Summary of Monte Carlo results 
A large number of Monte Carlo simulations have been performed for a neonatal phantom, 
to calculate entrance dose, absorbed energy and contrast for various combinations of filter, 
generating tube potential, contrast media and image receptor. Results have been presented in 
terms of variation in each parameter with tube load, and analysed in terms of absorption and 
transmission spectra through the various media. 
For radiographic examinations, it was shown that increasing the amount of aluminum 
filtration beyond 3mm was an inefficient method of dose reduction. Copper gave the best 
dose reduction performance, out of the materials included in the study, with tin a particularly 
poor filter. For the rare earth filter materials, dose reduction increased with atomic number. 
In all cases, the reduction in absorbed energy was less than that for entrance dose. 
The reduction in absorbed dose and entrance dose was accompanied in each case by a 
reduction in contrast. However, by lowering the generating tube potential to 55 kV from 60 
kV, contrast could be maintained while preserving a moderate dose reduction, for some filter 
materials. In particular, for copper filtration, absorbed dose reduction of 10% was attainable 
without loss in contrast. 
Using replacement instead of additional filtration shows no decrease in relative dose reduction 
for the same tube load. Use of a different image receptor did not significantly affect the 
results. 
For fluoroscopy examinations using iodine or barium contrast media with a caesium iodide 
detector, the dosimetry results were very similar to those for radiography. For a high contrast 
object, contrast was minimally affected by the beam spectra, whereas for lower contrast 
studies the contrast depended on the precise spectral shape and the K-edge of the contrast 
media. Improved contrast could be obtained over a range of added filter materials and, for 
small tube loads, contrast was maintained close to reference level for virtually all filters. 
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Results were similar for both iodine and barium, though contrast improved over a wider 
range of tube loads for the latter case. 
Copper was shown to be the optimal filter for dose reduction in neonates, with gadolinium 
or samarium filtration suitable for improving image contrast. 
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Chapter 7 
Experimental Techniques 
7.1 Introduction 
Experimental work was undertaken for two reasons. The first of these was to verify the 
results obtained from the Monte Carlo simulations. This was necessary as, however well 
designed and tested the code, there was always the possibility that an approximation in the 
processes modelled, or a hidden bug, might bias the results obtained. The second reason was 
to establish that the theoretical results could be carried through to a clinical environment. This 
was important as, in practice, parameters are rarely as well defined or as continuously 
variable as they can be for a theoretical simulation (eg only discrete mAs values may be 
available, acceptible background densities are likely to be assessed visually rather than 
numerically etc) and the true geometry is likely to be more complex than that modelled. 
To address each of the above, different types of experimental measurement were carried out. 
The first set were designed to match the computer simulations, in order to verify the code 
and the results obtained from it. These measurements were carried out in the departmental 
X-ray laboratory, irradiating simple slab phantoms corresponding as closely as possible those 
modelled in the Monte Carlo code. A second set of measurements were then performed to 
assess the application of results to clinical practice. This latter stage of the work was carried 
out in a local radiology department, with a high throughput of paediatric patients. Two types 
of clinical measurements were carried out; one simulating plain film radiography on a mobile 
X-ray set; the other simulating fluoroscopic procedures in the paediatric screening room. The 
former examination was selected as being representative of the most common X-ray 
procedure for neonates on a special care nursery and, therefore, an important category of 
examination for optimisation. Fluoroscopic procedures were included since they give a much 
higher dose per examination then simple radiography. All irradiations made in the clinical 
environment were performed on a neonatal anthropomorphic child phantom, and the close 
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cooperation of the senior paediatric radiographer was obtained in establishing suitable 
experimental parameters. 
Dose measurements for all experimental work were made using thermoluminescent dosimeters 
and contrast was assessed from film density measurements. Sensitometric techniques were 
used to characterise the film response. Image quality was also judged subjectively, by 
experienced staff, from radiographs and the visual display unit (VDU) of the fluoroscopy 
equipment. These techniques are outlined in detail below, as are the experimental procedures. 
7.2 TLD dosimetry 
Thermoluminescent dosimeters (TLD) have been widely used and recommended for making 
measurements of patient dose from diagnostic radiology (IPSM, 1988; IPSM, 1992). The 
most usual form of TLD used is lithium fluoride, doped with magnesium and titanium. This 
has the advantage of near tissue equivalence in its radiation response, relative insensitivity 
to light and a low fading rate (Chandra et al, 1982). The problems identified in Chapter 2, 
regarding the use of TLD for paediatric dose measurement, did not affect their use in these 
experiments as there was no necessity to use low doses. Two types of TLD were used for this 
work, both supplied by Harshaw and read out using Harshaw readers which employ hot 
nitrogen gas heating with a closed loop feedback system producing linearly ramped 
temperatures (Moscovitch et al, 1990). 
For the laboratory measurements, using the slab phantom, Harshaw 'X-Rad' dosemeters were 
used. These consist of 3mm by 3mm chips of lithium fluoride type TLD-700 (99.93% Li-7; 
0.07% Li-6) doped with magnesium and titanium, hermetically bonded to a kapton substrate. 
These dosemeters were individually calibrated, and read out using a Harshaw 6600 reader 
with a heat cycle consisting of a heating rate of 15°C sec' upto 300°C, with an acquire time 
of 20s. These dosemeters have been widely investigated for use in patient dosimetry 
(Broadhead, 1997), showing reproducibility to within 3% and a minimum detectable dose of 
the order of 0.16 mGy. The energy response of the dosemeters was shown to be constant to 
within 7% for diagnostic X-ray beams from 60 to 100 kV. Before each use, the dosemeters 
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were annealed by putting them through the usual read cycle, as was recommended by 
Broadhead, then packaged in small plastic pouches for protection. The TLDs were read out 
approximately 24 hours after irradiation, at which time the rate of fading is low. For each 
experiment, ten dosemeters were retained to assess the background dose, which was then 
subtracted from each measured dose. 
For the dosimetry with the anthropomorphic phantom, Harshaw TLD 100 chips were used. 
These consist of 3 mm by 3 mm lithium fluoride, 1 mm thick. They were oven annealed (1 
hour at 400°C and 16 hours at 80°C), as recommended by Harshaw, before use and packed 
in small plastic sachets which were then either placed on the phantom surface or rolled and 
inserted into the holes inside the phantom, for assessment of organ doses. The dosemeters 
were read out on a Harshaw 5500 machine, also with a heat cycle consisting of a heating rate 
of 15°C sec' upto 300°C, with an acquire time of 20s, and the chips were individually 
calibrated, as before. The reproducibility of these chips has been shown to be 3.5%, with a 
detection limit of 0.05 mGy. Energy response was constant to within 5% for diagnostic 
spectra from 60 to 100 kV (Broadhead, 1997). As for the former set of measurements, ten 
chips were retained to assess the background dose for each experiment. 
7.3 Image quality measurements 
Definitions of contrast have been discussed earlier in Chapter 4. For radiographs and spot 
films, contrast is most easily expressed simply as a difference in optical density between 
adjacent areas of film. Optical densities were measured using a Parry digital transmission 
densitometer DT1505, for which the stated accuracy is 1% of reading ± 0.01D. Fog levels, 
as determined from an unexposed portion of the film, were subtracted from all readings. 
7.3.1 Sensitometry 
Sensitometry is the study of the quantitative relationship between exposure and optical 
density. It may be carried out in terms of either light or X-ray sensitometry, using time or 
intensity scale exposures. In light sensitometry a strip of film is exposed to a series of 
different light intensities, at a wavelength appropriate for the film used, in the form of narrow 
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steps. For X-ray sensitometry using time scale exposure, successive exposures are given on 
adjacent areas of a photographic layer by using a constant exposure rate at increasing times 
of exposure. Intensity scale exposure for X-rays consists of taking increasing exposures on 
strips of film at a given time, usually by changing the source-film distance. After processing 
the film or films and correcting measured densities for background fog levels (deduced from 
a processed unexposed film) a plot of film density against the logarithm of relative exposure 
gives the characteristic curve which demonstrates the reponse of the film. 
Prior to commencing the initial laboratory measurements, both light and X-ray sensitometry 
was carried out on the film to be used in the experiments. The former used an X-Rite 383 
light beam sensitometer on the `green' setting, ie emitting light at the green end of the 
spectrum as do the screen phosphors used, and the X-ray sensitometry was carried out by 
moving a piece of lead stepwise across the film as a series of exposures was made on the X- 
ray set, at fixed settings. All films produced during the laboratory measurements were also 
exposed to the light beam sensitometer prior to processing, firstly as a check on the film 
quality and the processing - so that the effect of temporal variations in these parameters could 
be excluded - and secondly so that the radiographic contrast could be related to the exposure 
contrast. The latter bore a more direct relationship to the absorbed energy contrast in the 
screens, as determined from the Monte Carlo code. The exposure contrast, calculated from 
the sensitometric curve is given by the formula 
11 
C= 
100.15sn1 _ 100.15sn2 (7.1) 
100.15sn, 
where sn, and sn2 refer to the sensitometric step numbers corresponding to the densities 
beside and behind the contrast detail respectively. 
7.4 Patient phantoms 
7.4.1 Tissue equivalent slabs 
For the experimental verification of the Monte Carlo results, slabs of the tissue equivalent 
material (MS20, SB5 and LN100) simulated in the code were used, from RMI. These 
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materials form part of a series of epoxy resin based tissue substitutes, described by White et 
al (1977) that were formulated from an analytical procedure using basic interaction data 
(White, 1977). For MS20, a muscle substitute, the mass attenuation and energy absorption 
coefficients are given as within 3% of that for actual muscle across the diagnostic energy 
range. A muscle equivalent material was selected for soft tissue simulation, in preference to 
one simulating adipose tissue since for children, particularly very young children, muscle is 
the predominant soft tissue component (White et al, 1991). For the hard bone substitute, SB5, 
the mass attenuation and energy absorption coefficients are accurate to within 2%. The lung 
equivalent material is manufactured from epoxy resin expanded using foam (White et al, 
1986). The amount of foam added for this series of materials affects the density, thus lung 
at different stages of inflation can be simulated. LN100 is the material simulating fully 
inflated lung tissue. This was considered the most appropriate as chest radiography is 
normally carried out on inspiration. The mass attenuation and energy absorption coefficients 
for LN100 are within 3% of those for the simulated tissue across the diagnostic energy range. 
The tissue equivalent slabs, all 50 x 50 cm, were obtained in thicknesses of 0.5 (for SB5 
only), 1.0,2.0 and 5.0 cm. At the centre of some of the slabs a small disc of material was 
removed, of diameter 1.5cm. Small disks of the different materials were cut to fit the holes 
made, so that a number of different patient thicknesses could be simulated with either bone 
or lung detail in soft tissue, or bone detail in lung. This is illustrated in figure 7.1 for a1 cm 
thick detail in 5 cm tissue. The available slab dimensions were such that a range of total 
thicknesses could be obtained. 
131 
2cmI 
icmt 
2cmf 
Figure 7.1 : Exploded view of tissue equivalent phantom 
Using these slabs, geometries were obtained that were equivalent to those simulated in the 
Monte Carlo study, the only difference between being that for the computer simulation the 
slabs were assumed to be semi-infinite. Provided that, during the experimental work, the 
incident field-size was well within the area of the slab, this approximation should not 
significantly affect the results. 
7.4.2 Anthropomorphic phantoms 
An anthropomorphic phantom, representing a newborn infant was used for the second section 
of the experimental work. This was one (AHP-0) of a series of paediatric phantoms obtained 
from Latvian Medical Academy (Varchenya et al, 1993). The phantoms are illustrated in 
figure 7.2. 
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Figure 7.2 : Paediatric anthropomorphic phantoms 
The composition of the phantom was P2D-MBT tissue equivalent material (density 1050 
kgm-3) with a plastic skeleton (density 1400 kgm"') and plastic lung (450 kgm"3). It comprises 
20 slices, with separate detachable arms. A total of 134 holes are contained within the 
phantom, for location of thermoluminescent dosimeters, and details of the relationship 
between the internal organs and the different hole numbers were provided with the phantom. 
The construction of the phantom slices is exhibited below in Figure 7.3 
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Figure 7.3 : Internal construction of paediatric anthropomorphic phantoms 
The radiation equivalence of the phantom is stated to be close to that of the simulated tissues 
for energies from 20 - 100 keV, with linear attenuation coefficients agreeing to within 4% 
for all tissue types. Local measurements, however, have shown that at all tube potentials the 
phantoms significantly overestimate the attenuation, compared to water (Broadhead, 1998). 
However, this is unlikely to cause a problem for comparative dosimetry measurements. 
Although radiographs of the phantom enabled direct assessment of bone/soft tissue contrast, 
it was necessary to introduce artificial contrast media for simulation of fluoroscopic 
examinations, which commonly use either iodine or barium based contrast agent. To achieve 
this, an extra phantom slice was constructed, from a2 cm thick slab of MS20, to fit between 
slices 12 and 13 (around the abdomen of the phantom). At the centre of this slice, a 1.5 cm 
diameter hole was cut, and several small plastic vials manufactured to fit this hole. These 
could then be filled with the different contrast agents and placed in the additional phantom 
slice, which was then fitted into the rest of the phantom. Of necessity, this was only a rough 
approximation to an actual contrast examination as, in practice, the thickness and contours 
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taken up by the contrast within the body will vary hugely according to the examination being 
performed; eg urethers and bladder will be filled during a micturating cystogram, parts of the 
intestine during an enema etc. However, the method enabled contrast specific optimisation 
studies to be performed. 
7.5 Procedure for laboratory measurements 
The geometry used for the experimental verification of the Monte Carlo results is shown in 
figure 7.4 The X-ray unit comprised a Picker Vector 70 generator with a Picker X-ray tube 
attached to a Picker Cosmos tube stand. The nominal tube filtration was 2.5 mm Al, and with 
the DAP meter ionisation chamber attached the total filtration was 3 mm Al equivalence. 
Routine quality assurance is carried out on this tube and generator, and this showed that 
measured tube potentials were within ±2 kV of that set and that all other parameters were 
within specified tolerances. The slab phantom described in section 7.4.1, with 1 cm bone 
inset in 5 cm soft tissue, was set up on the floor with the tube head at its highest position, 
so as to obtain the maximum possible focus-skin distance (FSD). This was to alleviate one 
of the main practical problems encountered, namely the difficulty in obtaining sufficiently 
small values of mAs for the desired film density (of around 1.0). The phantom was placed 
directly on an Agfa Geveart screen containing Kodak Regular film. This configuration 
matches that of the computer simulations, and is representative of clinical practice for 
neonatal radiography. Tape was used to mark the position of the screen and phantom on the 
floor, and the position of the tube head, so that the geometry could be reproduced for each 
series of measurements. 
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Figure 7.4 : Laboratory irradiation geometry 
A number of filters were available for study, as listed in table 7.1. 
0.1 mm copper (Cu) 
0.2 mm copper (Cu) 
0.1 mm erbium (Er) 
0.1 mm samarium (Sm) 
0.1 mm tin (Sn) 
0.1 mm gadolinium (Gd) 
Table 7.1 : Filters used in experimental measurements 
The filters were obtained from Goodfellows and each was in the form of a5 cm square sheet 
held within a slide mount for convenience and protection. The stated purity of the metals, on 
dispatch from the supplier, was greater than 99%, but they had been stored within the 
department for a number of years. 
All measurements were compared to reference exposure conditions of 60 kV with no 
additional filtration. For each filter under investigation, measurements were carried out at 
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both 60 kV and 55 kV. Tube voltages on the set were checked as part of routine QA, and 
the most recent set of measurements showed them to be within tolerance (ie measured values 
were within ±2 kV of those set). The first step, for each tube voltage and filter combination, 
was to carry out exposures at a number of mAs values, to determine the exposure parameters 
required to achieve an optical density close to 1.0. The accuracy to which this could be 
achieved was limited by the discrete nature of mAs values that could be selected, and the 
lack of stability of the tube output at the low mA bands and exposure times required. In some 
instances a combination of two of the available exposure times was necessary to obtain a 
suitable exposure. The mA band, once selected, was altered as little as possible so as to 
minimize one source of uncertainty in the measurements. Table 7.2 lists these experimentally 
determined exposure factors with which the radiographs that were used for comparing filter 
performance were taken. Prior to processing, all films were exposed with an X-Rite 
sensitometer as described in section 7.3.1. They were then processed using an Agfa Curix 
Compact daylight processor on which regular QA checks are performed. 
Filter 
Al 
only 
0.1mm 
Cu 
0.2mm 
Cu 
0.1mm 
Er 
0. lmm 
Sm 
0. lmm 
Sn 
0. lmm 
Gd 
@ 60 kV 3.0 5.0 7.2 8.0 8.4 14.2 9.0 
mAs 
@ 55 kV - 9.0 13.4 13.4 12.9 21.2 13.4 
Figure 7.2 : Exposure factors used to produce test radiographs 
Although ideally dosimetry would have been carried out concurrently with the film 
exposures, the radiation dose from a single exposure was too low for accurate TLD 
dosimetry. It was therefore necessary to use larger mAs values (simulating multiple 
exposures) when making the dosimetry measurements, than those used when exposing the 
film. As a result, the dosimetry measurements for each filter were made directly after 
obtaining the radiographs. Doses were measured at several points on and within the phantom 
using the X-rad dosemeters described in section 7.2. Doses were measured at four levels 
within the phantom; on both entrance and exit surfaces of the slab, and at 2 cm and 3cm 
depth (ie between slabs). Six dosemeters were used at each location, placed near the centre 
of the phantom without overlapping the area of bone detail. For all measurements of both 
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dose and contrast a large area ionization chamber (20X5-60,60cc chamber; Radcal Inc. ) was 
placed at a marked position on the surface of the phantom, inside the beam area but not 
covering the area of contrast material. The ion chamber readings were used to normalize the 
dose results to the exposure level corresponding to that used when taking the radiograph. This 
methodology was used as inconsistent results were obtained when extrapolating doses 
according to mAs values, as tube output was not linear in this region of the low mA/low 
exposure bands being operated. 
7.6 Procedure for hospital measurements 
Two sets of experimental measurements were carried out at the Royal Victoria Infirmary, 
Newcastle Upon Tyne, for plain film radiography and fluoroscopy respectively. These were 
carried out using the newborn anthropomorphic phantom. 134 TLD were used inside the 
phantom, for assessment of internal organ doses, and a total of 22 dosemeters were placed 
on the surface of the phantom, for the assessment of skin dose and entrance surface dose. 
Organ doses were calculated and also the effective dose, using the organ weighting factors 
given by the ICRP (ICRP 60,1991). The calculation of effective dose provided a dose 
quantity for comparative purposes only, as the field sizes and positioning used for the 
experiments did not correspond to any particular type of examination. 
7.6.1 Plain film radiography 
In the first experiment, the phantom was radiographed on an MX4 mobile, similar to that 
used on the special care baby unit (SCBU), using an Ultravist screen-film system (a 
lanthanum based screen), which is the screen-film combination routinely used in the 
department. The phantom lay directly on the film casette, placed on a trolley and the initial 
radiographs were taken without any additional filtration at 60 kV, with the paediatric 
radiographer advising on the technique factors to be used (6 mAs). Further radiographs were 
taken with additional filters of 0.1 mm copper and then 0.1 mm dysprosium, both at 56 kVp 
(the nearest available setting to 55 kV). Available mAs settings were in discrete steps of 3 
mAs, so it was not possible to match the background film densities exactly. Acceptable 
exposures were obtained using 12 mAs for the copper filter and 18 mAs for the dysprosium 
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filter. For the dosimetry measurements, doses were integrated over 20 exposures. The 
experimental geometry is shown figure 7.5. The field-size used was 22 cm x 18 cm, with a 
focus-skin distance (FSD) of 80 cm The tube was centred over the abdomen, and the extent 
of the beam area - as indicated by the light beam diaphragm- noted, to aid reproducibility. 
Contrast measurements were made from the radiographs obtained, using the lowest lumbar 
vertabrae as the area of interest and the surrounding soft tissue as background. 
Figure 7.5 : Geometry of irradiations on MX4 
7.6.2 Fluoroscopy 
Fluoroscopy measurements were carried out in the Paediatric screening room. The equipment 
used was a Shimadzu 3 phase 12 peak generator HDISOB - 30 with a Circlex tube, a 
Shimadzu image amplifier and Philips 100mm camera. The undercouch tube was not easily 
accessible for mounting additional filtration on the tube head, as is customary, so 0.1 mm 
copper filtration was introduced into the beam by means of a 50 x 50 cm sheet, placed on 
the couch directly beneath the phantom. The geometry is illustrated in figure 7.6. 
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Figure 7.6 : Geometry for experimental measurements in paediatric screening 
room 
The newborn anthropomorphic phantom was used, with an additional slice containing a 
cylinder of Isopaque Cysto, an iodine based contrast media used for neonatal cystograms, as 
previously described. The paediatric radiographer assisted in the preliminary trial of exposure 
factors for the experiment, to ensure that those chosen were clinically representative. 
Fluoroscopic screening in this room is normally carried out under manual control of 
technique factors. The technique factors used were 60kV and 0.5 mA, and these factors were 
unchanged with the copper filter in place as no adverse effect on image quality, as judged 
by the radiographer, was observed when viewing the image on the visual display unit. 
100mm spot films are normally taken under AEC, with fixed tube voltage and current and 
this resulted in a slight increase in exposure time (from 8 to 9 ms) for films taken with the 
copper filter in place (at 60 kV and 150 mA). 
For the dosimetry measurements, the phantom was screened for 5 minutes with the tube static 
and centred over the abdomen. The phantom was loaded with TLD as for the previous 
experiment, and the dose area product reading was also recorded. A single spot film was 
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taken at the end of the period of fluoroscopy in order to make objective measurements of 
contrast using the area of contrast media and the surrounding tissue. 
7.7 Accuracy of measurements 
There are many factors influencing the level of uncertainties in the experimental results. 
Assessment of the uncertainties in TLD measurements has been discussed in the National 
Protocol for patient dose measurements (IPSM, 1992). As, for this work, no calibration of 
the TLD was carried out, the dose is given by 
D=X-B (7.2) 
where X and B are the mean measured and background counts respectively. The standard 
error in D, SD is given simply by the quadrature sum of the individual standard errors. 
SB 2 In 
Sx i+ (7.3) SD nB 
D (X-B) 
The standard deviation of X is used, in preference to the standard error, since it is the 
uncertainty associated with a single measurement, not the mean of a series of measurements, 
that is required (IPSM, 1992). The total random uncertainty for individual TLD 
measurements, at the 95% confidence limit is thus 
S2lrz 
Uo =2 
1S12 
+nB (7.4) 
(X-B) 
where Sx is the standard deviation of counts from a series of identical doses to the same 
TLD, SB the standard deviation in the background and nb the number of TLD used to assess 
the background. Non-random uncertainties are more difficult to quantify and may arise from 
the energy response of the dosemeters, non-linearity with dose, fading of the TLD signal and 
temporal variations in the TLD reader. For the TLD system used here, the non-random 
uncertainty has been shown to be less than 10% (Broadhead, 1997). Uncertainties in 
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calculated organ doses and in effective dose are greater than these, and depend on the size 
of the organ, the number of TLD used to assess the dose and the uncertainties in the organ 
weighting factors. 
For density assessments, the uncertainty in each individual density measurement is 1% of the 
reading, but the main source of uncertainty in the contrast measurements arises from 
fluctuations in density, within a uniformly irradiated area of the film. These were assessed 
by making a series of density readings around each point of interest, and calculating the 
standard deviation of these. As 
C= D1 -D2 (7.5) 
The standard error in the calculated contrast is also given by the quadrature sum of the 
individual standard errors, and the overall uncertainty at the 95% confidence level by 
S 
Di 
2+S 
D2 
21/2 
(7.6) 
Uc =2 
n°, nD2 
Dl -D2 
where DI and D2 are the adjacent mean values of optical density for the two areas of interest, 
nD, and nm are the number of measurements of each density and SDi and SD2 are the standard 
deviations in the readings. 
If absolute measurements of the dose and image quality parameters were required, other 
factors such as uncertainty in calibration of the TLD, the tissue equivalence of the phantoms 
etc would also have to be assessed, but for comparative measurements these have little 
importance as they affect all the measurement in the same way. Uncertainties arising from 
inaccurate repositioning between experiments, or variations in tube parameters could influence 
the result, but these have been minimized as far as possible. 
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7.8 Summary of chapter 
In this chapter, the reasons for carrying out the different types of experimental measurements 
have been explained, and the techniques used for assessing dose and image quality described. 
These involved TLD dosimetry and contrast measurements both directly from film densities 
and using sensitometric techniques. The phantoms used in making the measurements were 
also described, and consisted of simple slab phantoms for the laboratory work and an 
anthropomorphic newborn phantom for the hospital based measurements. The various 
irradiation geometries used have been illustrated, and the experimental procedures outlined. 
The methods used for calculating the uncertainties in the measured quantities have also been 
presented. 
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Chapter 8 
Results of Experimental Verification 
8.1 Introduction 
The results of the experimental measurements used to verify the Monte Carlo code are 
presented in this chapter. The first section gives the numerical derivation of the measurement 
uncertainties, for both dose and contrast measurements. The results from the laboratory 
measurements are then presented and compared with the theoretical predictions, in terms of 
both absolute values and the ratios of each quantity relative to baseline values. The results 
of the two types of clinical measurements are then given, and the factors affecting these 
discussed. 
8.2 Uncertainties in measurements 
The various sources of uncertainty in the experimental measurements have been discussed in 
the previous chapter. The total random uncertainty at 95% confidence level for individual 
TLD measurements was assessed for each set of results, according to equation 7.4, from the 
background TLD readings. The results are summarised in Table 8.1 below for the maximum 
and minimum values of X (TLD reading) found in each set of data, where the symbols are 
as given in section 7.7. MX4 refers to film-screen radiography on the hospital MX4 mobile 
X-ray set, and fluoro to measurements made in the paediatric fluoroscopic room. The figures 
in the table demonstrate that when X is much greater than B the measurement uncertainty 
arises almost entirely from the reproducibility of the TLD signal, Sx. 
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Measurement set Sx SB nB X B UD 
0.1 mm copper 3% 4.3 10 253.7 35.5 7.1% 
1746 6.1% 
0.2 mm copper 3% 5.8 10 224.8 24.1 7.0% 
874.1 6.2% 
0.1 mm erbium 3% 6.7 10 193.8 27.7 7.3% 
968.7 6.2% 
0.1 mm samarium 3% 5.1 10 276.1 27.4 6.6% 
1280 6.1% 
0.1 mm tin 3% 7.2 10 192.3 24.6 7.4% 
1053 6.2% 
0.1 mm gadolinium 3% 4.2 8 285.1 22.5 6.6% 
1033 6.1% 
MX4 - no added 3.5% 0.008 17 0.095 0.062 23.3% 
filtration 4.969 7.1% 
MX4 - with copper 3.5% 0.006 10 0.088 0.056 22.6% 
/dysprosium 2.042 7.2% 
Fluoro - with/ 3.5% 0.008 10 0.077 0.044 22.4% 
without copper 32.86 7.0% 
Table 8.1 : Uncertainties in TLD measurements 
For the laboratory measurements, all uncertainties are around 6-7% of the dose value. The 
uncertainty arising from repositioning between experiments was assessed to be less than I%, 
so the combined uncertainty was thus taken to be ± 7% for all laboratory dose measurements. 
For the hospital measurements, uncertainties range from around 7% for superficial organs 
within the beam area to over 20% for organs well outside the beam. For the clinical 
measurements, uncertainties also arise from the calculation of individual organ doses from 
the TLD measurements. These were assessed to be 20% for small organs such as the thyroid 
or ovaries where only 1 or 2 TLD were used to calculate the dose, 10% for larger organs, 
and 10% for distributed organs such as bone marrow dose. Uncertainties due to repositioning 
between experiments are also large for organs on the periphery of the beam, as dose drops 
sharply at the beam edge. Such uncertainties were judged to be in the order of 20% whereas 
repositioning uncertainties for other organs were close to zero. The combined uncertainties, 
for the clinical measurements, were obtained by summing the various components in 
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small organs large organs 
beam centre 22% 14% 
beam periphery 30% 25% 
outside beam 28% 22% 
Table 8.2 : Uncertainties for different sized organs at various beam positions. 
quadrature and values used for different organ types are listed in Table 8.2. The uncertainty 
in calculated contrast for each radiograph is similarly given in Table 8.3 where the symbols 
are as defined in equation 7.5. 
Meas. Set SDI SD2 nDI nD2 D, D2 Uc 
0.1mm Cu 0.01 0.01 10 10 1.00 0.52 1.9% 
0.2mm Cu 0.01 0.01 10 10 0.98 0.51 1.9% 
0.1mm Er 0.01 0.01 10 10 0.99 0.50 1.8% 
0.1mm Sm 0.01 0.01 10 10 1.07 0.46 1.5% 
0.1mm Sn 0.01 0.01 10 10 0.92 0.42 1.8% 
0.1mm Gd 0.01 0.01 10 10 0.98 0.42 1.6% 
MX4-Al(pelvis) 0.02 0.05 5 5 1.59 1.42 28.3% 
MX4-A1(spine) 0.09 0.05 5 5 1.78 1.31 19.6% 
MX4-Cu(pelvis) 0.03 0.07 5 5 0.78 0.57 32.4% 
MX4-Cu(spine) 0.06 0.07 5 5 1.00 0.58 19.6% 
MX4-Dy(pelvis) 0.02 0.04 5 5 0.70 0.53 23.6% 
MX4-Dy(spine) 0.07 0.03 5 5 0.72 0.39 0.66% 
Fluoro - Al 0.02 0.004 5 5 0.27 0.01 8.2% 
Fluoro - Cu 0.02 0.00 5 5 0.13 0.00 15.5% 
Table 8.3 : Uncertainties in calculated contrast 
For the laboratory measurements, fog levels on the various films were consistent to within 
40.01. Sensitometric measurements showed consistency in processing to within 1% across the 
range of exposure levels. Slight repositioning errors did not have an effect on the calculation 
of contrast, so that combined uncertainties at 95% confidence level were as listed in 
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Table 8.3 above. The uncertainty in contrast measurements on the laboratory film are low as 
there are only two, clearly defined areas on the film corresponding to the uniform tissue and 
contrast detail in the slab phantom. The contrast measurements made on the hospital films 
have a much greater level of uncertainty as the use of the anthropomorphic phantom resulted 
in large fluctuations of density over a small area, making repeatable density measurements 
difficult. 
8.2 Laboratory measurements 
Measurements of entrance dose, depth dose and film contrast were made, as described in 
Chapter 6 for a number of different beam filters, using the 5 cm tissue phantom containing 
1 cm bone. The exposure factors used to acquire radiographs with a background density close 
to 1.0, as found experimentally, are listed in Table 8.4. for each filter, along with the actual 
background density obtained. As measurements corresponding to different filters were made 
on different days, baseline measurements, without additional filtration, were made on each 
occasion. The exposure factors used for these baseline radiographs were 60 kVp and 3 mAs. 
baseline filter @ 60 kV filter @ 55 kV 
Filter bkgd density mAs bkgd density mAs bkgd density 
0.1mm copper 0.98 5.0 0.99 9.0 1.00 
0.2mm copper 1.02 7.2 0.98 13.4 0.97 
0.1mm erbium 1.02 8.0 0.99 13.7 1.06 
0.1mm samarium 1.05 8.4 1.07 12.9 1.06 
0.1 mm tin 0.90 14.2 0.92 21.2 0.90 
0.1mm gadolinium 1.03 9.0 0.98 13.4 1.01 
Table 8.4 : Exposure factors used for laboratory measurements (uncertainty in all density 
measurements ± 0.01) 
Each of the above exposure factors was determined after experimenting with different mAs 
values to obtain the optimum film density, which is inevitably limited by the discrete nature 
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of the available tube current and exposure time settings. It can be seen from Table 8.4 that 
it was not possible to achieve identical film densities for the different combinations of tube 
voltage and filter, but the radiographs were adequate for use in making comparisons of film 
contrast. It is also apparent from the table that, although the same technique factors were set 
each time for the baseline radiographs, the background film density was not consistent. 
Possible reasons for this are fluctuations in the film quality, processing changes, or drift in 
the generator parameters over time. Routine QA checks on the set show that although tube 
output is generally consistent, and the measured tube voltages remain within ±2 kV of the 
nominal values, the exposure timer performs erratically at the short exposure times 
corresponding to those used for these measurements. Prior to the start of the experimental 
work, the exposure timer error at a nominal setting of 30 ms was 18%, with a more recent 
measurement giving a 6% error. As all results have been considered in terms of the ratio of 
each quantity of interest for the test conditions relative to baseline values, the effect of such 
variation in equipment performance has been accounted for. 
8.2.1 Contrast measurements 
Film contrast for each radiograph was calculated as the difference in film density behind and 
beside the area of bone detail, the latter being the background density. These measured values 
of film contrast are given in Table 8.5, together with the corresponding values predicted from 
Monte Carlo simulations. The predicted contrast for baseline filtration of 3mm aluminium 
only is 0.423 ± 0.003. 
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filter experimental results (± 0.01) Monte Carlo results 
baseline @ 60 kV @ 55 kV @ 60 kV @ 55 kV 
0.1mm copper 0.48 0.42 0.48 0.375±0.004 0.438±0.005 
0.2mm copper 0.55 0.47 0.52 0.339±0.004 0.371±0.005 
0.1mm erbium 0.60 0.49 0.57 0.353±0.004 0.391±0.005 
0.1mm samarium 0.62 0.61 0.66 0.413±0.005 0.448±0.005 
0.1mm tin 0.57 0.50 0.52 0.366±0.007 0.425±0.010 
0.1mm gadolinium 0.60 0.56 0.61 0.405±0.007 0.432±0.005 
Table 8.5 : Measured and predicted values of film contrast 
It can be seen that although experimental contrast values are all greater than those predicted, 
the relative values (ie values with additional filtration compared to those without) are 
consistent, as will be illustrated in Table 8.7, which gives the ratios of contrast values for 
each filter relative to the appropriate baseline value. One source of difference between the 
measured and predicted values is that the calculated contrasts are primary contrast values, 
derived from energy absorption in the screen. For these contrast values to relate accurately 
to differences in film density requires both measurement points to lie on the linear portion 
of the characteristic curve for the film. To investigate the extent to which this criteria affects 
the results, the sensitometric measurements made on each film processed were used in a 
separate derivation of contrast, based on film exposure, rather than film density as described 
in Chapter 7. These contrast values are given in Table 8.6. 
filter baseline filter @ 60 kV filter @ 55 kV 
0.1mm copper 0.425 0.362 0.415 
0.2mm copper 0.472 0.394 0.415 
0.1mm erbium 0.472 0.404 0.463 
0.1mm samarium 0.499 0.444 0.516 
0.1mm tin 0.516 0.415 0.463 
0.1mm gadolinium 0.481 0.454 0.499 
Table 8.6 : Contrast values derived using sensitometric techniques (all ±5%) 
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For the first row of data in the table, that relating to added filtration of 0.1 mm copper, 
contrast values derived in this way show excellent agreement with those predicted. The 
contrast values derived in this way are all less than those measured directly from the film, 
but the relative changes for each different filter are not significantly affected by the 
calculation technique. This is illustrated in Table 8.7 which summarises the contrast ratios 
with and without additional filtration for the two measurement techniques and the predicted 
values. 
ratios of contrast for filter with respect to baseline 
@60 kV @55 kV 
direct 
(± 0.01) 
sensitom. 
(± 0.06) 
predicted 
(± 0.02) 
direct 
(± 0.01) 
sensitom. 
(f 0.07) 
predicted 
(f 0.02) 
0.1mm Cu 0.88 0.85 0.89 1.00 0.98 1.04 
0.2mm Cu 0.80 0.83 0.80 0.88 0.88 0.88 
0.1mm Er 0.82 0.86 0.83 0.95 0.98 0.92 
0.1mm Sm 0.98 0.91 0.98 1.06 1.03 1.06 
0.1mm Sn 0.88 0.80 0.85 0.91 0.90 1.00 
0.1mm Gd 0.93 0.94 0.96 1.02 1.04 1.02 
Table 8.7 : Measured and predicted ratios of contrast for each irradiation condition with respect 
to baseline 
The three sets of derived contrast ratios are in good agreement, within the stated 
uncertainties. This indicates that the Monte Carlo code gives good prediction of contrast 
changes, though absolute contrast values are less reliable. This is due to the large number of 
factors affecting them, such as the film, processor and variations in X-ray generator 
performance. It can be seen from Tables 8.4 and 8.5 that the best agreement between 
measured and calculated values is for the first set of measurements (those carried out with 
0. lmm copper filtration) and that subsequent baseline measurements - made with identical 
technique settings - show a variation in contrast, with an overall increase observed over the 
period during which measurements were carried out. To assess the influence of changes in 
film or processing, the sensitometric curves for the various films were plotted , as shown in 
Figure 8.8, along with the date of measurement. 
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Figure 8.8 : Variation in sensitometric curve over time 
Although slight changes in the shape of the characteriatic curve are apparent, they are within 
the expected day to day variations. In addition, there is no link to the time of irradiation and 
processing, or to the contrast values obtained. The differences between the curves also occur 
mainly at film densities greater than those used for the contrast measurements made: In the 
light of these comments, film response was deduced to be an unlikely cause of the 
fluctuations in contrast on different dates. These were most likely caused by fluctuations in 
the X-ray generator operating characteristics. Although of interest, they do not affect the 
experimental results, as it was the comparative readings from the same day that were being 
used to validate the Monte Carlo results. 
8.2.2 Dosimetry measurements 
Entrance dose was calculated as the mean dose measured by the six TLD at the surface of 
the slab phantom. The mid-body dose was calculated as the average of doses from the six 
TLD placed at 2 cm depth and the six TLD placed at 3 cm depth, and this quantity was 
compared to Monte Carlo calculated values of absorbed energy as both give a more 
representative assessment of patient dose than a simple entrance dose value, although they 
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can not be expected to be numerically equal as mid body dose will only be a very rough 
approximation to absorbed dose throughout the body. Exit dose values were also measured, 
using six TLD at the exit surface of the phantom. For each filter, measurements were carried 
out at both 60 and 55 kV with mAs values of 400 (for no additional filtration) or 1000 (with 
additional filtration), and results were then normalised to conditions of equal background 
density as described in section 7.5. The normalised dose values are presented in Table 8.8. 
It should be noted that the results for different measurement sets (ie different rows of the 
table) do not necessarily relate numerically to one another, as two different dosemeters were 
used during the course of the study and calibration factors have not been applied to the 
results. The object of the measurements was to compare results for a given filter with the 
corresponding baseline measurement (made in the same day with the same dosemeter) ie 
numbers along a single row. 
baseline filter @ 60 kV filter @ 55 kV 
filter top mid exit top mid exit top mid exit 
0. l mm Cu 31.3 18.2 5.6 19.9 15.5 5.7 25.3 18.9 7.8 
0.2mm Cu 5.10 2.94 1.49 2.95 2.33 1.31 4.08 2.90 1.52 
0.1mm Er 5.16 3.17 1.42 3.42 2.55 1.54 4.18 2.73 1.57 
0.1mm Sm 5.43 2.99 1.42 5.03 3.32 1.64 5.73 3.60 1.82 
0.1mm Sn 5.09 3.17 1.45 4.81 2.93 1.51 6.49 3.41 1.47 
0.1mm Gd 3.84 2.21 1.14 2.26 1.61 0.79 3.42 2.21 1.09 
Table 8.8 : Measured relative dose values at different depths : all values have uncertainty ± 7% 
It can be seen from Table 8.8 that exit doses within each measurement set, ie along a single 
row, are very similar, as would be expected for conditions of equal background density. The 
more obvious differences are mirrored by differences in the background density of the test 
radiographs concerned, as given in Table 8.4 eg for 0.1 mm gadolinium filtration, the 
radiograph carried out at 60 kV had a background density of 0.98, compared to 1.03 at 
baseline. 
The results were compared with those predicted by the Monte Carlo calculations by looking 
at the ratios of each dose quantity with and without the additional filter. These values are 
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given in Table 8.9 for entrance dose, mid slab dose and absorbed energy. The uncertainty in 
each experimental dose ratio, to within 95% confidence limits is ±10%. The uncertainty in 
the predicted ratios are 2.8% for entrance dose and 0.1% for absorbed energy. 
@ 60kV @ 55kV 
filter experiment predicted experiment predicted 
ent. dose 
(±10%) 
mid dose 
(±10%) 
ent. dose 
(±2.8%) 
abs. en. 
(±0.1%) 
ent. dose 
(±10%) 
mid dose 
(±10%) 
ent. dose 
(±2.8%) 
abs. en. 
(±0.1%) 
0.1mm Cu 0.64 0.85 0.72 0.84 0.81 1.04 0.89 0.96 
0.2mm Cu 0.58 0.79 0.60 0.77 0.80 0.99 0.72 0.89 
0.1mm Er 0.66 0.80 0.73 0.82 0.81 0.86 0.77 0.93 
0.1 mm Sm 0.93 1.11 0.84 1.03 1.06 1.20 0.96 1.09 
0.1mm Sn 0.94 0.92 0.88 1.18 1.28 1.08 1.16 1.45 
0.1mm Gd 0.67 0.83 0.72 0.88 0.89 1.00 0.89 1.02 
Table 8.9 : Comparison of measured and predicted ratios of dose with and without filter 
It can be seen from the figures in the table that the measured and predicted dose ratios agree 
to within the quoted uncertainties in all but two of the twenty-four data pairs. There does not 
appear to be any bias in the results, as the observed dose ratios are sometimes greater and 
sometimes smaller than those predicted. The only discrepancies are for absorbed energy 
reduction with the tin filter, for which measured values are less than those predicted by 22% 
and 25% at 60 kV and 55 kV respectively. This is explained by the fact that the experimental 
measurements are for mid body dose (ie at a depth of 2 cm) rather than total energy absorbed 
in the body. For most of the beam spectra involved in the experiments, the ratio of two such 
depth doses (with and without the additional filter) is very close to the ratio of energy 
imparted, but with tin filtration the beam spectrum has a sharp peak just under 30 keV, and 
photons of this energy will be absorbed within a short distance in the phantom tissue, thus 
contributing to the absorbed energy (as calculated by Monte Carlo) but not to the measured 
mid-body dose. The experimentally determined dose values are thus less than those predicted. 
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8.2.3 Tube loading 
A comparison of predicted and measured tube loading, using the convention that this is 
proportional to the product of kV and mAs was initially made from consideration of the mAs 
values required for radiographs of equal background density. As the mA and exposure time 
settings on the X-ray set were shown to be inaccurate at the low levels used here (as 
discussed in section 7.5) relative output was also calculated from the ion chamber readings 
used for dose normalisation. Both derivations of tube load are given in Table 8.10, together 
with that predicted by the Monte Carlo calculations from a consideration of both the relative 
number of particle histories required for equal background density, and the tube voltage used 
in the simulations. 
relative tube load at 60 kV relative tube load at 55 kV 
filter 
from 
mAs 
from ion 
chamber 
from Monte 
Carlo 
from 
mAs 
from ion 
chamber 
from Monte 
Carlo 
0.1mm Cu 1.7 1.5 1.6 2.3 2.4 2.5 
0.2mm Cu 2.4 2.0 2.4 4.1 3.5 3.9 
0.1mm Er 2.7 2.2 2.2 4.1 3.2 3.4 
0.1mm Sm 2.8 2.4 2.2 3.9 3.0 3.1 
0.1mm Sn 4.7 3.4 2.9 6.5 5.1 4.7 
0.1mm Gd 3.0 1.7 2.0 4.1 2.9 2.9 
Table 8.10 : Comparison of measured and predicted tube loads. Uncertainties are ±10% for 
calculations for ion chamber readings and ±1% for Monte Carlo readings. 
Agreement between measured and predicted tube loads is good for those calculated from the 
ion chamber measurements, but more variable when considering the mAs values alone, as 
was expected due to the known mAs problem. Results are in better agreement at 60 kV than 
at 55 kV, which may be due to the more complex method of calculating the tube load for the 
lower tube voltage. At 60 kV, a simple ratio of the number of photon histories required for 
equal background density could be used to determine relative mAs. For simulations using a 
55 kV beam spectra, the relative number of photons produced for the two input spectra were 
calculated using the spectra generation program described earlier. The results for 0.1 mm tin 
154 
filtration show the greatest discrepancy between measured and predicted tube loads. although 
this is less than 10%. 
8.3 Hospital measurements using plain film radiography 
The second set of experimental measurements were carried out as described in section 7.6, 
using the neonatal anthropomorphic phantom and irradiating with a mobile X-ray set in a 
hospital radiology department. The measurements were designed to extrapolate the theoretical 
results to a clinical setting, and test the predicted effects of two specific filters (0.1 mm 
copper and 0.1 mm dysprosium) on dose and contrast. 
8.3.1 Dosimetry measurements 
Table 8.11 presents the measured values of entrance dose, absorbed dose to a selection of 
organs and effective dose calculated according to ICRP 60 for the three irradiation conditions; 
Baseline conditions of 60 kVp with no additional filtration, 56 kVp with O. Imm copper 
filtration added and 56 kVp with 0.1mm dysprosium added. For the baseline measurements, 
mAs was selected according to advice from the paediatric radiographer. With the additional 
filtration in place, values of mAs were selected to give films subjectively assessed to be of 
similar density to the original, again by the paediatric radiographer. Values of effective dose 
are the average of male and female values. 
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Dose (mGy) / Effective Dose (mSv) 
Baseline 0.1mm Cu @ 56 kV 0. lmm Dy @ 56 kV 
entrance dose 4.76 t 0.33 1.93 f 0.14 1.34 ± 0.09 
thyroid 3.01 t 0.90 1.10 f 0.33 0.97 ± 0.29 
lungs 1.47 t 0.21 0.86 f 0.12 0.68 ± 0.10 
stomach 2.25 t 0.32 1.23 f 0.17 0.98 ± 0.14 
kidneys 0.79 f 0.11 0.39 f 0.05 0.33 ± 0.05 
ovaries 1.28 t 0.28 0.63 f 0.14 0.53 ± 0.12 
testes 3.63 f 1.09 1.64 f 0.49 1.17 t 0.35 
breasts 3.95 f 0.55 1.56 t 0.22 1.28 t 0.18 
bone marrow 1.13 f 0.20 0.55 f 0.10 0.51 f 0.09 
skin 1.75±0.32 0.73±0.13 0.47 ±0.08 
colon 0.95-+0.13 0.43 f 0.06 0.40 f 0.06 
effective dose 
i 
1.95 ± 0.39 
I 
0.93 f 0.19 
I 
0.75 f 0.15 
i 
Table 8.11: Dosimetric measurements for the different irradiation conditions 
The results for the different organs are also presented graphically in Figure 8.3. 
Dose 
(mGy or mSv) 
location 
Figure 8.3 : Organ dose variation for different irradiation conditions 
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ED thy. lungs atom. kid. on. test. breast b. m. skin colon DE 
For the copper filter, it can be seen that entrance dose and doses to superficial organs, such 
as thyroid, breasts, testes and also the skin, are reduced by a factor of around 2.5. Dose to 
deeper organs, such as ovaries or kidneys, and dispersed organs such as bone marrow, is 
reduced by a factor closer to 2. For the dysprosium irradiation, entrance dose is reduced by 
a factor of 3.5, superficial organ dose by a factor of 3, and other organs by a factor of around 
2-2.5. Values of effective dose have been calculated for interest, and for comparison of the 
dose reduction obtained with the different filters for these particular irradiation conditions. 
They have not, however been used as a major parameter of interest for two reasons: 
" As discussed earlier, effective dose is not an appropriate risk estimator for children 
" Values of effective dose are highly dependant on the beam size and positioning 
which, for the measurements performed here did not correspond to those for any 
particular examination. Measurements would have to be performed for a variety of 
beam sizes and positions for values of relative effective dose to be used 
meaningfully. 
Dose reduction has instead been expressed for different types of organ, eg superficial organs 
within the beam area, superficial organs outside the beam area, small mid plane organs, 
dispersed organs etc to give a more general description of the effect of the additional 
filtration on dose. Greater dose reduction was observed for the dysprosium filter than for the 
copper filter. This may in part be explained by a consideration of the tube loads involved. 
For the copper filter, 12 mAs was used, a relative tube load of 1.9, and for the dysprosium 
filter 18 mAs, giving a relative tube load of 2.8 - each compared to radiographs without 
additional filtration at 60 kV and 6 mAs. The greater tube load would be expected to give 
greater dose reduction, as illustrated by the Monte Carlo results previously obtained. 
Background film densities were somewhat lighter for both additional filters, as mAs could 
only be set in discrete steps of 3 mAs. This biases the results toward lower doses, although 
this is a reflection of what would occur in clinical practice using this equipment. 
The results were compared to those predicted from the Monte Carlo calculations and, in the 
case of the copper filtration, those obtained from laboratory measurements using the slab 
phantom. The ratios of dose values with and without the filter are given for each case in 
Table 8.12. 
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dose reduction for Cu filter dose reduction for Dy filter 
phantom slab Monte Carlo phantom Monte Carlo 
entrance 
dose 
0.41 ± 0.04 0.81 t 0.08 0.89 ± 0.02 0.28 f 0.03 0.78 ±0.02 
absorbed 
energy 
- - 0.96 ±0.001 - 0.90 ±0.001 
mid slab 
dose 
- 1.04 f 0.10 - - - 
ovaries 0.49 ± 0.15 - - 0.41 f 0.13 - 
effective 
dose 
0.37 ± 0.10 - - 0.30 f 0.08 - 
Table 8.12 : Comparison of measured and predicted ratios of dose quantities with and without 
each filter for copper (Cu) and dysprosium (Dy) 
The differences between measured and predicted dose reduction appear large, but should be 
considered in the light of the constraints on technique factor selection that were mentioned 
above. The mAs values used for the experimental measurements were 6 for the baseline 
measurements, 12 for the copper measurements and 18 for the dysprosium measurements. 
These factors were selected to give the `best' images possible ie the best approximation to 
the background film density considered optimal by the paediatric radiographer. As the next 
selection either way was ±3 mAs, it is possible that the optimal background density might 
have hypothetically been obtainable at 5 mAs for the baseline radiograph and 13 mAs for the 
radiograph made with copper filtration. This slight change in mAs values would change the 
entrance dose ratio for the copper filter to 0.53 from 0.41 -a 30% difference. The 
discrepancies observed between measured and predicted dose ratios highlight one of the 
problems in many theoretical optimisation studies where parameters, such as background 
density are constrained in a way that exceeds normal clinical practice. Such theoretical studies 
may then considerably underestimate the dose reductions which may be obtained. This is 
particularly the case for examinations such as plain film radiography of infants, especially 
on older equipment, where there is often difficulty in obtaining low enough exposures, and 
a lighter film may well be preferred if obtainable. The range of acceptable density levels is 
highly operator dependant and will usually be fairly broad. 
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Other factors that gave rise to differences between the theoretical simulation results and those 
obtained in the experiment were differences between the simulated slab phantom and the 
anthropomorphic phantom used here and differences between the theoretical and experimental 
beam spectra. The latter arise from the different tube voltage used experimentally (56 kV was 
the closest option to the 55 kV simulated), and the lower tube filtration (2.5 mm Al compared 
to 3 mm Al). Each of these will tend to increase the dose reduction attainable through 
additional filtration, and so contributes to the lower experimental dose ratios observed in 
Table 8.12. 
8.3.2 Contrast measurements 
The radiographs taken of the neonatal phantom included almost the entire trunk, and film 
density readings were taken at a number of locations including the spine, pelvic bone, and 
soft tissue surrounding these areas. From these measurements two contrast specifications were 
calculated; lumbar vertabrae against surrounding tissue, and pelvic bone against surrounding 
tissue. These contrast values are given in Table 8.13 for the different irradiation 
conditions, with uncertainties derived according to values given in Table 8.3. 
Baseline 0.1mm Cu @ 56 kV 0.1mm Dy @ 56 
kV 
contrast of pelvis 0.17 f 0.05 0.21 ± 0.03 0.17 ± 0.02 
contrast of spine 0.47 ± 0.10 0.42 ± 0.04 0.33 ± 0.02 
bone/soft tissue 
contrast in lab 
0.48 ± 0.01 0.48 ± 0.01 - 
predicted bone/soft 
tissue contrast 
0.42 ± 0.01 0.44 ± 0.01 0.40 t 0.01 
Table 8.13 : Measured contrast from radiographs of anthropomorphic phantom 
For pelvic bone contrast, relative contrast values are the same as predicted, within 
experimental uncertainties, although the absolute values are lower. This corresponds to the 
smaller thickness of bone in the area of pelvis measured compared to that simulated. For the 
spine a slight loss of contrast was observed experimentally with the dysprosium filter, 
although this lies only just outside experimental uncertainties. Considering the differences in 
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phantom, X-ray spectra and relative background densities the agreement between theory and 
experiment is very good. 
8.4 Hospital measurements using fluoroscopy 
The second set of hospital measurements was carried out in the paediatric screening room, 
as described in section 7.6.2. Dosimetry results for irradiation of the neonatal phantom using 
five minutes fluoroscopy and a single spot film are presented in Table 8.14, which gives 
entrance dose, organ dose and effective dose values for irradiation with and without the 
copper filter. The technique factors used were 60 kV and 0.5 mA for fluoroscopy and 60 kV, 
150 mA for the spot films. The exposure times for the spot films were 8ms without the 
copper and 9ms with the copper filter in place. For these technique factors, the relative tube 
load with each filter is 1.001, as the slight increase in exposure time for the spot film is 
negligible compared to the fluoroscopy time. 
Dose (mGy) / Effective Dose (mSv) 
Baseline 0. lmm Cu @ 60 kV Dose ratio 
entrance dose 32.7 ± 2.3 17.6 ± 1.3 0.54 t 0.05 
thyroid 0.23 ± 0.06 0.12 ± 0.03 0.52 ± 0.21 
lungs 1.98 ± 0.50 0.74 f 0.19 0.34 ± 0.12 
stomach 6.30 ± 0.88 3.43 f 0.48 0.54 ± 0.04 
kidneys 20.60 t 2.88 12.00 f 1.68 0.58 ± 0.11 
ovaries 8.68 f 1.91 5.58 f 1.23 0.64 ± 0.20 
testes 0.47 f 0.14 0.29 f 0.09 0.62 ± 0.26 
breasts 0.35 f 0.05 0.20 t 0.03 0.57 ± 0.11 
bone marrow 2.89 f 0.52 1.5910.29 0.55 ± 0.14 
skin 4.26 t 0.77 3.40 ± 0.61 0.80 ± 0.20 
colon 7.53 f 1.05 5.08 ± 0.71 0.67 f 0.13 
effective dose 4.26 f 0.89 2.54 ± 0.53 0.60 ± 0.18 
DAP 211±2 207±2 0.98±0.03 
Table 8.14 : Dosimetry measurements for fluoroscopy of phantom 
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These results may be compared with those predicted from the Monte Carlo simulations which 
give entrance dose ratios of 0.74 ±0.02 and absorbed energy ratios of 0.83 ±0.02. These 
values are somewhat higher than those found experimentally. However, the simulated results 
were obtained for equal background density, with a relative tube load of 1.5 for irradiations 
performed with the copper, whereas the experimental results were performed at equal tube 
load. If the theoretical results are extrapolated to equal tube load (by dividing by 1.5) to 
correspond to the experimental conditions, dose ratios of 0.49 ±0.01 and 0.55 ± 3-10' are 
obtained for entrance dose and absorbed energy respectively. The measured and predicted 
entrance dose ratios would then be the same, to within the quoted uncertainties. The 
experimental absorbed dose ratios for mid-plane organs such as the stomach or ovaries would 
be close to that predicted theoretically for values of absorbed energy. 
Other points to be noted from Table 8.14 are, firstly, that the DAP values recorded during 
the experimental measurements are not significantly different from each other. This is as 
expected, as the additional filtration is situated further down the imaging chain than the DAP 
meter, and technique factors were not significantly changed for the measurements made with 
the copper filtration. It is also apparent that the dose to the lungs was reduced by a greater 
amount than the entrance dose, which would contradict theoretical analysis. However, the 
lungs cover a large area that was partially within and partially outside the direct beam. The 
uncertainties associated with this dose measurement are thus large, and the apparent 
discrepancy would arise from a small shift (around 0.5 cm) in the position of the beam. This 
could easily have occurred, as for fluoroscopy there is no light beam diaphragm to check 
beam position prior to irradiation, and the phantom had to be moved between measurements 
to change the TLD. 
Image contrast was assessed visually by the radiographer during fluoroscopy, and judged to 
be adequate without changing the exposure factors after addition of the copper filtration. 
Density measurements behind and beside the region of contrast on the spot films were used 
for objective assessment of contrast, and the values obtained are listed in Table 8.15 together 
with values predicted from Monte Carlo calculations. 
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experimental measurements predicted values 
contrast with aluminium only 0.25 ± 0.02 0.414 f 0.003 
contrast with copper filter 0.16 ± 0.02 0.417 t 0.004 
contrast ratio 0.64 ± 0.11 1.007 t 0.012 
Table 8.15 : Measured and predicted contrast for fluoroscopic examination 
Although the Monte Carlo predictions are for unchanged contrast with the copper filter in 
place, the experimental results show a reduced contrast for the latter case. This is due to the 
combined effect of the lower background density for the copper irradiation and the high 
contrast of the iodine and can be illustrated using Figure 8.4 which shows a typical film 
characteristic curve, plotting density against the log of the exposure to the film. 
Den 
Log (exposure) 
Figure 8.4 : Sensitometric curve showing how film 
contrast may be affected by the background 
exposure level 
If the three points on the graph P, Q and R represent three points on a film, the contrast 
between two sets of points (P, Q and Q, R) are given by the density differences between them 
(Cl and C2). If the exposure to the whole film is reduced by a constant factor, all the points 
will be shifted along the x-axis by a constant amount - as a multiplication of E corresponds 
to an addition to log(E). The new film densities at the 3 points will then be represented by 
P', Q' and R', and the new contrast values by Cl' and C2'. It can be seen that when both 
measurement points lie on the linear portion of the characteristic curve (eg P& Q), the film 
contrast is not affected by a change in exposure (Cl and C1' are approximately equal). 
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However, when one of the points lies in the low density `toe' region of the curve (eg Q) the 
lower exposure leads to a reduced contrast as in this region density varies only slightly with 
exposure (C2' is less than C2). For the experimental measurements here, the density behind 
the contrast media was measured as zero above fog level for irradiation with the copper filter, 
and so lies in this `toe' region of the characteristic curve. This results in the observed reduced 
contrast for the copper irradiation, for which the background film density was 0.133 f 0.023 
compared to the irradiation without the copper (background density 0.266 ± 0.023). 
Despite the numerical differences in measured contrast, the mass thickness of iodine used was 
great enough for differences between irradiations with and without copper to be subjectively 
undiscernible with the imaging equipment being used. This highlights two points: 
The clinically required contrast or information content is of more importance in an 
optimisation study than numerically equal contrast/information content. 
There is little gain in pursuing slight modifications in image quality using beam 
spectral shaping if the imaging performance is limited by the equipment itself. 
8.5 Conclusions from experimental verification 
The results from the laboratory irradiations of tissue equivalent slabs validate the Monte Carlo 
predictions of both dose and contrast variation for different combinations of tube voltage and 
tube filtration. Absolute values of film contrast are not so well predicted, though this is of 
less relevance to the comparative study being carried out. In particular, the predicted dose 
saving characteristics of additional copper filtration, with maintained contrast at reduced tube 
voltage, were reproducible experimentally. 
The measurements made in the hospital radiology department indicate that the predicted dose 
savings can be achieved in a clinical setting. Predictions of contrast changes are also shown 
to be valid under clinical conditions. Practical constraints, such as lack of flexibility in 
exposure settings may results in more variable dose savings than those predicted, and this is 
an important consideration when extrapolating theoretical results to a hospital environment. 
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The importance of the influence of other parts of the imaging chain ie image intensifier and 
camera, on achievable contrast and thus maximum dose savings was illustrated. The influence 
of a limited range of technique factor settings on the optimisation process was also 
highlighted. 
The benefit of additional copper filtration for fluoroscopic examination of infants was 
confirmed. 
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Chapter 9 
Clinical Trial of Additional Filtration 
9.1 Introduction 
The motivation for carrying out the investigation into the use of additional tube filtration was 
to find ways of improving dose optimisation in clinical practice. It was therefore important 
to consider the implementation of any suggested improved filtration combination in a clinical 
setting, to assess its practicality on a routine basis and assess changes in dose and image 
quality for a cohort of patients. The results obtained theoretically, and from experimental 
measurements would be of little practical value if they did not lead to benefit for the 
patients. 
As fluoroscopic procedures account for higher doses than simple film screen examinations, 
a paediatric screening room was selected for the clinical trial. This was the same room in 
which experimental measurements had been undertaken, so the anticipated benefit to the 
patient had been well established (Chapter 8). Filtration of 0.1 mm copper was used for the 
trial as it had been shown to give the greatest dose saving, while maintaining contrast, for 
the patient sizes and tube potential range studied. Copper is also a relatively inexpensive 
material and is non-toxic - an important consideration for an impermanent filter, particularly 
in a children's room. 
The practicalities of using additional filtration and the design of the trial are described 
below, followed by details of the techniques used for assessing the impact of the filter on 
both dose and image quality. The preliminary results of the trial are then described, 
including discussion of the practicalities of the filter's use. Discussion of the implications 
and conclusions drawn from the trial are presented at the end of the chapter. 
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9.2 Use of filter 
A Shimadzu HDISOB-30 X-ray set was used for the trial. This had a sealed undercouch 
tube which was inaccessible without engineering intervention. Constraints within the 
department meant that the room was regularly used for a range of adult fluoroscopic work 
in addition to paediatric fluoroscopy. For these reasons, additional filtration could neither be 
attached and removed by radiographic staff as required, nor permanently installed. A solution 
to this practical problem was to use a large area sheet of copper, placed directly beneath the 
patient. The 0.1 mm thick copper sheet used for experimental measurements in the room was 
laminated with a double layer of plastic for protection and used as a removable filter in this 
way. 
9.2.1 Simulation of trial geometry 
The geometrical configuration used in the trial was slightly different from that used in the 
Monte Carlo simulations described earlier, in Chapter 5, as the original geometry simulated 
overcouch irradiation with additional filtration attached to the tube head. A small number 
of further simulations were carried out to confirm that the results were not significantly 
affected by the change in geometry. The new simulation geometry is shown in Figure 9.1. 
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x-ray tube 
ý- table 
filter(s) 
patient 
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Image 
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Figure 9.1 : Geometry used in Monte Carlo simulations 
of clinical trial. 
In this geometry, the additional filtration is in direct contact with the entrance surface of the 
patient phantom, with an air gap between the phantom and image receptor, to simulate 
undercouch fluoroscopy of an infant lying on a sheet of filtration. The phantom used in the 
simulations was 1 cm iodine in 5 cm soft tissue and the tube voltage was 60 kV. The 
following additional filters were simulated. 
" no additional filtration (3 mm aluminium only) 
" 0.1 mm copper 
" 0.1 mm copper + 0.1 mm aluminium. 
The last of these was included to investigate whether additional aluminium filtration was 
required after the copper to absorb low energy K-fluorescence, as has been suggested 
(Jennings, 1988). 
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The results from these simulations are summarised in Table 9.1 where the ratios of each 
calculated quantity for simulations with and without additional filtration are presented. The 
results obtained for the original simulation geometry are also included for comparison. 
original geometry 
(0.1 mm Cu) 
trial geometry 
(0.1 mm Cu) 
trial geometry 
(0.1mm Cu +0.1mm Al) 
Entrance dose ratio 0.69 0.74 0.74 
Absorbed dose ratio 0.80 0.84 0.84 
Contrast ratio 0.99 0.99 1.00 
Table 9.1 : Results of Monte Carlo simulations of trial geometry: Ratios of dose and contrast (with 
additional filtration / without additional filtration). 
The results show that the use of extra aluminium beyind the copper filter is not required, as 
it makes no difference to the entrance dose to the patient. The K-fluorescence from copper 
is of such a low energy (8.98 keV) that it is almost totally absorbed in the filter. In practice, 
there is also a thin layer of plastic coating and the patient clothing present to attenuate the 
extreme low energy end of the filtered spectrum. The copper sheet was thus used without 
the additional aluminium sheet throughout the trial. The results for the trial geometry show 
a small loss in dose reduction, compared to those obtained for the original geometry. This 
is due to the additional filtration of the couch on which the patient is lying as this `hardens' 
the reference beam, and makes the effect of additional filtration slightly less pronounced. 
The benefit to the patient from the increased filtration, however, is still apparent. 
9.3 Design of the Trial 
The aims of the clinical trial were as follows: 
0 to assess the change in radiation dose to patients resulting from use of a 0.1 mm 
copper filter 
" to assess the effect of the filter on image quality 
0 to assess the practicality and acceptibility of routine use of the filter. 
Ethical approval for the trial was obtained from Newcastle and North Tyneside Health 
Authority and formal consent from the chief executive of the Royal Victoria Infirmary, 
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where the measurements were to be carried out, was also obtained. The parental information 
and consent forms that were designed and used are given in Appendix D. 
Participants in the trial were infants from birth up to the age of 1 year, presenting for any 
type of fluoroscopic procedure. This age range was selected for the following reasons: 
0 simulation and experimental verification was carried out for neonatal sizes and, 
while results may be easily extrapolated to slightly larger patients, they cannot be 
assumed to apply to all paediatric age ranges. 
0 the size of the copper sheet (50 X 50 cm) limited the range of patient sizes that 
could be positioned accurately on the filter, particularly as young patients are 
frequently difficult to immobilise. 
All children who were within the defined age band were included in the study, provided that 
parental consent was obtained. This excluded some in-patients whose parents were not 
available to give consent prior to the examination. Dosimetry data had been routinely 
collected in the room for several years, so this data was available for making comparisons 
of doses with and without the filter in place. A `control' group of patients was thus 
established, comprising all children in the specified age-group who underwent radiological 
examination in the room during the 6 months preceeding the trial. Infants excluded from the 
trial solely due to lack of parental consent were also included in this control group. The full 
trial was designed to include measurements on 100 patients. 
The following procedure was used for examinations with the filter: 
0 The purpose and nature of the trial were explained to the parents of the child by the 
radiographer, and they were given the patient information sheet and consent form 
to sign for the child's inclusion in the trial. 
0 Prior to commencing the examination, the copper filter was placed beneath the child. 
0 The examination was performed in exactly the same way as usual. Fluoroscopic 
technique factors were selected manually, according to normal practice. Any spot 
films required were taken using automatic exposure control - also according to 
normal practice. 
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" Dosimetry data was collected in the routine manner, as described in section 3.3 
using a laptop computer connected to a DAP meter. A note regarding use of the 
copper was entered in the comments field during data entry for the examination. 
" In the unlikely event of any overcouch radiographs being required (using the ceiling 
tube) the radiographer was instructed to remove the copper filter prior to taking the 
radiograph. 
" The filter was to be removed immediately if, at any time during the examination, 
any dissatisfaction was felt by radiologist, radiographer, or adult accompanying the 
child, regarding image quality, patient comfort or ease of use. 
" Any observations or remarks pertaining to use of the copper for the examination 
were written on the consent form. The forms were then all retained for future 
reference. 
The dosimetry data obtained with the filter in place was compared with data obtained for 
patients in the control group. Spot films from closely matched patients, examined with and 
without the filter were used in a blind trial of image quality. 
9.4 Dosimetry 
Routine dose-area product measurements were already made on the fluoroscopic X-ray set 
used in the trial, with data logged on a laptop computer as described in Chapter 3. This 
practice continued throughout the trial of the copper filter. As the DAP meter was fixed to 
the tube head, below the additional filtration on which patients were lying, the presence of 
the filter would not be expected to affect the recorded DAP values, unless its use required 
changes in technique factors (kV and mA) from the values which would otherwise have been 
set. The DAP value at the patient entrance surface, however, will change as the filter 
attenuates the x-ray beam. The ratio of entrance doses with and without the x-ray beam is 
given by 
ESDfýtr 
f, x 
DAPfdr 
ESD0 DAP0 
where ESDf, t and ESD0 are the entrance surface dose values with and without the filter in 
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place respectively, and DAPf, t and DAP0 are the corresponding values for recorded dose-area 
product values. The factor f incorporates the dose reduction arising directly from the 
attenuation of the copper filter, and the DAP ratio incorporates any effects from changes in 
technique factors (tube voltage, tube current or exposure/screening time). The equation 
assumes that field size remains constant, which is valid when considering the same 
examination performed with and without the filter. 
The factor f was determined from the experimental measurements described in Chapter 8, 
and was taken to be 0.5 (Table 8.14). This factor is strictly valid only for the tube potential 
used during the measurement (60 kV both with and without the additional filter), as a change 
in tube voltage would change the attenuation of the copper. The magnitude of this effect is 
small, as the simulation results showed that the absorbed energy with the copper filter 
relative to reference conditions was the same at 70 kV as at 60 kV. 
To describe the patient dose more completely, the measurements made with the 
anthropomorphic phantom were also employed to derive normalised organ dose factors, both 
with and without the copper filter present. These factors are calculated from the results 
presented in Table 8.14, and have been assessed for different groups of organs ie superficial 
organs inside and outside the beam area, deep organs inside and outside the beam area, large 
organs partially within the beam area, and dispersed organs (such as red bone marrow) 
located throughout the body. These normalised organ dose factors are listed in Table 9.2. 
Dose factors for specific named organs were not derived individually, as these depend 
crucially on beam size and position, and hence on the type and complexity of examination 
being performed. The more general dose factors allow assessment of patient dose under a 
wider range of examination conditions. 
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organ dose /entrance surface dose (mSv mGy-') 
Organ Type without added filtration with 0.1mm copper 
I superficial organ within beam 0.6 0.7 
II deep organ within beam 0.2 0.3 
III organs outside beam 0.01 0.01 
IV partially irradiated organ 0.05-0.2 0.05-0.2 
V dispersed organ 0.1 0.1 
Table 9.2 : Organ dose conversion factors 
The use of these general organ dose coefficients has been compared with the use of effective 
dose coefficients derived from individual organ doses calculated using Monte Carlo 
techniques (Hart et al, 1996). Table 9.3 lists the organs included in the calculation of 
effective dose, and the category into which each falls (using the classification system 
described above) for urinary bladder examination, AP projection - using the field size and 
position described by Hart et al (1996). The organ factors given in Table 9.2 have then been 
used to derive effective dose factors both with and without additiional copper filtration for 
comparison with those published. It can be seen that the effective dose values calculated 
from the categorised organ dose factors used here are within 30% of values calculated from 
individual organ dose calculations. These published effective dose values have compared to 
previous factors published in Germany and are quoted as showing reasonable agreement to 
within 30% (Hart et al, 1996), with differences being ascribed to differences in organ 
positioning in the different phantoms. The fact that the discrepancies between alternative 
conventional calculations of effective dose conversion factors are similar to those between 
the conventional method and the organ categorisation used here, justifies the use of the latter 
method of dose assessment. It also corroborates the view that the use of the effective dose 
concept is inappropriate in paediatric radiology. 
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Organ category 
inar bladd ( 
organ dose factors (from Table 9.2) mSv mGy-' 
ur y er 
AP) 60 kV, 3mm Al 60 kV, 3mm Al + 0.1mm Cu 
lungs III 0.01 0.01 
stomach III 0.01 0.01 
liver III 0.01 0.01 
oesophagus III 0.01 0.01 
bone marrow V 0.10 0.10 
skin V 0.10 0.10 
gonads (M/F) I/II 0.6/0.2 0.7/0.3 
colon II 0.20 0.30 
bladder II 0.20 0.30 
thyroid III 0.01 0.01 
breast III 0.01 0.01 
bone V 0.10 0.10 
adrenals III 0.01 0.01 
brain III 0.01 0.01 
u. large 
intestine 
IV 0.15 0.15 
sm. intestine II 0.20 0.30 
kidney III 0.01 0.01 
muscle V 0.10 0.10 
pancreas III 0.01 0.01 
spleen III 0.01 0.01 
thymus III 0.01 0.01 
uterus II 0.20 0.30 
remainder total 0.71 0.91 
Effective Dose 
factor 
0.14 0.17 
Effective Dose 
factor 
(Hart et al) 
0.21 0.24 
Table 9.3 : Comparison of effective dose factors derived using the analysis given here with 
published data (Hart et al, 1996) 
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9.5 Assessment of Image Quality 
The quality of images obtained during the trial, both on the screen and 100mm spot films 
was assessed continually in terms of clinical acceptability, by the radiologists and 
radiographers working in the room. Any comments regarding the quality of the images were 
noted on the relevant consent form and staff were instructed to remove the filter if there was 
any doubt concerning the acceptibility of the images. A more formal assessment of image 
quality was also performed, using some of the 100mm spot films obtained. Comparison of 
films obtained with and without the filter present required careful selection of pairs of 
patients matching one another as closely as possible. The following criteria were used for 
matching patients, in priority order: 
(1) examination type 
(2) similar weight 
(3) radiologist performing the examination 
It would have been more desirable to match both weight and equivalent diameter, but little 
height information was collected for the infants examined in this room, due to practical 
difficulties, so values of equivalent diameter were not always available. 
A total of nine pairs of patient examinations were identified, and the appropriate spot films 
retrieved from the patient files. All spot films taken in the department are stored by 
laminating those for each examination in a single sheet, so the entire set of films was used 
for the image quality assessment in each case. The patient information was masked and each 
sheet of films labelled, with those taken with and without the filter randomly assigned either 
A or B. A simple questionnaire was drawn up, asking the following questions for each pair 
of image sets: 
(1) Which set of images do you prefer 
(strongly A, slightly A, no preference, slightly B, strongly B) ? 
(2) Are the images of satisfactory diagnostic quality (neither, A only, B only, both) ? 
A copy of the questionnaire is given in Appendix D. It was completed by five members of 
staff (two paediatric radiographers, two paediatric radiologists and one physicist) and the 
results analysed. The radiographers and radiologists work routinely in the trial department 
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and the physicist is responsible for intensifier QA in the region but had no direct involvment 
in either the department or the project. 
9.6 Results 
Analysis of the results has been carried out, for a total of 34 patients examined during the 
first 5 months of the trial. The details of this patient group are given below in Table 9.4. 
Examination Type Num of patients Mean age (months) Mean weight (kg) 
Barium meal 1 1 4.00 
Barium meal & swallow 5 5 3.27 
Barium Swallow 3 4 5.46 
Cystogram 18 5 6.25 
Cystometrogram 2 5 6.50 
Intussuception air reduction 1 4 7.60 
Loopogram 3 4 1.95 
Water soluble swallow 1 12 7.30 
Table 9.4 : Patients examined with copper filter 
Details of the control group of patients ie those in the same age range undergoing 
fluoroscopic examination within the previous six months without use of the copper filter, are 
given in Table 9.5. The mean age and weights for each group have been presented in the 
tables to aid the interpretation of the dosimetry results. 
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Examination Type Num of patients Mean age (months) Mean weight (kg) 
Barium meal 18 8 6.81 
Barium meal & swallow 30 8 . 
6.78 
Barium Swallow 3 6 9.71 
Cystogram 93 7 7.03 
Cystometrogram 7 6 9.74 
Intussuception air reduction 2 5 8.17 
Loopogram 9 8 7.91 
Water soluble swallow 2 2 3.95 
Table 9.5 : Control group of patients 
9.6.1 Dosimetry Results 
The results of the routine dose assessments have been analysed by grouping them according 
to the various examination types listed in Tables 9.4 and 9.5. Values of mean DAP, 
screening time, and DAP normalised to unit screening time are presented in Table 9.6 below. 
Results with copper filter Results from control group 
Exam. 
DAP 
(mGycm Z) 
scr. time 
(s) 
DAP/ 
time 
DAP 
(mGycm 2) 
scr. time 
(s) 
DAP 
/time 
Ba. M. 598.5 240 2.49 680.0 135 5.64 
Ba. M. &S. 609.2 176 3.37 678.7 125 7.29 
Ba. S. 951.7 136 7.10 590.7 130 4.12 
Cyst. 209.5 56 4.86 414.4 91 6.23 
Cystomet. 155.5 87 1.77 197.6 96 3.35 
Intus. 598.5 120 4.99 1360.1 210 5.44 
Loop. 342.4 140 2.86 354.7 131 2.84 
WS. S. 514.8 24 21.45 624.1 150 3.47 
Table 9.6 : Dosimetry results from clinical trial 
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For most categories of examination, numbers of patients are too small to claim any statistical 
significance in the results. However, it can be seen from Table 9.6 that both DAP and 
normalised DAP values are mostly lower for examinations performed with the filter than for 
those without. The only examination for which the DAP is higher with the copper is barium 
swallow for which there are only 3 patients in each group. Normalised DAP is also higher 
for water soluble swallow, for which the single examination performed with copper was 
carried out with a very short screening time. The results indicate that use of the filter did not 
result in greatly increased technique factors. Screening times are also similar or lower with 
the filter in place. 
For the cystogram examination the number of patients included in the trial was sufficient for 
statistical tests to be performed to investigate whether the normalised DAP results are 
significantly different when using the copper filter ie to demonstrate that the sample of DAP 
values for cystograms performed with the copper filter is taken from the same distribution 
as the sample of DAP values for cystograms performed without the filter. The common tests 
of significance apply only to normal distributions, whereas the normalised DAP distribution 
is skewed with a high dose tail, as shown in Figure 9.2 (i). However, it forms what is known 
as a log normal distribution as the log(DAP) values can be shown to be approximately 
normal, as illustrated in Figure 9.2 (ii) for both the trial and the control group data. 
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Figure 9.2 : Distribution of (i) DAP and (ii) log(DAP) for cystograms in the trial and control 
groups of patients 
The usual method of demonstrating that two sample distributions are taken from the same 
population is to set the null hypothesis that there is no difference between the two estimates 
of the population mean, fe between the two sample means. As the two samples are 
reasonably large, the two sample z test may be used. The test statistic z is computed as the 
difference between the means divided by the standard error of the difference. 
z= 
(xl - x2) 
Sli 2 
+S2 
N nl n2 
x, and x2 are the means of the log(DAP) samples, s1 and s2 the standard deviation of the 
samples and n, and n2 the number of measurements in the sample. Under the null hypothesis, 
z is distributed approximately as a Normal distribution with mean zero and standard 
deviation 1. For the log(DAP) data presented here, the parameter values are: 
trial group x, = 0.599 s, = 0.259 n, = 18 
control group x2 = 0.652 s2 = 0.365 n2 = 93 
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which gives z=0.726. The corresponding p value is 0.465. This is the probability of 
obtaining the given difference in means if the null hypothesis was true. Common practice 
is to require p<0.05 in order to reject the null hypothesis. The large value of p leads to the 
conclusion that there is no significant difference between the two sample means, and DAP 
values (as measured at the tube head) are not significantly different with the copper filter in 
place than without the filter. 
If then it is assumed that DAP values are not affected by use of the filter, the patient dose 
saving may be derived directly from the conversion factors listed earlier in Table 9.2. These 
show an entrance surface dose reduction of 0.5 and reduction of 0.6 and 0.75 for superficial 
and deep organs respectively within the beam area. This represents a large dose saving to 
the patient. The reduction in the associated risk to the patient will depend on the size and 
positioning of the beam, and the weighting factors used for organ radiosensitivity. Using the 
above factors would lead to a reduction in radiation risk of at least 25%. 
9.6.2 Assessment of Image Quality 
Throughout the trial, there were no adverse comments made on the standard of image 
quality, and at no time was it felt necessary to remove the filter in order to proceed with an 
examination. The results of the subjective assessment of image quality are summarised in 
Table 9.7 below. 
number of image 
number of times each preference specified sets of diagnostic 
quality 
strongly slightly no slightly strongly with without 
with Cu with Cu preference without without Cu Cu 
Cu Cu 
radiologists 1 1 9 7 0 18 18 
radiographers 1 6 3 8 0 18 16 
physicist 1 0 3 5 0 - - 
total 3 7 15 20 0 36 34 
Table 9.7 : Results of image quality assessment 
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From the Table it may be seen that, although the images taken without the copper came out 
as being `slightly preferred' in the majority of cases, none were `strongly preferred' and, 
more importantly, none of them were considered diagnostically unacceptable. 
Of the comments made on the image sets, one of the radiographers noted that the edge of 
the copper could be seen on two of the film sheets, where the filter had slipped relative to 
the patient during the examination. It was also noted that two of the image sets were 
overexposed - one to the extent of being of unacceptable diagnostic quality to both 
radiographers. Both of these overexposed sets were from examinations performed without 
the copper. Interestingly, the `unacceptable' set of images was actually preferred by one of 
the radiologists. 
The results of the questionnaire, along with the experience of staff throughout the trial 
demonstrated that, with respect to its effect on image quality, the filter would be acceptable 
for use on a routine basis. 
9.7 Practical Considerations 
An important factor in determining whether the filter would be suitable for routine use in 
the paediatric fluoroscopy room, was whether any practical difficulties were experienced 
during the trial. Discussion with the staff involved yielded the following points: 
0 The time taken in placing the filter prior to the examination did not cause any 
disruption to work in the room. 
0 After 6 months use, there was no significant physical deterioration of the filter from 
handling, contamination or any other cause. 
0 There had been no indication that use of the filter caused any discomfort to the 
patient. 
" The size of the filter (50 x 50 cm) meant that some difficulty was experienced in 
keeping some of the children, particularly the larger patients, over it throughout the 
entire examination. 
The final point listed here was the only negative feature to emerge from the trial. To assess 
whether the possible slippage of the copper during an examination was a serious enough 
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drawback to restrict its routine use, required consideration of the consequences involved. As 
automatic exposure control is not used during fluoroscopy, there was no danger that a 
sudden loss of the copper filtration could cause changes in exposure factors that might have 
an adverse effect on either dose or image quality. If tube voltage or current were habitually 
being set higher when performing an examination with the copper, the unexpected removal 
of the copper from the field could cause overexposure to the patient. As, however, technique 
factors were not significantly changed as a result of the trial, this would not be a problem. 
Thus, inadvertent movement of the filter would negate the dose reduction anticipated but 
would not increase the patient dose. At worst it might be expected to provide a slight 
distraction to the staff viewing the image on the screen, but no adverse comments were made 
to this effect. A larger sheet of copper would ease these positioning problems, but would be 
more cumbersome to handle, besides being difficult to obtain and prepare for use. 
From a practical point of view, the filter was thus judged to be acceptable for use with 
infants within the age range of the trial patients. It was felt though that, as expected, the 
filter would not be suitable for use with older children. Even if they could be immobilised 
sufficiently over the copper sheet, the usual practice during cystograms of taking post- 
micturition exposures erect for children old enough to stand would require procedural 
changes to prevent the filter from falling. 
9.8 Discussions and conclusions 
One important consideration that has been highlighted during the trial is the issue of 
acceptable versus best image quality. This has been discussed theoretically in Chapter 4, and 
the results of the image quality assessment carried out as part of this clinical trial confirm 
that a much greater dose reduction may be achieved when considering acceptability rather 
than equality of images. This was evidenced by the difference between the theoretical change 
in dose with use of the filter (26% reduction in entrance dose), which was based on constant 
energy absorption in the phosphor, and that achieved in practice, which was considerably 
larger (50% reduction in entrance dose). It has also been shown that, for subjective 
assessment of images, the decision on what constitutes best may be very dependant on the 
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viewer, thus indicating that considerable latitude in image parameters may be permissable 
in many circumstances. 
In conclusion, the clinical trial of a 0.1 mm copper filter for use in fluoroscopy examinations 
of infants has been successfully initiated in a paediatric fluorocopy room in a large general 
hospital. The practical difficulties of -attaching an additional filter to a non-dedicated 
undercouch tube were successfully addressed by lying the infants on a copper sheet. 
The results obtained during the clinical trial have been influenced to a marked degree by the 
manual control of technique factors that was employed by the radiographic staff. If an AEC 
device were used, it would almost certainly increase the exposure factors used with the 
copper in place, to maintain the brightness at the phosphor. This would result in higher DAP 
values for examinations performed with the filter and thus reduce the dose saving provided. 
However, the DAP values would need to increase by as much as 30% in order to obscure 
the absorbed dose reduction, and by a factor of 2 before the entrance dose reduction is no 
longer observed. In practice, general AEC performance is so poor for children, as discussed 
in Chapter 4, that its use is uncommon for paediatric fluoroscopy examinations. 
The initial results of the trial showed that the filter was found to give substantial reductions 
in patient dose. Entrance surface doses were reduced by 50%, superficial organ doses by 
40% and deep organ doses by 25%. The reduction in risk was more variable, depending on 
the specifics of each individual examination, but was estimated to be in the order of at least 
25%. 
Use of the filter did not significantly affect image quality, and made no impact on the 
diagnostic results of the examination. The only practical difficulty experienced lay in keeping 
some of the older children over the filter throughout the examination, but this was not felt 
to be a insuperable problem. These results lead to the conclusion that the copper filter would 
be suitable for routine use during fluoroscopic examination of infants in the paediatric 
screening room. 
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Chapter 10 
Application to Other Patient Categories and 
Suggestions for Further Work 
10.1 Introduction 
The preceeding chapters have presented an optimisation strategy for paediatric radiology, 
comprising dosimetry techniques, theoretical simulations, experimental verification and 
clinical implementation. This strategy has been applied in detail to the optimisation of 
radiation dose for neonates for both bone radiography and fluoroscopic examination using 
iodine or barium contrast agents. Theoretical simulations were performed for a wide range 
of filter materials and thicknesses, and the effect of changes in tube voltage, varying screen 
phosphor and the use of replacement or additional filtration were studied. Results have been 
analysed in terms of beam spectra, and the findings verified experimentally. 
In this chapter, the applicability of the optimisation strategy to other situations will be 
considered, in the light of the results already obtained. In particular, the effect of variations 
in patient size will be addressed, as this is a fundamental issue in paediatric radiology, and 
also the effect of different tissue types. Each of these will be discussed in terms of the beam 
spectra and the transmission properties of the phantom, in a similar way to the analysis 
presented in Chapter 6. This enables some general predictions to be made regarding the effect 
of size and tissue type on results. The results of a small number of further Monte Carlo 
simulations, for a range of sizes and two pairs of contrasting tissues, were used to test these 
predictions, and these are also presented. There were two reasons for carrying out such 
simulations: 
0 to make a preliminary assessment of how the results may be extended to other age 
groups and tissue types 
" to identify the most promising areas for further study 
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At the end of the chapter, suggestions for the focus of further work are given, both for Monte 
Carlo study and experimental verification. Suggestions are also made for advancing some of 
the general concepts utilised in paediatric dose optimisation. 
The specific phantom sizes and compositions considered for application of the techniques 
were: 
9 bone detail in 10 cm soft tissue 
0 iodine in 10 cm soft tissue 
0 barium in 15 cm soft tissue 
0 lung detail in 5 cm soft tissue 
0 bone detail in 5 cm lung tissue. 
The first of these represents bone radiography on a child of around 1 year of age, and the 
contrast media studies represent a water soluble contrast examination, also on a1 year old, 
and a barium examination on a child of around 5 years. The selection of examination types 
covers a range of examination categories and includes examinations that are frequently 
performed for the relevant age group. The last two phantom specifications in the list above 
involve lung tissue, firstly as contrast tissue then as background, as this is the only major 
tissue type (affecting radiological examination) that has not been incorporated into the initial 
optimisation study. The effect of lung tissue in the phantom has important implications for 
the optimisation of radiographic examination of the chest. 
The uncertainties for values calculated in the Monte Carlo simulations are given in 
Table 10.1. They have been derived according to equation 5.1, as before. 
abs. energy ent. dose bkgd contrast 
bone in 10cm soft tissue ±0.04% ±2.4% ±0.2% ±10-20% 
iodine in 10cm soft tissue ±0.11% ±6.0% ±0.4% ±6-10% 
barium in 15cm soft tissue ±0.09% ±4.5% ±0.4% ±14-27% 
bone in 5cm lung ±0.04% ±8.2% ±0.2% ±1-3% 
lung in 5cm soft tissue ±0.19% ±4.9% ±0.3% ±9-25% 
Table 10.1 : Uncertainties in Monte Carlo calculations 
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The results of the simulations are presented in a similar format to that used previously 
(Chapter 6), with trends in dose and contrast plotted against tube load for different filter 
materials, for comparison with the trends predicted from a consideration of the beam spectra. 
10.2 Effect of patient size on optimisation study 
Paediatric patients have sizes ranging from that of a premature neonate to that of a young 
adult, and the effects of beam filtration on contrast and the dose to a patient of a particular 
size cannot simply be extrapolated to a different size. The size of the patient's body will 
affect the amount of energy absorbed in it, and since it filters the beam spectrum it also 
affects the contrast achievable. Tube voltage will also need to increase with increasing patient 
size, to achieve the necessary exposure level at the image receptor. 
10.2.1 Dose 
The effect of varying patient thickness on absorbed dose can be considered in terms of the 
absorption spectra of different phantom thicknesses. Figure 10.1, shows absorption spectra 
for the 5 cm phantom at 60 kV and for the 10 cm and 15 cm phantoms at 70 kV. 
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Figure 10.1 : Absorption spectra in different size phantoms 
It is apparent from the Figure that there is only a slight change in the normalised beam 
spectra for the different sized phantoms, with the absorption peak shifting to higher energies 
185 
with increasing size. The effect of filtration on dose to the larger phantoms may be predicted 
from consideration of the filtered 70 kV beam spectra, and those for several different filters 
are given in Figure 10.2. 
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Figure 10.2 Spectra for 60 kV and 70 kV beams filtered by (i) copper (ii) erbium (iii) tin and 
(iv) samarium : reference spectrum 70 kV, 3 mm aluminium 
Analysis of the earlier results for the 5 cm phantom (Chapter 6) demonstrated that the K-edge 
of tin coincided with the absorption peak in the phantom and resulted in increased dose with 
tin filtration. The shift in absorption peak energy with phantom size (Figure 10.2ii) actually 
crosses over the tin K-edge, so that the adverse dose effects of tin can be expected to 
decrease for thicker phantoms. For other filters, where the K-edge lies towards the edge of 
the absorption peak, previous results showed that the dose reduction properties of filters 
depended critically on the mean beam energy (Section 6.2.3). Figure 10.2 shows that, at 
70 kV, K-edge filters such as erbium attenuate a greater proportion of the high energy part 
of the spectrum than at 60 kV, as the K-energy is further below the maximum beam energy. 
For this reason, the mean beam energy of the K-edge filtered beams will be relatively lower, 
compared to a copper filtered beam, than at 60 kV and the relative absorbed dose reduction 
obtained with copper could be expected to increase. This effect of raising the tube voltage 
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is likely to be more significant to the behaviour of the K-edge filters than the change in 
phantom thickness itself, since the change in beam spectra (Figure 10.2) is greater than the 
change in phantom absorption spectra (Figure 10.1). Dose variation can be expected to be 
independent of the composition of the contrast detail simulated, and the independence of dose 
reduction with image receptor that was shown earlier in Section 6.2.4 is likely to hold. 
To test these predictions, Monte Carlo simulations were carried out for 1 cm bone in 10 cm 
soft tissue with 6 different filter materials, and the variation in each dose quantity with tube 
load is shown in Figure 10.3. The data points and error bars are included on the graph. The 
error bars for absorbed energy values are of the same magnitude as the data points 
themselves. Simulations were also carried out for 10 cm tissue with iodine contrast and 15 
cm tissue with barium contrast, each with a caesium iodide detector. These results are given 
in Figures 10.4 andl0.5. 
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The variation of both dose quantities in the 10 cm phantom is very similar for the simulations 
of both bone (Figure 10.3) and iodine (Figures 10.4 and 10.5), as was predicted above. Dose 
variation for the 15 cm phantom is also very similar to that of the 10 cm phantom. The main 
difference is that both of the curves for tin (ie entrance dose and absorbed dose variation) 
show a greater rate of decrease for the larger phantom, sufficient to shift their position 
relative to the other curves. Out of the filter materials simulated, copper exhibits the greatest 
amount of dose reduction, for both phantom thicknesses. Samarium shows increasing dose 
with tube load and gadolinium and terbium give fairly flat curves. 
When dose results are compared to those presented in chapter 6 for the 5 cm phantom 
(Figure 6.3) several differences are apparent for the two larger sizes: 
" Tin shows increasing dose reduction with increasing phantom thickness 
" Samarium shows increasing dose with tube load instead of the virtually flat curve 
exhibited previously for the 5 cm phantom 
0 the curves for gadolinium and terbium show little change in dose with tube load 
" the remaining K-edge materials also exhibit slightly less dose reduction compared to 
that for the 5cm phantom, although the curves for copper and aluminium are very 
similar. 
To illustrate the trends itemised above, the Z-dependance for relative absorbed energy is 
shown in figure 10.6 for the three different phantom sizes. All data are for a tube load of 1.5, 
relative to the appropriate reference conditions (60 kV, 3 mm Al for the 5 cm phantom and 
70 kV, 3 mm Al for the 10 cm and 15 cm phantoms). 
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Figure 10.6 :Z dependence of relative absorbed energy for different phantom sizes 
As predicted above, the benefit of copper over K-edge filters increases with phantom 
thickness. The properties of the tin filter are most effected by the phantom change, as 
predicted from the position of the K-edge. It is interesting to note that for the K-edge filters 
curves are virtually identical for the two larger phantom sizes. Both of these sets of 
simulations were carried out at the 70 kV. The dose reduction properties of the K-edge filters 
are significantly greater for the 5cm phantom originally studied, using a 60 kV beam. 
However, the copper has a greater effect on dose at the higher kV. This confirms that for the 
K-edge materials in particular, the kV used is likely to affect the results more than the actual 
patient thickness. 
10.2.2 Contrast 
The effect of phantom thickness on contrast can be predicted from consideration of the signal 
spectrum for each phantom, where signal spectra are derived as explained in section 6.2.3. 
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Signal spectra for 1 cm bone in 10 cm tissue, and 100 mg cm-' iodine in 10 cm soft tissue 
are given in Figure 10.7. 
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Figure 10.7 : Signal spectra for 10 cm tissue with (i) lcm bone and (ii) 100 mg cm -2 
iodine 
The effect of the various beam filters on contrast may be assessed from a consideration of 
the beam spectra shown in Figure 10.2 and the signal spectra of Figure 10.7. From these it 
can be seen that, for the spectra plotted, all filter materials would be expected to give 
decreasing contrast, with the possible exception of tin where the K-edge peak occurs within 
the signal spectrum. Since the signal spectrum peaks at a slightly higher energy than the 
reference spectrum (70 kV, 3 mm Al) it is probable that very small amounts of additional 
filtration would give an increase in contrast. For iodine, the signal spectrum is very similar 
to that for the 60 kV beam (Figure 6.24) as the peak is fixed above the K-edge. The peak 
is slightly broader for the 70 kV beam and this, together with the slighly harder (relative to 
60 kV) filtered beam spectra, should make contrast variation for the 10 cm phantom follow 
similar trends to those for the neonate. 
To assess the predicted contrast results, the results of Monte Carlo simulations carried out for 
1 cm bone in 10 cm soft tissue are given in figure 10.8. These show variation in contrast 
with tube load for 6 different filters. 
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Figure 10.8 : Variation in contrast with tube load for lcm bone in 10cm tissue 
The large uncertainties in the data for the contrast graphs mean that there can be little 
confidence in the exact shape of the curves drawn. The indications are, however, that contrast 
initially increases with added filtration, although to a greater extent than was predicted above. 
This highlights an area where further work would be of particular merit. 
10.3 Effect of varying tissue type 
Variations in the composition of the phantom background and contrast tissues, although less 
influential than patient size, will still affect the results of an optimisation study. The 
composition of the main body of the phantom will affect the absorbed energy and entrance 
dose, and changes in either of the contrasting tissues will obviously alter the behaviour of 
contrast with additional filtration. The effect on dose and contrast of substituting lung 
equivalent material into the phantom has been considered. 
10.3.1 Dose 
The absorption spectra for 5 cm lung tissue is shown in Figure 10.9. This was generated by 
assuming the same composition as soft tissue with a decreased density so is, in effect, 
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equivalent to a smaller thickness of soft tissue. The absorption spectra for 5 cm soft tissue 
is shown for comparison. 
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Figure 10.9 : Absorption spectra for 5cm lung equivalent material and 
5cm soft tissue 
Figure 10.9 shows the similarity between the absorption spectra for the two phantom 
materials. That for lung peaks at a slightly lower energy than that for soft tissue, 
corresponding more closely to the K-edge of tin. It would thus be expected that tin filtration 
might give even greater dose increases with tube load in lung than those observed for soft 
tissue. For other filter materials, the small difference in beam spectra is unlikely to affect the 
dose trends. 
Monte Carlo simulations were carried out for 5 cm lung, containing 1 cm bone detail, at 
60 kV with a lanthanum screen. Figure 10.10 shows the variation in dose quantities with tube 
load for these conditions. 
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Figure 10.10 : Variation in (i) absorbed energy and (ii) entrance dose for lcm bone in 
5cm lung tissue 
The graphs for absorbed energy show the familiar shapes, with tin giving increasing dose 
with tube load, samarium a fairly flat response and the remaining curves showing decreasing 
dose with tube load. Although the curves for bone in lung appear closer together than those 
previously shown for bone in soft tissue (Figure 6.3), the percentage dose reduction is 
actually approximately the same as for soft tissue (around 75% at a tube load of 2.0), but the 
dose increase with the tin filter is much greater (around 145% at a tube load of 3, compared 
to 124% for soft tissue) - as was predicted from consideration of the absorption and beam 
spectra. The curves for entrance dose variation, however, show different characteristics to 
those observed previously, as several of the curves show dose starting to increase at high tube 
loads. The uncertainties on the data points are high, and this apparent effect may not be 
genuine, particularly as no corresponding effect is seen for the absorbed energy curves. 
10.3.2 Contrast 
The contrast of bone in lung may be interpreted in terms of the signal spectrum, given in 
figure 10.11. 
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Figure 10.11 : Signal spectrum for lcm bone in 5cm lung tissue 
The signal spectrum exhibits a low energy peak, at a slightly lower energy than that for bone 
in soft tissue, so that any additional filtration (which will increase mean beam energy) would 
be expected to reduce contrast more than for the simulation of bone in soft tissue. Even tin 
is likely to reduce contrast as the signal spectrum peaks below the tin K-edge. The 
corresponding curves for lung in soft tissue are shown in Figure 10.12. 
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Figure 10.12 : Signal spectrum for lcm lung in 5cm soft tissue 
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For lung in soft tissue, the signal spectrum exhibits a broader peak than that for bone in lung. 
This means that, although the larger amounts of filtration will reduce contrast, the situation 
for small amounts of additional filtration is likely to be more complex. Figure 10.13 shows 
the signal spectrum superimposed on a number of filtered beam spectra for a 60 kV beam 
(taken from Chapter 6). From this it can be seen that additional aluminium filtration should 
increase contrast, as the filtered spectra shown in Figure 10.13(i) give increasing overlap with 
the signal spectrum. The same is true for samarium filtration, although the effect is less 
marked and tails off for increasing filter thicknesses. For the remaining filters, the beam 
hardening should decrease contrast, as there is less overlap between filtered and signal spectra 
than for the reference spectrum. 
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Figure 10.13: Signal spectra for lung (shown in dotted line) in soft tissue with filtered beam 
spectra for (i) aluminium (ii) copper (iii) dysprosium (iv) erbium (iv) samarium and 
(vi) tin. The reference spectrum (70 kV, 3 mm Al) is also plotted. 
The variation in contrast with tube load, as determined by Monte Carlo simulation is shown 
in Figure 10.14 for 1 cm bone detail in 5 cm lung tissue and Figure 10.15 for 1 cm lung 
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detail in 5 cm soft tissue. The former shows that, as predicted above, contrast is reduced for 
bone in lung for all added filtration. The curves for lung in soft tissue show an increase in 
contrast with tube load for aluminium, and an initial incease for samarium. Tin filtration 
gives a slight drop in contrast and the other curves lie close together, giving a contrast 
reduction of around 10% at a tube load of 2. These results confirm the predictions given 
above, in spite of the relatively large uncertainties in the data points. 
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Figure 10.14 : Variation of contrast with tube load for lcm bone in 
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Figure 10.15 : Contrast variation for 1cm lung in 5cm soft tissue 
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It is interesting to note that the situation simulated here is effectively the contrast between 
different thicknesses of the same material, as the composition of the lung and soft tissue 
substitutes is virtually identical, apart from the density. This may thus be comparable to 
circumstances where the required information from an image concerns fluctuation in tissue 
density, rather than different tissue types. 
10.4 Summary of predictions for other patient categories 
Spectral analysis and test simulations carried out for larger phantom thicknesses suggest that 
the results obtained for the neonatal phantom may broadly apply to older children. The 
general shape of dose and contrast variation curves will be similar to those obtained for the 
neonatal phantom. However, it is likely that for added tin and copper filtration the relative 
dose reduction will increase with patient thickness, for the values of tube potential used here, 
and for k-edge filters be reduced. The behaviour of the K-edge filters may depend more on 
the tube potential used than on the actual phantom thickness. 
Consideration of the inclusion of lung substitute material in the phantom indicates that the 
results obtained earlier for bone in soft tissue may be applied also to radiography in the chest 
region. The pattern of dose reduction is likely to be similar, except for the tin filter which 
is predicted to give even bigger doses with increasing tube load when imaging the lungs. 
Contrast is likely to decreases more, at equivalent tube loads, for bone in lung than for bone 
in soft tissue. For lung in soft tissue, contrast may increase slightly for small amounts of 
added aluminium or samarium. 
10.5 Suggestions for further work 
The large number of variable parameters for these simulations mean that the possibilities for 
extending the theoretical analysis are extensive. However, a number of specific areas worthy 
of further study may be highlighted. These can be categorised into theoretical simulations, 
experimental and clinical measurements, and general dosimetry concerns I 
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10.5.1 Monte Carlo simulations 
The recommended next stage in the computer simulation work would be to look in detail at 
the effect of varying tube potential on the test results described here for the larger phantom 
sizes. The two specific questions to be addressed are: 
0 For radiography, can a reduction in tube potential, in conjunction with added 
filtration, maintain image contrast and significant dose reduction, as was suggested 
for the neonatal work. 
0 Does a more careful selection of tube potential affect the performance of the K-edge 
filters, with respect to either dose or image quality, for the thicker phantoms. 
An assessment of contrast variation for fluoroscopy work with contrast media is also required, 
and a general extension of all results to very low contrast imaging, representing specific 
clinical situations would be a valuable area of study. The latter would require additional 
variance reduction techniques, or lengthy computational times to obtain statistically significant 
results. 
10.5.2 Experimental work 
Laboratory measurements with the slab phantoms are recommended to verify the results 
described in this chapter fe for thicker phantoms and also for lung equivalent material. The 
potential for a thin filter of gadolinium or samarium to be used as a contrast enhancing filter 
for fluoroscopic examination of neonates should be investigated in a clinical setting. A 
general use filter for older patients, most probably copper as suggested by initial results, 
should also be investigated clinically. The practical problems anticipated with its use also 
need to be addressed. 
Any simulations carried out for low contrast situations would also need to be verified 
experimentally. This would entail substantial practical difficulties using the current laboratory 
facilities, and would probably require use of a more modem, high power, steady output X-ray 
generator in order to achieve measurable and consistent results. 
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10.5.3 General dosimetry considerations 
Two aspects of general paediatric dosimetry are recommended for further work. These are 
firstly an investigation of how field size varies with patient size for different fluoroscopic and 
radiographic examinations. This would involve collecting and analysing patient and 
examination data. Secondly the question of a suitable risk related quantity, or quantities, for 
paediatric radiology needs to be addressed. This could possibly involve considering absorbed 
dose or energy imparted to different `compartments' of the body, as an intermediary between 
the total energy imparted concept, which can be easily applied to a specific patient 
examination but does not allow for different tissue sensitivities, and effective dose which 
includes organ sensitivities but is virtually impossible to assess accurately for a specific 
patient examination. Identification and incorporation of realistic organ risk factors for 
paediatrics would also need to be included in this project. 
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Chapter 11 
Summary and Conclusions 
11.1 Paediatric patient dosimetry 
The collection and analysis of good quality paediatric dose data is a prerequisite to any dose 
optimisation stategy. As shown in Chapter 3, the current literature demonstrates that, although 
results of a number of paediatric dosimetry surveys have been published in recent years, the 
amount of data available is small. This is particularly a problem when the wide range of patient 
sizes is considered. There has been no consistent approach to dealing with variations in patient 
size when analyzing and comparing dosimetry data. The routine collection of dosimetry data has 
been made possible by a semi-automated system, utilising a laptop computer connected to a DAP 
meter. This enabled large quantities of paediatric dose-area product data to be collected from a 
number of hospitals, which could then be reported back to each department to complete the dose 
audit chain. The results showed considerable variation between centres, highlighting the potential 
for optimisation of doses. A method of correcting dosimetry data for patient size, within each of 
the 5 agebands defined by the CEC, was developed and shown to reduce variability in DAP due 
to size. The size correction method utilises the concept of equivalent diameter, and the 
exponential attenuation of X-ray energy within the patient. 
The choice of dose descriptor for paediatric dosimetry is complicated by the need to balance the 
desirability for a quantity related to radiation risk with the need for ease of assessment and 
applicability to any given patient examination. The currently popular concept of effective dose 
is inappropriate for paediatric dosimetry as the risk factors from which it is derived are not 
applicable to paediatric patients. In addition, although data is available for calculating effective 
dose from directly measurable quantities such as entrance dose or DAP, these data will only apply 
to examinations for which parameters such as field size and position correspond exactly to those 
used in their derivation. For fluoroscopic procedures, this constraint will rarely be satisfied, and 
the calculation of effective dose for a specific patient examination will involve large uncertainties. 
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11.2 Results from theoretical simulation 
Monte Carlo code has been developed, and verified experimentally, to investigate the effect of 
added filtration on patient dose and image contrast for a range of conditions, primarily for 
neonates. The main results can be summarised as follows : 
" Additional copper filtration exhibited the greatest dose reduction for equal tube load. 
" For radiography of bone in soft tissue, a reduction in tube voltage in conjunction with 
small amounts of additional filtration could be used to maintain contrast and reduce both 
entrance dose and absorbed energy. The theoretical absorbed dose reduction is of the 
order of 10% for equal contrast. 
0 For fluoroscopy using iodine or barium contrast agents, contrast was not markedly 
affected by small amounts of additional filtration, enabling significant dose reduction to 
be achieved - of the order of 40% reduction in entrance dose and 15% reduction in 
absorbed energy. 
"A thin filter of samarium or gadolinium was found to give enhance contrast without 
increasing patient dose, for imaging of iodine or barium. 
0 The choice of image receptor did not have a significant effect in determining values of 
dose or image quality. 
0 The use of replacement filtration was demonstrated to offer no advantage over additional 
filtration. 
0 Experimental verification of the Monte Carlo predictions gave good agreement for values 
of absorbed dose, entrance dose, contrast and tube load, to within the calculation and 
measurement uncertainties. 
11.3 Clinical Implementation 
An extensive theoretical study alone is of no practical benefit to patients. Consideration of how 
theoretical results may be implemented in clinical practice is an essential stage of an optimisation 
strategy. For this work, experimental measurements were carried out in a clinical environment, 
and these yielded a number of important points concerning the application of optimisation 
techniques, which may be summarised as follows: 
0 Parameters that may be constrained to remain constant in a theoretical simulation are 
unlikely to remain rigidly so during clinical practice. Eg background density may 
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fluctuate quite considerably within an acceptable range and, for paediatric exposures will 
often be limited by the discrete nature of exposure factor settings. 
0 Acceptable contrast is usually more relevant than equal contrast, particularly as the latter 
is hard to judge subjectively. This may depend on the nature of the examination involved. 
0 Image quality may also be limited by the X-ray equipment being used, particularly for 
older image intensifier systems, where small changes in primary contrast may not be 
discernible due to degradation along the imaging chain. 
A 0.1mm copper filter was used in a clinical trial, for fluoroscopic examination of infants, and 
resulted in dose reduction of 50% for entrance dose and 25-40% for organ doses, without 
significant loss of image qualiy. The practical problems associated with using the filter were 
overcome by lying the children on a large copper sheet. 
11.4 Optimisation 
The optimisation of paediatric patient dose with image quality is not a subject that should be over 
simplified, as it is affected by a large number of factors as discussed in Chapter 4. While 
generalisations, such as the CEC image quality criteria may be a useful `first step', the specific 
requirements and complications of individual patient examinations need to be addressed. In order 
to achieve this, the underlying principles and effects of varying parameters on one another need 
to be understood, and related to the clinical situation. Diverse factors such as the type of 
equipment available, whether or not the equipment is dedicated to paediatric use and the 
compliance of patients need to be considered, as well as the information required from the 
examination being performed. The practical implications of any optimisation strategy, such as cost 
and acceptability to overworked staff are also important. The success of optimisation procedures 
can only be assessed when reliable methods of assessing patient doses are in place. 
The work presented here has addressed the most important of these issues by, firstly, developing 
a strategy of paediatric dose measurement. Secondly, an optimisation strategy has been developed 
incorporating theoretical simulation, experimental verification and clinical implementation. The 
specific optimisation technique of beam filtering has been studied in detail, through both 
simulation and experiment, from an approach of studying trends in different parameters rather 
than applying a number of constraints in an attempt to find an absolute ranking of filter materials. 
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The extrapolation to clinical use has been achieved for a particular category of radiological 
examination, namely fluoroscopy in infants, and consideration has been given as to how the 
techniques and results might be applied to other paediatric age groups and examination categories. 
A number of suggestions have been made regarding future progression of the work, based on the 
success of the strategies that have been developed. The methodologies described here may also 
be applied to the optimisation of both computed tomography and computer radiography, which 
are increasingly becoming the techniques of the future. Such scientifically based, yet practical 
strategies, for both dosimetry and optimisation are required for the continued reduction of 
radiation dose in paediatric radiology. 
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Appendix A 
Results of dose survey 
Mean screening times (s) 
Hospital ID 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
A2 101 146 
BI 53 56 84 120 
C1 35 59 82 82 
C2 63 161 118 
D 66 116 
E 114 28 145 
F1 288 191 126 158 126 
G 78 
H 130 96 120 
I 47 133 85 
11 6 240 
K1 96 
K2 92 214 234 210 98 
L2 81 119 72 138 
MI 154 185 175 97 168 
Ni 48 10 
N2 66 36 80 
01 11 75 
02 34 54 67 
P1 87 93 276 84 31 126 
R 100 12 20 108 
Table A. 1 : Screening time data for neonates 
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Mean numbers of radiographs (R) and spot/DSI films (S) 
Hospital ID Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
R S R S R S R S R S R S 
A2 1 5 7 11 
B1 4 3 5 1 3 
Cl 20 3 14 5 
C2 3 3 
D 5 4 1 6 
E 4 4 4 
F1 1 14 1 6 1 8 1 7 4 
G 13 
H 6 3 16 7 
I 2 10 2 
J1 7 11 
K1 
K2 6 7 15 10 6 
L2 7 9 9 12 9 
M1 14 6 1 8 3 3 7 
Ni 4 15 
N2 16 14 6 
01 6 2 13 8 6 
02 1 
P1 6 5 13 3 3 2 6 
R 3 6 5 6 
Table A. 2 : Numbers of radiographs and spot films for neonates 
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Mean Tube Potential (kV) 
Hospital ID 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
A2 63 50 
BI 62 72 77 90 
Cl 63 62 50 60 
C2 60 62 60 
D 69 55 57 
E 68 62 90 
FI 60 69 90 60 60 
G 81 
H 70 50 60 
I 65 88 71 
J1 60 70 
K1 70 
K2 60 62 60 50 60 
L2 59 59 58 52 58 
MI 65 61 68 93 50 
NI 80 60 
N2 60 78 75 
01 62 90 68 65 
02 59 50 62 
P1 58 60 60 90 70 90 
R 64 62 68 70 
Table A. 3 : Tube voltage data for neonates 
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Mean Size Corrected Energy Imparted (mJ) 
Hospital ID 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
A2 9.43 11.96 
BI 4.02 4.14 40.22 
Cl 7.03 3.30 4.80 3.87 
C2 2.51 8.19 8.80 
D 1.21 1.29 3.39 
E 8.49 5.34 9.06 
F1 5.31 7.07 38.22 2.14 
G 97.94 
H 5.49 1.13 4.90 
I 2.01 8.02 5.70 
11 0.86 27.02 
KI 5.00 
K2 9.35 9.11 25.65 5.54 
L2 3.07 4.13 7.77 11.22 3.48 
M1 12.93 15.05 17.20 19.71 9.30 
Ni 1.80 0.90 
N2 0.29 2.93 2.32 
01 0.54 1.41 1.97 0.78 
02 0.43 0.46 0.94 
P1 3.28 3.17 5.87 12.34 32.58 
R 2.77 1.70 2.51 7.89 
Table A. 4 : Energy imparted data for neonates 
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Mean screening times (s) 
Hospital ID 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Meal&Swal 
Al 65 144 
A2 72 19 198 
B1 82 121 113 63 
C1 43 37 105 26 
C2 81 109 78 91 
D 74 59 56 258 150 
E 75 52 286 
F1 134 95 101 219 104 
H 136 292 254 408 
I 64 128 124 156 108 
11 41 77 120 60 
J2 68 78 
KI 252 
K2 126 167 222 199 
L2 43 40 82 6 179 
M1 88 139 132 217 132 
Ni 45 168 
N2 83 79 125 
01 1 2 19 4 
02 36 96 66 
P1 88 86 7 
Q1 6 122 
R 17 2 14 78 
S 114 
Table A. 5 : Screening time data for infants 
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Hospital ID Mean numbers of radiographs (R) and spotIDSI films (S) 
Cystogram Ba Swal. Ba Meal Ba Enema Ba Meal&Swal 
R S R S R S R S R S 
Al 1 3 9 
A2 2 6 6 
B1 2 7 2 4 4 
Cl 10 5 16 7 
C2 7 4 
D 4 4 6 5 5 
E 5 9 1 
Fl 7 17 6 8 5 
H 8 12 9 7 
I 1 6 5 4 6 
JI 5 20 10 7 
J2 8 
K1 4 
K2 6 7 5 7 
L2 6 7 9 1 7 9 
M1 1 7 1 4 5 3 1 4 
N1 3 6 
N2 5 4 6 
01 6 6 8 6 5 
02 1 29 
P1 3 10 8 
Q1 8 
R 1 5 3 4 5 
S 4 6 5 
Table A. 6 : Numbers of radiographs and spot films for infants 
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Mean Tube Potential (kV) 
Hospital ID 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Meal&Swal 
Al 60 90 
A2 53 80 50 
BI 72 73 80 80 
Cl 61 64 67 64 
C2 56 56 60 60 
D 57 67 66 60 60 
E 75 90 70 
Fl 63 62 62 75 67 
H 62 67 70 70 
I 65 72 76 74 80 
11 67 62 60 60 
J2 60 60 
KI 70 
K2 70 58 60 62 
L2 60 62 61 60 60 
M1 57 64 73 73 58 
NI 72 50 
N2 66 72 67 
01 65 70 70 68 77 
02 60 70 63 
P1 62 62 67 
Q1 60 70 
R 62 70 68 70 
S 70 
Table A. 7 : Tube voltage data for infants 
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Mean Size Corrected Energy Imparted (mJ) 
Hospital ID 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Meal&Swal 
Al 1.87 4.95 
A2 5.48 2.16 16.19 
B1 6.84 9.85 13.39 6.56 
Cl 4.99 5.94 14.34 4.83 
C2 5.25 11.89 6.02 7.55 
D 2.70 8.61 3.94 6.42 3.14 
E 22.09 22.25 37.24 
FI 6.53 3.92 5.26 21.74 5.81 
H 4.83 19.12 10.16 41.11 
I 4.53 11.29 12.81 128.58 14.20 
11 6.64 6.11 7.02 4.86 
J2 15.00 2.17 
K1 508.2 
K2 14.80 12.89 10.94 11.45 
L2 3.96 6.83 6.55 8.51 5.00 
MI 8.83 26.78 18.6 29.05 12.53 
NI 1.50 3.37 
N2 4.11 4.41 7.01 
01 1.06 1.46 3.10 1.41 2.54 
02 0.68 1.66 1.43 
P1 5.12 6.48 10.66 
Q1 0.13 12.14 
R 2.76 4.33 2.06 1.68 
S 43.14 
Table A. 8 : Energy imparted data for infants 
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Mean screening times (s) 
Hospital ID 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
Al 48 
A2 159 82 104 342 
BI 69 95 89 
B2 240 54 
Cl. 74 72 88 222 171 
C2 46 91 62 30 106 
D 76 37 100 
E 194 244 
F1 185 78 76 147 60 
G 210 
H 137 186 132 222 42 285 
I 90 128 108 221 71 124 
11 42 42 600 120 
J2 90 192 
K1 588 
K2 102 152 330 132 
L2 62 76 86 60 120 
M1 162 196 118 104 
Ni 51 24 
N2 61 67 86 142 96 84 
01 12 13 29 4 17 90 
02 41 83 71 
P1 98 97 134 186 97 67 
Q1 126 
R 41 34 
S 54 
T 60 
Table A. 9 : Screening time data for 1-5 year olds 
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Hospital ID Mean numbers of radiographs (rads) and spot/DSI films (films) 
Cystogram Ba Swal. Ba Meal Ba Enema Ba Fol. Thr. Ba Meal&Swal 
R S R S R S R S R S R S 
Al 2 
A2 10 9 9 4 13 
Bl 3 5 5 4 
B2 8 12 
Cl 10 4 17 12 
C2 1 8 4 3 4 
D 3 7 7 
E 12 5 2 
Fl. 6 8 7 7 1 
F2 2 
o 8 10 
H 8 8 5 3 8 
I 1 14 3 5 4 6 
J1 6 30 20 30 
J2 2 17 
K1 
K2 4 4 9 6 
L2 7 9 9 7 2 9 
M1 1 6 12 4 1 2 
Nl 2 
N2 3 1 4 1 7 9 5 
01 6 17 8 5 6 4 
02 1 5 
P1 3 5 8 8 6 4 
Q 2 8 
R 
F 
4 
[ E 
7 
T 1 2 
Table A. 10 : Numbers of radiographs and spot films for 1-5 year olds 
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i l 
Mean Tube Potential (kV) 
Hosp ta ID 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fo1. Thr. 
Ba 
Meal&Swal 
A2 62 90 62 90 
BI 68 73 78 90 
B2 90 70 
Cl 62 60 72 83 50 63 
C2 63 60 63 
D 62 90 68 
E 90 94 
F1 65 62 65 71 60 
F2 90 
G 85 
H 68 65 77 60 70 65 
I 66 66 73 75 67 
11 63 70 70 60 
J2 60 70 
K1 70 
K2 60 61 60 60 
L2 64 66 67 68 62 68 
M1 62 72 90 77 
NI 61 50 
N2 65 65 74 83 90 70 
01 67 67 69 60 70 77 
02 60 60 63 
P1 64 64 66 60 76 72 
Q 95 
R 64 79 
S 50 
T 50 
Table A. 11 : Tube voltage data for 1-5 year olds 
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Mean Size Corrected Energy Imparted (mJ) 
Hospital ID 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
A2 27.34 19.89 13.35 260.58 
BI 8.26 12.05 10.59 29.29 
B2 73.27 
Cl 11.29 0.87 11.35 32.3 22.00 
C2 7.62 16.02 27.79 12.79 20.31 
D 8.42 5.33 6.82 
E 17.88 64.16 
F1 14.29 4.40 7.64 12.14 10.58 
F2 3.95 
G 375.41 
H 12.64 37.68 17.40 10.49 6.89 25.61 
I 9.29 24.55 19.69 37.77 12.46 17.10 
J1 12.98 5.99 54.98 7.76 
J2 8.42 9.94 
K1 41.97 
K2 12.53 10.12 30.23 14.88 
L2 9.07 14.25 13.06 23.47 3.93 11.49 
Ml 31.65 44.28 26.04 29.80 
Ni 3.95 1.30 
N2 3.27 2.59 4.58 19.47 34.75 1.85 
01 2.48 3.08 5.08 1.49 1.85 21.43 
02 1.61 3.37 2.40 
P1 9.03 9.02 16.05 22.47 20.33 11.45 
Q1 235.58 
R 4.26 8.92 
S 1.77 
T 0.30 
Table A. 12 : Energy imparted data for 1-5 year olds 
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Mean screening times (s) 
Hospital ID 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
A2 507 134 348 
B1 97 108 136 
Cl 168 102 226 170 90 
C2 80 116 66 75 92 
D 122 84 
E 160 
F1 154 77 120 80 108 
G 132 
H 100 141 182 114 102 
I 90 73 116 42 83 128 
JI 78 150 40 
J2 84 
K2 77 176 84 168 116 
L2 58 93 69 147 57 146 
M1 88 88 177 180 96 
NI 48 78 
N2 129 100 136 78 
01 27 56 109 75 
02 40 81 
P1 103 66 141 98 57 162 
QI 44 113 132 90 
R 19 37 
S 
U 132 
Table A. 13 : Screening time data for 6-10 year olds 
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Hospital ID Mean numbers of radiographs (rads) and spot/DSI films (films) 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
R S R S R S R S R S R S 
A2 25 5 13 5 
B1 1 4 8 4 5 
Cl 2 2 33 1 60 
C2 1 3 5 2 5 
D 8 6 
E 4 9 
FI 6 14 20 2 3 9 
G 5 7 
H 8 4 10 4 9 
I 1 14 5 7 3 12 
11 7 12 10 
J2 77 
K2 4 7 10 6 11 
L2 7 10 10 10 3 4 10 
M1 5 1 11 6 2 8 
Ni 3 9 
N2 4 7 8 4 4 
01 7 8 1 7 7 
02 4 6 
P1 3 8 9 1 7 4 26 
QI 11 7 
R 5 5 5 
S 
U 10 
Table A. 14 : Numbers of radiographs and spot films for 6-10 year olds 
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Mean Tube Potential (kV) 
Hospital ID 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
olThr. 
Ba 
Meal&Swal 
A2 60 70 70 
BI 83 70 79 
Cl 67 65 70 75 70 
C2 63 62 70 65 62 
D 66 60 
E 90 
F1 69 75 70 78 70 
G 86 
H 70 70 67 70 70 
I 69 82 73 70 75 68 
11 75 60 75 
J2 60 
K2 60 60 60 60 77 
L2 72 71 78 84 90 80 
M1 77 100 60 95 60 
NI 70 90 
N2 72 76 72 90 
01 66 72 78 72 
02 62 62 
P1 65 70 73 83 67 70 
Q1 60 60 
R 63 74 70 
S 60 
U 60 
Table A. 15 : Tube voltage data for 6-10 year olds 
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Mean Size Corrected Energy Imparted (mJ) 
Hospital ID 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
A2 106.53 46.88 79.49 
B1 17.30 21.61 20.16 
Cl 27.17 13.91 48.18 54.50 10.28 
C2 24.74 33.79 27.39 26.06 25.01 
D 13.38 10.12 
E 18.01 
FI 26.35 7.22 12.03 107.19 10.90 
G 221.33 
H 8.56 19.82 23.33 23.45 25.52 
I 15.55 20.79 27.42 32.42 27.04 35.11 
J1 13.56 10.82 12.49 
J2 7.25 
K2 13.74 18.38 67.89 24.91 30.31 
L2 15.51 11.49 22.78 65.93 7.23 21.36 
M1 25.53 134.58 42.34 112.69 37.87 
Ni 46.05 17.31 
N2 9.20 45.77 12.94 4.62 
01 4.25 13.20 15.46 10.15 
02 9.25 4.51 
P1 19.24 14.50 46.10 50.62 12.05 39.74 
Q1 5.39 23.01 11.95 
R 4.77 6.68 
S 23.21 
U 38.37 
Table A. 16 : Energy imparted data for 6-10 year olds 
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l ID H i 
Mean screening times (s) 
osp ta 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
Al 168 
A2 423 92 53 126 
BI 72 57 48 54 
C1 102 96 92 54 
C2 84 105 146 63 
D 96 109 
E 121 
F1 115 62 117 60 
G 89 102 
H 194 105 204 
I 98 85 159 112 58 75 
J1 115 
K1 302 246 
K2 102 120 108 266 285 
L1 54 
L2 42 76 36 185 208 117 
M1 114 63 90 516 36 135 
Ni 96 
N2 30 60 100 84 66 
01 66 41 68 50 110 22 
02 42 66 112 42 59 
PI 80 90 156 218 97 108 
Q 107 124 
R 34 49 62 78 
S 108 80 
Table A. 17 : Screening time data for 11-16 year olds 
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Mean numbers of radiographs (R) and spot/DSI films (S) 
Hospital ID 
Cystogram Ba Swal. Ba Meal Ba 
Enema 
Ba 
Fo1. Thr. 
Ba 
Meal&Swal 
R S R S R S R S R S R S 
Al 1 6 
A2 12 10 2 
B1 2 8 7 6 
Cl 2 34 16 
C2 1 8 16 2 7 
D 11 10 7 
E 7 
F1 6 6 3 5 1 8 
G 18 8 
H 12 10 10 
I 1 12 10 2 7 3 7 
J1 3 11 
K1 7 7 
K2 5 38 14 11 2 6 
LI 6 
L2 7 13 12 5 8 7 15 
MI 6 4 5 1 4 11 
NI 8 
N2 4 8 4 6 2 1 2 4 
01 7 14 10 1 5 6 3 
02 2 1 2 7 
P1 4 9 1 7 2 5 1 5 8 
QI 8 10 
R 3 5 5 8 
S 10 1 4 
Table A. 18 : Numbers of radiographs and spot films for 11-16 year olds 
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i l ID H 
Mean Tube Potential (kV) 
ta osp 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
Al 90 
A2 70 70 70 70 
BI 90 90 90 
Cl 70 70 72 50 
C2 70 65 70 75 80 
D 90 68 70 
E 90 
F1 70 65 80 80 
G 70 90 
H 70 70 65 
I 69 82 94 88 81 70 
11 75 
K1 77 70 
K2 70 67 90 90 
LI 90 
L2 76 80 81 86 100 88 
M1 60 80 60 60 70 83 
Ni 80 
N2 70 80 73 100 80 
01 69 72 70 73 70 60 
02 60 60 65 90 62 90 
P1 74 66 77 90 70 90 
QI 72 71 
R 68 66 79 90 
S 70 70 60 
Table A. 19 : Tube voltage data for 11-16 year olds 
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it l ID H 
Mean Size Corrected Energy Imparted (mJ) 
a osp 
Cystogram Ba Swal. Ba Meal Ba Enema Ba 
Fol. Thr. 
Ba 
Meal&Swal 
Al 1.59 18.41 
A2 208.43 137.85 9.82 
BI 8.97 20.06 20.75 23.61 
CI 5.13 20.55 35.01 12.26 
C2 36.32 52.95 73.27 28.24 
D 50.34 43.46 16.86 
E 134.08 
F1 28.07 16.11 77.35 21.72 
G 13.45 138.04 
H 54.95 39.06 67.14 
I 29.85 26.71 75.48 87.88 35.25 50.36 
JI 75.77 
KI 60.41 43.56 
K2 73.93 54.26 131.21 213.56 
L1 17.64 218.19 
L2 38.84 31.11 50.13 165.25 84.69 40.80 
M1 75.95 40.55 78.24 163.83 27.71 67.95 
NI 39.49 
N2 2.09 7.31 25.77 72.15 38.11 19.24 
01 13.78 9.22 12.93 13.48 43.35 2.64 
02 1.25 8.00 11.76 13.16 11.30 
P1 45.38 44.69 43.23 172.33 38.06 66.04 
Q1 43.76 58.59 
R 18.76 13.90 15.45 22.17 
S 39.66 
Table A. 20 : Energy imparted data for 11-16 year olds 
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Appendix B 
Usercode Listing 
%L 
%E 
! INDENT M 4; "INDENT MORTRAN LISTING BY 4 PER LEVEL" 
! INDENT F 2; "INDENT FORTRAN OUTPUT BY 2 PER LEVEL" 
', ************************************************************* 
.. n 
rr ** rr 
PEDSIMI. MOR 
n** rr 
n ***************** n 
it it 
" This code is used to simulate paediatric x-ray examinations, using 
if a simple body phantom, k-edge filtration, diverging beam geometry, 
and an input kV spectrum. Quantities measured include the energy 
" absorption in the phantom and energy absorbed in a screen phosphor. " 
Particle splitting is used as a means of variance reduction, and K- " 
edge photons are tracked in the filter and phosphor. to 
of of 
************************************************************* 
1----------------------------------------------------------------«----- 
"STEP 1: USER-OVERRIDE-OF-EGS4-MACROS 
--------------------------------1. 
REPLACE {$MXMED} WITH {20} "20 media in the problem(default 10) 
REPLACE {$MXREG} WITH {20} " 20 geometric regions (default 2000) 
REPLACE {$MXSTACK} WITH {5000}"maximum number of particles on stack 
REPLACE {$MXPLNS) WITH {8} "maximum number of planes to 
REPLACE {$MXELEMS} WITH {3} "maximum number of elements in one medium 
11 
"** Random Number Generator **" 
REPLACE {; COMIN/RANDOM; } WITH {; COMMON/RANDOM/IXX; } 
PI = 3.141592654; 
REPLACE {$RANDOMSET#; } WITH 
{IXX=IXX*663608941; {P 1 }=0.5 + IXX*0.23283064E-09; } 
OPEN(1, 'INPUT. DAT', STATUS='OLD'); 
$UINPUT(1) IXX; (19); 
"** Parameters for diverging beam **" 
$UINPUT(1) ANGLE; (F6.4); " ANGLE SET BY USER" 
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ANGFACT=1-COS(ANGLE); 
"MACRO TO DETERMINE DIRECTION OF INCIDENT PARTICLE" 
REPLACE {$SELECT DIRECTION; } WITH 
{$RANDOMSET RANDIRI; $RANDOMSET RANDIR2; 
COSTHE=1.0-RANDIRI *ANGFACT; 
S1NTHE=SQRT(1.0-COSTHE*COSTHE); 
PHI = RANDIR2*2*PI; 
COSPHI = COS(PHI); 
SINPHI = S1N(PHI); 
UIN = SINTHE*COSPHI; 
VIN = SINTRE*SINPHI; 
WIN = COSTHE; } 
"** Parameters for input energy spectrum **" 
REPLACE {$KV} WITH {70} "kVp of spectrum used 
"DEFINE A COMMON FOR SPECTRUM GENERATING & PARTICLE 
SPLITTING 
VARIABLES" 
REPLACE {; COMINIUSER/; } WITH 
{; COMMON/USER/IENERGY, IRAWDATA($KV), ISUMDATA($KV), EBINA($KV), 
SPECTRUM($KV), RANDX, IRSPLT($MXREG), LSPLT, NSPLT; ) 
"RANDOM ENERGY SELECTION FROM SPECTRUM" 
REPLACE {$SELECT ENERGY; } WITH {$RANDOMSET RANDX; IENERGY=1; 
WHILE (RANDX > SPECTRUM(IENERGY)) [IENERGY=IENERGY+1]; 
EIN=IENERGY/1000.0; EBINA(IENERGY)=EBINA(IENERGY)+1; } 
"** Parameters for particle splitting **" 
"TRANSFER OF PROPERTIES TO SPLIT PARTICLES" 
REPLACE {$PARTICLE-SPLITTING; } WITH 
{; IF(LSPLT. NE. O) [WT(NP)=WT(NP)/LSPLT; DO ISPLT=I, NSPLT [ 
$TRANSFER PROPERTIES TO (NP+ISPLT) FROM (NP); 
U(NP+ISPLT)=U(NP); V(NP+ISPLT)=V(NP); W(NP+ISPLT)=W(NP); 
E(NP+ISPLT)=E(NP); IQ(NP+ISPLT)=IQ(NP); ] NP=NP+NSPLT; ]) 
"** Parameters for K-edge fluorescence **" 
REPLACE {; COMIN/EDGE/; } WITH 
{; COMMON/EDGE/IEDGFL($MXREG, $MXELEMS), ELEM($MXMED, 2, $MXELEMS), 
$LGN(EKALPH, EKBETA, BKR 1, BKR2, PROP, CUMPROP, EKBIND($MXMED, $MXEL 
E 
MS)); } 
"NOTE 1: COMMON/EDGE/ IS A NON-EGS4 COMMON THAT IS DEFINED 
HEREIN 
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it ORDER TO BE ABLE TO INCLUDE IT IN 'COMIN/.... /' BELOW. 
"NOTE 2: THE K-EDGE FLUORESCENT TRANSPORT OPTION IS 
CONTROLLED BY 
of A FLAG (FOR EACH 'REGION') CALLED IEDGFL. IEDGFL MUST 
to BE SET TO ZERO FOR ALL REGIONS, AND THEN REDEFINED TO 
11 NON-ZERO FOR THOSE 'K-EDGE TRANSPORT' REGIONS, PRIOR TO 
" CALLING THE USER-DEFINED SUBROUTINE EDGSET. 
is of 
"** Parameters for ten-region geometry **" 
REPLACE {; COMIN/GEOM/; } WITH 
{; COMMON/GEOM/TFILT, FSD, TBODY, TGAP, TPHOS, 
TCONT, RCONT, DCONT; } 
NREG=$MXREG; 
NMED=$MXMED; 
NPLAN=$MXPLNS; 
NCYL=1; 
"** Parameters for scoring **" 
REPLACE {; COMIN/SCORE/; } WITH 
{; COMMON/SCORE/ENAB S, ENENT, ENSCON, ENSBAK, RADIN2, RADOUT2, RCONT 
2, 
MXNP; ) 
; COMINBOUNDS, CYLDTA, EDGE, GEOM, MEDIA, MISC/; 
; COMIN/PHOTIN, PLADTA, RANDOM, SCORE, STACK, THRESH, USER/; 
" THE ABOVE EXPANDS INTO A SERIES OF COMMON STATEMENTS" 
1---------------------------------------------------------------------11 
"STEP 2 PRE-HATCH-CALL-INITIALIZATION 
11---------------------------------------------------------------------- 
$TYPE MEDARR(24, $MXMED) /$S'AIR', 21*' ', $S'PERSPEX', 17*' ', 
$S'MS20', 20*' ', $S'SB5', 21*' ', $S'LN10_00', 17*' ', $S'LN1O_100', 16*' ', 
$S'CAWO4', 19*' ', $S'GD2O2S', 18*' ', $S'CSI', 21*' ', $S'LAOBR', 19*' ', 
$S'AL', 22*' ', $S'BA', 22*' ', $S'CU', 22*' ', $S'ER', 22*' ', $S'FE', 22*' ', 
$S'GD', 22*' ', $S'I', 23*' ', $S'NB', 22*' ', $S'PB', 22*' ', $S'DY', 22*' 
It PLACE MEDIA NAMES IN AN ARRAY" 
of $S IS A MORTRAN MACRO TO EXPAND STRINGS" 
it $TYPE IS INTEGER(F4) OR CHARACTER*4(F77)" 
DO J=1, NMED[ 
DO I=1,24 [MEDIA(I, J)=MEDARR(I, J); ]] 
"THIS IS TO AVOID A DATA STATEMENT FOR A VARIABLE IN COMMON" 
"DUNIT DEFAULTS TO 1, I. E. WE WORK IN CM" 
$UINPUT(1) IFILT, DUMP, IPHAN, DUMP, ICONT, DUMP, IPHOS, DUMP, IGAP; 
(4(I2, I1), I2); 
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/MED(1), MED(7)/=0; " REGIONS 1&7 ARE VACUUM" 
MED(2)=IFILT; " REGION 2 IS FILTER MATERIAL" 
/MED(8), MED(9), MED(4)/=IPHAN; " REGIONS 8,9 &4 ARE PHANTOM 
MATERIAL" 
MED(10)=ICONT; " REGION 10 IS CONTRAST MEDIA" 
MED(6)=IPHOS; " REGION 6 IS PHOSPHOR MATRIAL" 
MED(3)=1; " REGION 3 IS AIR" 
MED(5)=IGAP; " REGION 5 IS AIR OR PERSPEX" 
/ECUT(2), ECUT(4), ECUT(6), ECUT(8), ECUT(9), ECUT(10)/=0.70; 
" TERMINATE ELECTRON HISTORIES AT 0.70 MEV IN ALL MEDIA" 
/PCUT(2), PCUT(4), PCUT(6), PCUT(8), PCUT(9), PCUT(10)/=0.01; 
11 TERMINATE PHOTON HISTORIES AT 0.01 MEV IN ALL MEDIA" 
DO I=1, NMED[ 
IRAYLR(I)=1; " TURN ON RAYLEIGH SCATTERING IN ALL MEDIA 
DO J=1, $MXELEMS[ 
IEDGFL(I, J)=O; ]" TURN OFF K-EDGE FLAG FOR ALL ELEMENTS IN ALL 
MEDIA " 
I 
IRAYLR(1)=0; IRAYLR(7)=0; "TURN OFF RAYLEIGH OPTION FOR VACUUM 
REGNS" 
"ENTER ATOMIC NUMBER OF ELEMENT TO ENABLE FLUORESCENCE" 
$UINPUT(l) IEDGFL(2,1), DUMP, IEDGFL(2,2), DUMP, IEDGFL(2,3 ); 
(2(12,11), 12); 
$UINPUT(1) IEDGFL(6,1), DUMP, IEDGFL(6,2), DUMP, IEDGFL(6,3); 
(2(I2, I1), I2); 
" NOTE: A SPECIAL VERSION OF SUBROUTINE PHOTO MUST BE 
INCLUDED " 
WITH THIS USER CODE WHEN IEDGFL-VALUE(S) ARE NON-ZERO. 
%E 
'I----------------------------------------------------------------------- 
"STEP 3 HATCH-CALL 
; OUTPUT; (' l START SIMULATION'// 
'CALL HATCH TO GET CROSS-SECTION DATA'/); 
CALL HATCH; " PICK UP CROSS SECTION DATA FOR W" 
to DATA FILE MUST BE ASSIGNED TO UNIT 12" 
; OUTPUT AE(1)-0.511, AP(1); 
('OKNOCK-ON ELECTRONS CAN BE CREATED AND ANY ELECTRON 
FOLLOWED 
DOWN TO' 
/T40, F8.3, ' MeV KINETIC ENERGY'/ 
' BREM PHOTONS CAN BE CREATED AND ANY PHOTON FOLLOWED 
DOWN TO 
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/T40, F8.3, ' MeV '); "NOTE, AE VALUES CAN OVER-RIDE ECUT VALUES" 
"SET UP K-EDGE PARAMETERS NEEDED BY SUBROUTINE PHOTO" 
"first enter symbols of each element in fluorescence media 
$TYPE ELEM; 
$TYPE ELEMARRI(2, $MXELEMS) /$S'CA', $S'W ', $S'O '/; 
DO J=1, $MXELEMS [ 
DO I=1,2 [ELEM(4, I, J)=ELEMARRI(I, J); ]] 
"enter relative proportion of each element, and its binding energy" 
"default is 1 element with binding energy EBINDA of 
DO I=1, NMED [PROP(1,1)=1; EKBIND(I, 1)=EBINDA(I); 
IF($MXELEMS. GT. 1) [DO J=2, $MXELEMS [PROP(I, J)=0; 
EKBIND(I, J)=0.0; ]]] 
PROP(7,1)=0.1666667; PROP(7,2)=0.1666667; PROP(7,3)=0.6666666; 
EKBIND(7,1)=0.00404; EKBIND(7,2)=0.06951; EKBIND(7,3)=0.00053; 
PROP(8,1)=0.831; PROP(8,2)=0.0845; PROP(8,3)=0.0845; 
EKBIND(8,1)=0.05023; EKBIND(8,2)=0.00053; EKBIND(8,3)=0.00247; 
PROP(9,1)=0.512; PROP(9,2)=0.488; 
EKBIND(9,1)=0.03596; EKBIND(9,2)=0.03316; 
PROP(10,1)=0.592; PROP(10,2)=0.068; PROP(10,3)=0.34; 
EKBIND(10,1)=0.03893; EKBIND(10,2)=0.00053; EKBIND(10,3)=0.01348; 
"calculate cumulative proportions " 
DO I=1, NMED [CUMPROP(I, 1)=PROP(I, 1); 
IF($MXELEMS. GT. 1) [DO J=2, $MXELEMS [ 
CUMPROP(I, J)=CUMPROP(I, J-1)+PROP(I, J); ]] 
IF(CUMPROP(I, $MXELEMS). NE. 1) [ 
OUTPUT I; (' INCORRECT PROPORTIONS GIVEN FOR MEDIA ', I3); ]] 
CALL EDGSET; 
------------------------------------------------------------------------- 
"STEP 4 INITIALIZATION-FOR-HOWFAR 
"PARTICLE SPLITTING PARAMETERS" 
$UINPUT(1) LSPLT; (13); 
"0 FOR NO SPLITTING, ELSE EQUALS NUMBER OF SPLITS" 
NSPLT = 0; 
IF(LSPLT. NE. 0) ["DO ONLY IF SPLITTING TURNED ON" 
NSPLT=LSPLT-1; ] 
DO IRL=1, $MXREG [IRSPLT(IRL)=0]; 
"SPLITTING TURNED ON IN REGIONS 3,5 & 10" 
IRSPLT(5) = 1; 
"TFILT; THICKNESS OF FILTER" 
"FSD FOCUS-SKIN-DISTANCE" 
"TBODY BODY THICKNESS Of 
"TGAP DISTANCE FROM LOWER BODY SURFACE TO SCREEN " 
"TPHOS PHOSPHOR THICKNESS " 
"TCONT LENGTH OF CONTRAST CYLINDER 
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"RCONT RADIUS OF CONTRAST CYLINDER 
"DCONT DEPTH OF CONTRAST CYLINDER 
$UINPUT(1) 
TFILT, DUMP, FSD, DUMP, TBODY, DUMP, TGAP, DUMP, TPHOS, DUMP, 
TCONT, DUMP, RCONT, DUMP, DCONT; (7(F7.4,1 1), F7.4); 
"PLANE DEFINITION - ALL PERPENDICULAR TO Z AXIS" 
DO J=1,8 [ 
PCOORD(1, J)=0.0; PCOORD(2, J)=0.0; 
PNORM(1, J)=0.0; PNORM(2, J)=0.0; PNORM(3, J)=1.0; ] 
PCOORD(3,1)=0.0; PCOORD(3,2)=TFILT; PCOORD(3,3)=FSD; 
PCOORD(3,4)=PCOORD(3,3)+TBODY; PCOORD(3,5)=PCOORD(3,4)+TGAP; 
PCOORD(3,6)=PCOORD(3,5)+TPHOS; 
PCOORD(3,7)=FSD+DCONT; PCOORD(3,8)=PCOORD(3,7)+TCONT; 
CYRAD2(1)=RCONT*RCONT; 
n---------------------------------------------------------------------n 
"STEP 5 INITIALIZATION-FOR-AUSGAB 
----------------------------------------------------------------------- 
MXNP = 0; 
ENABS = 0; " ZERO ABSORBED ENERGY COUNTERS 
ENENT = 0; 
ENSCON = 0; 
$UINPUT(1) ENSBAK; (15); 
RADIN = 1.02*RCONT*(FSD+TBODY+TGAP)/(FSD+DCONT); 
RADOUT = 0.98*(FSD+TBODY+TGAP)*TAN(ANGLE); 
RADIN2 = RADIN * RADIN; 
RADOUT2= RADOUT*RADOUT; 
RCONT2 = RCONT * RCONT; 
11---------------------------------------------------------------------11 
"STEP 6 DETERMINATION-OF-INICIDENT-PARTICLE-PARAMETERS 
--------------- 
- ----------------------- 
to 
"DEFINE INITIAL VARIABLES FOR HIGH ENERGY BEAM OF e- NORMALLY 
INCIDENT" 
"ON THE SLAB" 
IQIN=O; " INCIDENT CHARGE - PHOTONS" 
/XIN, YIN, ZIN/=0.0; " INCIDENT AT ORIGIN" 
IRIN=2; " STARTS IN REGION 2" 
WTIN=1.0; " WEIGHT =1 SINCE NO VARIANCE REDUCTION USED" 
11 
-------------------------------------------------------------- ------t1 
"STEP 6B INITIALISATION FOR SELECTION FROM ENERGY SELECTION 
"INITIALISATION OF ARRAY ELEMENTS TO ZERO " 
DO I=1, $KV[ 
IRAWDATA(I)=0; ISUMDATA(I)=0; SPECTRUM(I)=0; ] 
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"KV SPECTRUM DATA (GENERATED BY BIRCH-MARSHALL PROGRAM) 
READ IN" 
"IRAWDATA ARRAY CONTAINS NUMBERS OF PHOTONS AT EACH 
ENERGY " 
"SUMDATA ARRAY CONTAINS CUMULATIVE TOTALS OF PHOTONS 
OPEN (2, 'ESPEC. DAT', STATUS='OLD'); 
READ (2,: formlab: ) IRAWDATA(1); 
ISUMDATA(1) = IRAWDATA(1); 
DO I=2, $KV[ 
READ (2, : formlab: ) IRAWDATA(I); 
ISUMDATA(I) = IRAWDATA(I) + ISUMDATA(I-1); ] 
: formlab: FORMAT(F30.6); 
"SPECTRUM ARRAY CONTAINS DATA NORMALISED TO A TOTAL OF 1 
PHOTON" 
FACTOR = ISUMDATA($KV); 
DO I=1, $KV[ 
SPECTRUM(I) = ISUMDATA(I)/FACTOR; ] 
"INPUT FILE CLOSED" 
CLOSE (2); 
11-----------------------------------------------------------------11 
"STEP 7 SHOWER-CALL of 
to to 
$UINPUT(1) NCASE; (19); "INITIATE THE SHOWER NCASE TIMES" 
DO I=1, NCASE[ $SELECT DIRECTION; $SELECT ENERGY; 
CALL SHOWER(IQIN, EIN, XIN, YIN, ZIN, UIN, VIN, WIN, IRIN, WTIN); 
OUTPUT I, MXNP; (I8, ' ', 18); ] 
11-------------------- 
------------------------11 
"STEP 8 OUTPUT-OF-RESULTS 
........ 
------- ---------------------------- -------------- 
OUTPUT ENABS, ENSCON, ENSBAK; ('0 ABSORBED ENERGY IS ', E10.4/, 
'0 SCREEN DETAIL IS ', E10.4/, '0 SCREEN BACKGROUND IS ', E10.4); 
OPEN(3, 'RESULTS'); 
CONT =1- (ENSCON/RCONT2)/(ENSBAK/(RADOUT2-RADIN2)); 
$UOUTPUT(3) ENABS, ENSCON, ENSBAK, CONT; (' ABSORBED ENERGY = 
', E10.4/, 
' CONT EXP = ', E10.4/, 'BKGD EXP = ', E10.4/, 'CONTRAST = ', E10.4); 
CLOSE(1); 
CLOSE(3); 
STOP; END; "END MAIN ROUTINE" 
11 ********#********************#*#************#***#********* 
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n #*####*##############################*#*#*###*#*########## 
11************************************************************* 
SUBROUTINE HOWFAR; 
n############################################################# 
########', 
COMIN/CYLDTA, PLADTA, STACK, EPCONT, GEOM, US ER/; 
IRL = IR(NP); 
IF (IRSPLT(IRL). EQ. I. AND. IRL. NE. IROLD. AND. IQ(NP). EQ. O. AND. W(NP). GE. O)[ 
$PARTICLE-SPLITTING; ] 
IF(IR(NP) = 7) [IDISC=1; 
"TERMINATE THIS HISTORY: IT IS BEYOND THE PHOSPHOR"] 
ELSEIF(IR(NP) = 1) [IDISC=1; 
"TERMINATE THIS HISTORY: IT IS REFLECTED TOWARDS 
SOURCE"] 
ELSEIF(IR(NP) = 2) [$PLAN2P(2,3,1,1,1; 1); 
"INSIDE FILTER "] 
ELSEIF(IR(NP) = 3) [$PLAN2P(3,8,1,2,2, -1); 
"BETWEEN FILTER & BODY"] 
ELSEIF(IR(NP) = 8) [$PLANE1(7,1, IHIT, TPLN); 
IF (IHIT=1)[ 
$FINVAL(TPLN, XF, YF, ZF); 
IF ((XF*XF + YF*YF). GE. CYRAD2(1)) 
[IRNXT=4; ] ELSE [IRNXT=10; ] 
$CHGTR(TPLN, IRNXT); 
I 
ELSEIF (IHIT=O)[ 
$PLANE 1(3, -1, IHIT, TPLN); 
IF (IHIT=1)[ $CHGTR(TPLN, 3); ] 
"IN BODY" 1 
ELSEIF(IR(NP) = 10) [$CYLNDR(1,1, IHIT, TCYL); 
IF (IHIT=1)[ $CHGTR(TCYL, 4); ] 
$PLAN2P(8,9,1,7,8, -1); 
"IN CONTRAST CYLINDER"] 
ELSEIF(IR(NP) = 4) [$CYLNDR(1, O, IHIT, TCYL); 
IF (IHIT=1)[ $CHGTR(TCYL, 10); ] 
$PLAN2P(8,9,1,7,8; 1); 
"IN BODY "] 
ELSEIF(IR(NP) = 9) [$PLANE 1(4,1, IHIT, TPLN); 
233 
IF (IHIT=1)[ $CHGTR(TPLN, 5); ] 
ELSEIF (IHIT=O)[ 
$PLANEI(8; 1, IHIT, TPLN); 
IF (IHIT=1)[ 
$FINVAL(TPLN, XF, YF, ZF); 
IF ((XF*XF + YF*YF). GE. CYRAD2(1)) 
[IRNXT=4; ] ELSE [IRNXT=10; ] 
$CHGTR(TPLN, IRNXT); 
I 
"IN BODY" I 
ELSEIF(IR(NP) = 5) [$PLAN2P(5,6,1,4,9; 1); 
"BETWEEN BODY & PHOSPHOR"] 
ELSEIF(IR(NP) = 6) [$PLAN2P(6,7,1,5,5, -1); 
"INSIDE PHOSPHOR"] 
RETURN; 
END; "END OF SUBROUTINE HOWFAR" 
n###########*#****##*#*#*############*##*########*####*####### 
SUBROUTINE AUSGAB(IARG); 
n############################################################# 
it it 
" In this AUSGAB routine we find the energy absorbed in regions 4, 
"8&9 (ie the body) and also the energy absorbed in the screen 
" both behind and beside the contrast detail. to 
of if 
#######n 
COMIN/EPCONT, GEOM, SCORE, STACK/; " WE USE EDEP FROM EPCONT 
RCONT FROM GEOM 
ENSCORE FROM SCORE 
"IR(NP) & IARG FROM STACK 
IF (NP. GE. MXNP) [MXNP = NP; ] 
IF (IARG. LE. 4) [ 
IF (IR(NP). EQ. 8)[ 
ENAB S=ENAB S+EDEP *W T(NP); 
IF ((Z(NP). LE. FSD+1.0). AND. (X(NP)*X(NP)+Y(NP)*Y(NP). LE. 1.0)) 
[ENENT=ENENT+EDEP * WT(NP); ] 
ELSEIF ((IR(NP). EQ. 4). OR. (IR(NP). EQ. 9))[ 
ENABS=ENABS+EDEP*WT(NP); ] 
ELSEIF (IR(NP)=6)[ 
IF (X(NP)*X(NP)+Y(NP)*Y(NP). LE. RCONT2) [ 
ENSCON=ENSCON+EDEP*WT(NP); ] 
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ELSEIF (X(NP)*X(NP)+Y(NP)*Y(NP). LE. RADOUT2). AND. 
(X(NP)*X(NP)+Y(NP)*Y(NP). GE. RADIN2)[ 
ENSBAK=ENSBAK+EDEP * WT(NP); ] 
I 
RETURN; END; "END OF AUSGAB" 
n#*####*######**##**#**#*#**####*#########*#######*#########*# 
#*###n 
SUBROUTINE EDGSET; 
****sýý 
" The flag IEDGFL(IR) contains the atomic number of the medium for " 
" each region (IR), or it contains zero in order to disable K-edge 
" fluorescence for that region. The cross sections and energies 
" are from: E. Storm and H. I. Israel, At. Data and Nucl. Data 
Tables 7 (1970) 565. " 
K-edge fluorescent yields are from: Lederer et at, Table of the 
of Isotopes (6th Edition). 
.. ************************************************************* 
*####n 
; COMIN/EDGE, MEDIA, PHOTIN, MISC/; 
DIMENSION EALF(100), EBET(100), OMEG(92), PHOTOK(100), PKA(100); 
it------------------------------------------------------------------' 
"Average photon energies (EALF) (L -> K electron transitions). 
of (Table 5 of Storm and Israel) " 
DATA EALF/0. , 
0. 
, 
0.054,0.109,0.184,0.297,0.393,0.524, 
0.675,0.849,1.041,1.255,1.487,1.739,2.014,2.307, 
2.622,2.957,3.312,3.690,4.088,4.508,4.949,5.411, 
5.895,6.400,6.925,7.472,8.041,8.631,9.243,9.876, 
10.532,11.210,11.907,12.630,13.375,14.142,14.933,15.746, 
16.584,17.443,18.327,19.235,20.167,21.122,22.103,23.108, 
24.13 8,25.192,26.272,27.378,28.510,29.667,30.851,32.062, 
33.297,34.564,35.858,37.179,38.528,39.906,41.313,42.750, 
44.218,45.714,47.242,48.801,50.392,52.014,53.670,55.3 56, 
57.078,58.832,60.620,62.443,64.303,66.200,68.133,70.103, 
72.113,74.159,76.246,78.378,80.547,82.757,85.018,87.321, 
89.662,92.050,94.491,96.977,99.516,102.10,104.74,107.44, 
110.20,113.03,115.93,118.89/; 
it------------------------------------------------------------------ 
"Average photon energies (EBET) (M -> K electron transitions). 
it (Table 5 of Storm and Israel) " 
DATAEBET/0. , 0. , 0. , 0. , 0. , 0. , 0. , 0. 0. , 0. , 0. , 0. , 0. , 1.838,2.142,2.468, 2.817,3.191,3.589,4.012,4.459,4.931,5.427,5.947, 
6.492,7.059,7.649,8.265,8.907,9.572,10.263,10.983, 
11.730,12.503,13.300,14.126,14.980,15.859,16.767,17.700, 
18.661,19.648,20.785,21.705,22.778,23.878,25.008,26.166, 
27.354,28.573,29.821,31.103,32.414,33.757,35.131,36.535, 
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37.966,39.431,40.93 0,42.460,44.024,45.622,47.253,48.918, 
50.618,52.352,54.123,55.930,57.772,59.652,61.572,63.531, 
65.529,67.564,69.642,71.759,73.919,76.121,78.367,80.656, 
82.991,85.370,87.796,90.273,92.794,95.365,97.989,100.66, 
103.39,106.17,109.01,111.90,114.85,117.86,120.93,124.08, 
127.29,130.58,133.96,137.41/; 
------------------------------------------------------------------' 
"Fluorescent yields (OMEG) (probability to get fluorescent photon 
" per K-shell vacancy. (Table III. IV from Bambynek et al) it 
DATA OMEG/0. , 
0. 
, 
0. 
, 
0. 
, 
0. , 
0. 
, 0. , 
0. 
0. , 0. , 0. , 0. , 0.0357,0.0470,0.0604,0.0761, 0.0942,0.115 0.138 0.163 0.190 0.219 0.250 0.282 , 0.314 0.347 0.381 0.414 0.445 0.479 0.510 0.540 , 0.567 0.596 0.622 0.646 0.669 0.691 0.711 0.730 , 0.748 0.764 0.779 0.793 0.807 0.819 0.830 0.840 , 0.850 0.859 0.867 0.875 0.882 0.889 0.895 0.901 , 0.906 0.911 0.915 0.920 0.924 0.928 0.931 0.934 , 
0.937 0.940 0.943 0.945 0.948 0.950 0.952 0.954 , 
0.956 0.957 0.959 0.961 0.962 0.963 0.964 0.966 , 
0.000 0.968 0.000 0.000 , 0.000 , 0.000 , 0.000 , 0.000 , 
0.000 0.000 0.000 , 0.976/; 
------ ------------------------------------------ ------------------ 
"Probability for the removal of a K-electron by PE effect (PHOTOK) 
" =(K-shell PE cross section)/(total PE cross section). 
it (Table 8 of Storm and Israel) 
DATA PHOTOK/1. J. I. J. , 
1. I. J. J. 
1. J. , 
0.928,0.922,0.916,0.911,0.907,0.903, 
0.900,0.896,0.893,0.890,0.888,0.885,0.883,0.880, 
0.878,0.876,0.874,0.872,0.871,0.870,0.869,0.867, 
0.866,0.864,0.863,0.861,0.859,0.858,0.856,0.855, 
0.853,0.852,0.850,0.848,0.846,0.844,0.843,0.841, 
0.840,0.839,0.837,0.836,0.835,0.833,0.832,0.830, 
0.828,0.827,0.825,0.824,0.823,0.821,0.820,0.818, 
0.817,0.815,0.814,0.813,0.812,0.811,0.809,0.807, 
0.805,0.803,0.801,0.800,0.798,0.796,0.794,0.792, 
0.790,0.788,0.786,0.784,0.782,0.780,0.778,0.776, 
0.774,0.772,0.770,0.767,0.764,0.762,0.759,0.756, 
0.753,0.751,0.749,0.746/; 
------------------------------------------------------------------- 
"Relative probability of a K-alpha photon emission (PKA) 
" =(K-alpha intensity)/(K-alpha intensity + K-beta intensity). 
to (Table 6 of Storm and Israel) 
DATA PKA/1. J. J. J. J. J. J. J. 
1. J. , 1. J. J. J. , 1.0.955 , 
0.940 0.924 0.914 0.904 0.901 0.898 , 0.8965,0.895 , 0.894 0.893 , 0.8925,0.892 0.891 , 0.890 , 0.8875,0.885 , 0.8825,0.880 0.878 0.876 0.874 0.872 , 0.8685,0.867 , 0.865 0.863 0.861 0.859 , 0.8575,0.856 , 0.8545,0.853 , 0.852 0.851 , 0.8495,0.848 0.847 0.846 0.845 0.844 , 0.843 0.842 0.841 0.840 0.839 0.838 , 0.8365,0.835 , 0.8345,0.834 0.833 0.832 , 0.8315,0.831 0.830 0.829 , 0.828 0.827 , 0.8265,0.826 , 0.8255,0.825 , 0.8245,0.824 , 
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0.823 , 0.822 , 0.8215,0.821 , 0.8205,0.820 0.819 0.818 , 0.8175,0.817 , 0.8165,0.816 0.815 0.814 , 0.8135,0.813 , 0.8125,0.812 0.811 , 0.810/; it- - --------- ---u 
to The following are in COMMON/EDGE/ (see macro definition): 
--------------------------------------------------------------------- 
" EKALPH is the energy of the K-alpha X-ray. it 
to EKBETA is the energy of the K-beta X-ray. it 
to BKR1 is the probability for a K-shell emission times the to 
of probability for a fluorescent photon emission due to an to 
it electron transition from the X -> K shell. to 
to BKR2 is BKR1 times the probability that the fluorescent photon to 
of is due to an electron transition from the L -> K shell. to n------------------------------------------------------------------n 
to EBINDA is the energy of the K-edge (in COMMON/PHOTIN/). 
--------- 
-------------- ------------ ------- --------_--------------- 
it 
OUTPUT ; (' OUTPUT FROM SUBROUTINE EDGSET: '/ 
'REGION MEDIUM NAME ', 
'AV. K-EDGE EKALPH EKBETA BKRI BKR2'/); 
DO JJ=1, $MXREG [DO KK=1, $MXELEMS [IZ=IEDGFL(JJ, KK); IMED=MED(JJ); 
IF IMED. GT. O. [ 
IF IZ. GT. O [ 
BKRI (IMED, KK)=OMEG(IZ)*PHOTOK(IZ); 
BKR2(IMED, KK)=BKR1(IMED, KK)*PKA(IZ); 
EKALPH(IMED, KK)=EALF(IZ)* I . E-3; EKBETA(IMED, KK)=EBET(IZ)* 1. E-3; 
OUTPUT JJ, (MEDIA(I, IMED), I=1,24), KK, (ELEM(IMED, I, KK), I=1,2), 
EBINDA(IMED), EKALPH(IMED, KK), EKBETA(IMED, KK), 
BKRI (IMED, KK), BKR2(IMED, KK); 
(1X, 13,1X, 24A1, IX, I3,1X, 2A1,1X, 1P5E10.2); 
] 
ELSE [ 
OUTPUT JJ, (MEDIA(I, IMED), 1=1,24), KK, (ELEM(IMED, I, KK), 1=1,2); 
(1 X, 13,1X, 24A1,1X, I3,1X, 2A1, ' -- K-EDGE FLUORESCENCE OPTION', 
'NOT ENABLED FOR THIS REGION --'); 
]] 
ELSE [OUTPUT JJ, IMED; (2(1X, I6), ' VACUUM'); ]]] 
RETURN; 
"END OF SUBROUTINE EDGSET" END; 
n##*###########*#####*#######*#################*******R#**#### 
#####n 
SUBROUTINE PHOTO; 
STANFORD LINEAR ACCELERATOR CENTER" 
K-EDGE VERSION -- 3 JUN 1984/1330" 
"******* SPECIAL VERSION FOR TREATING K-EDGE FLUORESCENCE 
n************************************************************* 
237 
*****It 
Programmers: W. R. Nelson and T. M. Jenkins (SLAC) 
"************************************************************* 
****#n 
This is a special K-edge version of an EGS4 subroutine that is 
" patterned after a method developed in 1978 by A. Clark (LBL) 
with the help of W. R. Nelson (SLAC). It requires subroutine 
" EDGSET (or equivalent for setting up the branching ratios and 
" fluorescent photon energies. if 
', ************************************************************* 
*****11 
; COMIN/DEBUG, EDGE, EPCONT, MEDIA, PHOTIN, SCORE, STACK, UPHIOT, USEFUL/ 
$ENERGY PRECISION PEIG; 
COMIN/RANDOM/; "LOCATED HERE TO AVOID FORTRAN 77 DIAGNOSTIC" 
PEIG=E(NP); 
$RANDOMSET RANDK; "DETERMINE WHICH TYPE OF ATOM HAS BEEN 
HIT " 
NN=1; 
WHILE (RANDK. GT. CUMPROP(MEDIUM, NN)) [NN=NN+1]; 
NUMEL=NN; 
IF(E(NP). LE. EKBIND(MEDIUM, NUMEL)) [EDEP=PEIG; IBLOBE=1; ] 
ELSE [ 
IF(IEDGFL(IR(NP), NUMEL). NE. O) [ 
$RANDOMSET BR; 
IF(BR. GT. BKR1(MEDIUM, NUMEL)) [ENEW=0.0; ] 
ELSE [ICOUNT=ICOUNT + 1; 
IF (BR. LE. BKR2(MEDIUM, NUMEL)) [ENEW=EKALPH(MEDIUM, NUMEL); ] 
ELSE [ENEW=EKBETA(MEDIUM, NUMEL); ]]] 
ELSE [ENEW=0.0; ] 
EDEP=EKBIND(MEDIUM, NUMEL)-ENEW; 
E(NP)=EDEP; 
IBLOBE=O; "FLAG INDICATING 'NOT' BELOW BINDING ENERGY" 
"END OF 'K-EDGE P. E. IS POSSIBLE' LOOP"] 
$AUSCALL($PHOTXAUS); 
IF(IBLOBE. EQ. 1) [E(NP)=PZERO; ] 
ELSE [IQ(NP)=-l; "PHOTOELECTRON (ALWAYS SET UP)" 
E(NP)=PEIG-EKBIND(MEDIUM, NUMEL)+PRM; 
IF(IEDGFL(IR(NP), NUMEL). NE. O) ["SET UP FLUORESCENT PHOTON" 
IF(BR. GT. BKR1(MEDIUM, NUMEL)) [RETURN; ] 
"HOWEVER, K-EDGE NOT CHOSEN ABOVE" 
NP=NP+1; 
E(NP)=ENEW; 
IQ(NP)=0; 
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"PHOTON COMES OFF ISOTROPICALLY" 
$RANDOMSET RNISO; 
COSTHE=2.0*RNISO-1.0; 
SINTHE=SQRT(1.0-COSTHE* COSTHE); 
U(NP)=0.0; V(NP)=0.0; W(NP)=1.0; "MAKES THINGS EASIER IN UPHI" 
CALL UPHI(2,1); 
$TRANSFER PROPERTIES TO (NP) FROM (NP-1); 
"END OF FLUORESCENT PHOTON SET UP"] 
"END OF 'SET UP PARTICLE(S)' LOOP"] 
RETURN; 
"END OF SUBROUTINE PHOTO" END; 
%E 
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Appendix C 
Introduction to MORTRAN 
MORTRAN is a structured language, implemented as a set of macros which are used by the 
macro processor to translate the language into FORTRAN. Extensions to the language may 
be made at any time with user-defined macros. The language exhibits the following features: 
" Free-field (column boundaries may be ignored). 
" Alphanumeric labels of arbitrary length. 
" Comments inserted anywhere in the text. 
9 Nested block structure. 
" Conditional statements which may be nested. 
" Loops which test for termination at the beginning or end or both or neither. 
" EXIT any loop. 
" NEXT of any loop. 
" Multiple assignment statements. 
" Conditional compilation. 
" Program listing features include automatic printing of nesting level and automatic 
indentation according to nesting level. 
" Abbreviations for simple input/ouput statements. 
" Interspersion of FORTRAN text with MORTRAN text. 
The coding rules that apply may be summarized as : 
" Terminate statements with a semicolon (; ). 
" Enclose comments in quotation marks ("). 
" Enclose labels in colons (: ). 
" Enclose character strings in apostrophes ('). 
" Blanks may be inserted freely except in labels, character strings and user defined 
macros. 
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C. 1 Structure of code 
Any valid FORTRAN statement becomes a valid MORTRAN statement when any 
continuation marks have been deleted and the statement is terminated by a semicolon. A 
sequence of MORTRAN statements (S1, S2, S3 etc) may be enclosed in square brackets ([S,; 
S2; S3; ] to give a block. Such blocks may be nested to any level. In the descriptions below, 
an arbitrary block is indicated by [... ]. 
Conditional statements may take the following forms, where e, f, and g are any logical 
expressions. 
IFe[... ] 
IF e [... ] ELSE [... ] 
IF e [... ] ELSEIF f [... ] ELSEIF g [... ] ELSE [... ] 
Loops may be expressed with the logical condition e tested at either the beginning or end 
of the loop: 
WHILE e [.. ] 
LOOP [... ] WHILE e; 
Tests may also be made at both ends of the loop: 
WHILE e [... ] UNTIL f; 
WHILE e [... ] WHILE f; 
UNTIL e [... ] WHILE f; 
UNTIL e [... ] UNTIL f; 
Control variables may also be used in loops, in the following formats: 
FOR v=eTOfBYg[... ] 
FOR v=eBYgTOf[... ] 
FORv=eTOf [... ] 
The other types of loop that may be written are: 
DOI=J, K, N[... ] 
and LOOP [... ] REPEAT 
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to escape from this last loop requires use of the EXIT statement or 
IF (e) EXIT; 
C. 2 Other Features 
The value of some expression or variable may be assigned to several variables in a single 
statement by writing 
Ip, q, r.... zl =e 
where p, q, r.... z are variables and e is an expression, which is assigned to each variable in 
turn. 
Whenever input or output is to the standard FORTRAN input or output units, the following 
input/output (i-o) abbreviations may be used. 
INPUT i-o list; (format list); 
OUTPUT i-o list; (format list); 
Relational operators may be expressed in the usual FORTRAN notation, or may be denoted 
by 
<' <=' =<' =' -. =' =>' J=' 1 
and logical operators by 
& (AND), ; (OR), and - (NOT) 
Macro definitions are written in the form 
REPLACE {pattern} WITH {replacement} 
The pattern may contain up to 9 formal parameters, each of which represents a variable 
lenght character string, and is denoted by the symbol #. The replacement may contain an 
arbitrary number of occurrences of formal parameters of the form {Pi} (i=1,2,... 9). During 
expansion of the macro, each formal parameter {P; } of the replacement part is replaced by 
the i-th actual parameter. An example of such a macro is: 
REPLACE {PLUS #; } WITH {{P, }={P, }+1; ) 
This macro would match, for example, the program text 
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PLUS A(I, J, K); 
and expand it to 
A(I, J, K)= A(I, J, K)+1; 
A number of `processor control directives' are available in MORTRAN, and these may be 
either column-one-restricted-directive which each begin with a '%' in column 1 and for 
which only 1 per line is recognized, and free-form directives which may be unlimited and 
appear anywhere on a line. The latter begin with an exclamation mark and end with a 
semicolon. 
C. 3 Further Reading 
The above summary gives an outline of the main features of MORTRAN programming, to 
aid in the understanding of the usercode given in Appendix B, for a reader familiar with 
FORTRAN. A more in depth analysis of the MORTRAN programming language is given in 
the SLAC-265 manual (Nelson et al, 1985). 
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Appendix D 
Clinical trial documents 
Trial of New Radiographic Technique for Paediatrics 
INFORMATION SHEET FOR PARENTS 
Recent European guidelines on diagnostic radiographic imaging in paediatrics recommend that 
additional copper filtration be used for performing x-ray examinations of children. This removes 
some low energy components of the x-ray beam, and should result in a lower radiation dose to 
the patient. 
The use of such an additional filter is to be investigated for a trial period at the Royal Victoria 
Infirmary, for fluoroscopic examinations of children up to 1 year old. This will involve placing 
a laminated sheet of copper under the child for the duration of the examination. No other 
changes in normal procedure will be involved, and no extra radiation exposure will be given. 
It is anticipated that use of the copper sheet will reduce the radiation dose received by the child 
during the examination. Radiation doses are already routinely monitored in the room in which 
the trial is to take place and this will continue, to assess the effect of the additional filter. 
The copper filter may be removed at any time during the examination should the clinical or 
radiographic staff experience any disatisfaction with the procedure, or should you wish it for any 
reason. 
You may decline for your child to participate in this trial, or withdraw at any time, without 
giving a reason and without incurring displeasure or penalty. 
The radiographer giving this form to you will be happy to answer any queries or provide further 
information that you might require. In the event of any problem or further query arising, please 
contact either Ms Claire-Louise Chapple or Dr Keith Faulkner at the Regional Medical Physics 
Department, Newcastle General Hospital (Tel. 0191 273 8811 x22400). 
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Trial of New Radiographic Technique for Paediatrics 
CONSENT FORM FOR PARENTS 
I ........................................................ 
have read the accompanying information sheet, and consent for 
...................................................... to be included in the trial of use of additional copper filtration during x- 
ray examination. 
signed .......................................... (parent/guardian) date ........................... 
witnessed by .......................................... 
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Trial of Additional Copper Filtration in Rm 11 
Image Quality Assessment 
Image Set Which set of images do you prefer? Are the images of satisfactory 
diagnostic quality? 
1 strongly slightly no slightly strongly neither A only B only both 
prefer A prefer A preference prefer B prefer B 
comments : 
2 strongly slightly no slightly strongly neither A only B only both 
prefer A prefer A preference prefer B prefer B 
comments : 
3 strongly slightly no slightly strongly neither A only B only both 
prefer A prefer A preference prefer B prefer B 
comments : 
4 strongly slightly no slightly strongly neither A only B only both 
prefer A prefer A preference prefer B prefer B 
comments : 
5 strongly slightly no slightly strongly neither A only B only both 
prefer A prefer A preference prefer B prefer B 
comments : 
6 strongly slightly no slightly strongly neither A only B only both 
prefer A prefer A preference prefer B prefer B 
comments : 
7 strongly slightly no slightly strongly neither A only B only both 
prefer A prefer A preference prefer B prefer B 
comments : 
8 strongly slightly no slightly strongly neither A only B only both 
prefer A prefer A preference prefer B prefer B 
comments : 
9 strongly slightly no slightly strongly neither A only B only both 
prefer A prefer A preference prefer B prefer B 
comments : 
Name .................................................................... 
(optional) radiologist / radiographer / physicist 
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